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CHAPTER I. INTRODUCTION TO THIS THESIS 
I. Motives and definitions 
For a long time the investigations into the mechanisms of asthma were mainly 
focussed on allergy. Detailed studies were performed on allergens. lgE antibodies 
and mediator release from mast cells. However, it became apparent that allergy 
could not explain all aspects of asthmatic disease. The bronchial response to the 
non-allergic stimuli. such as physical and chemical agents, exercise, emotions and 
viral infections, was difficult to conceive on the basis of the lgE-mast cell model. 
Also, the allergen-induced bronchial response revealed unexplained features. 
The large molecules of most allergens hardly penetrate through the intact bronchial 
mucosa. Nevertheless bronchial obstruction occurs immediately after inhaling an 
allergen. Moreover the obtained reaction is not localized as could be expected in a 
pure lgE-mast cell reaction, but generalized. 
This implies that mechanisms which differ from the lgE-mast cell system may 
be important in the occurrence of an asthmatic reaction. Animal studies have 
shown that an imbalance in the autonomic nervous system may be an important 
factor. Various mechanisms seem to be involved in the overall reaction of the 
bronchi. 
The severity of the bronchial obstruction after non-allergic challenges varies 
between persons. This phenomenon is called bronchial responsiveness or reactivity. 
The degree of bronchial responsiveness is defined as the severity of the 
bronchial obstruction as indicated by lung function measurements, in relation to a 
standardized non-allergic stimulus. 
Bronchial hyperresponsiveness is defmed as a condition of increased reactivity 
of the bronchi i.e. the occurrence of bronchial obstruction after a stimulus in a dose 
which does not provoke such a reaction in most individuals. Bronchial hyper-
responsiveness is present in many asthmatic patients but not in most healthy 
subjects. 
Many different agents and actions are able to evoke exaggerated bronchial 
responses in susceptible subjects. Thus the state of hyperresponsiveness is mostly 
not confined to a particular stimulus. Stimuli which are allergens are often called 
specific, while other stimuli are nai:ned non-specific. 
Non-specific stimuli which are used to arouse bronchial responsiveness in 
experiments are: 
I. Physical: carbon dust (Widdicombe et al., 1962); cold air (Wells et al .. 1960; 
de Vries et al., 1964; Deal et al., 1980); fog (de Vries et al., 1964). 
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2. Chemical: Sulphur-dioxide (SO,) (Frank et al., 1962; Islam et al., 1972a; Nadel 
et al., 1965; de Vries et al., 1964). 
Nitrogen-oxide (NO,) (Orehek et al., 1967a). 
Ozone (Holtzman et al., 1979). 
Citric acid (Simonsson et al., 1967). 
Ammonia. 
Ether. 
3. Forced respiratory manoeuvres: hyperventilation, laughing (Nadel & Tierney, 
1961; Hafer & Cropton, 1968; Simmonsson et al., 1967; Gayrard et al., 
1975a; Orehek et al., 1975a; Kivity & Souhrada, 1981). 
4. Exercise. 
5. Natural occurring agents: 
histamine 
acetylcholine 
serotonin (Booy-Noord et al., 1969a) 
bradykinin (Simonsson et al., 1973) 
Prostaglandin F2, (Mathe et al., 1973: Patel, 1975a). 
6. Pharmacological agents: 
propanolol 
phenylephrine. 
2. Aims and scope 
The aim of the research described in this thesis is to get more insight into 
various aspects of bronchial responsiveness. The literature is reviewed and discussed 
in the first part of this thesis (chapters 2-5) and emphasis is placed on recent 
developments. In the review results from studies in animals and in humans are 
correlated as much as possible. 
Our own studies are designed to analyse various aspects of the mechanisms 
in bronchial responsiveness in children, as well as the role of bronchial responsive-
ness in the occurrence of symptoms. These studies, started in 1976, are divided 
into three groups: 
a. Dose- and time-response relationships using inhaled histamine. These are 
analysed and the methods for the measurement of bronchial responsiveness 
considered (chapter 6). 
b. Studies on mechanisms of: 
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L The relative contribution of the autonomic and the mast cell system in the 
pathogenesis of bronchial responsiveness using exercise is studied by means 
of protective agents (paragraph 7.1). 
2. The pattern of bronchial obstruction after exercise is evaluated with flow-
volume curves using air and helium/oxygen mixtures (paragraph 7.2). 
3. The feasibility of leucocytes as a model for hyperresponsiveness at a cellular 
level are performed by measuring the release of mediators (paragraphs 7.3 
and 7.4). 
c. The clinical significance of the relationship between bronchial responsiveness 
and the occurrence of bronchial obstruction after contact with allergens and 
after exercise (chapter 8). 
3. Remarks about terminology and methods 
The terms bronchial responsiveness and reactivity are both used to express 
the same phenomenon i.e. the degree of bronchial obstruction which occurs in 
relation to the dose of the trigger. We used mostly the term responsiveness. 
We have preferred the term bronchial obstruction instead of bronchoconstric-
tion because during the reduction in bronchial calibre it is impossible to separate 
the contribution of smooth muscle constriction. bronchial mucosal swelling and 
hypersecretion. In paragraph 7.1, 7.2 & 7.3 the term bronchoconstriction is used 
instead of bronchial obstruction because of editorial reasons. In the introduction 
and the review of the literature the term bronchoconstriction is used if we wanted 
to indicate smooth muscle contraction. 
The sympathetic system is often called the adrenergic system in the literature. 
We considered the terms synonymous. The term sympathetic is preferred by us, 
but we used the term adrenergic in the studies 7.1 and 7.2 for editorial reasons. 
We used inhaled histamine and exercise as stimuli to assess the non-allergic 
bronchial responsiveness. The severity of the bronchial obstruction due to each of 
both stimuli is considered as indicative for the degree of the bronchial responsi-
veness. This is justified in paragraphs 5.5, 7 .I and 8.1. 
The histamine threshold, or the provocation dose, is defined as the dose of 
the agonist after which a given degree of bronchial obstruction occurs. 
The term "'releasability .. is used according to the American literature. By 
releasability is meant the degree of mediator release in relation to the stimulus 
applied. 
We have used the term asthma instead of chronic non-specific lung disease 
15 
(CNSLD) (Fletcher et al., 1962) or in Dutch "Chronische Aspecifieke Respiratoire 
Aandoeningen" (CARA) (Orie et aL 1961). This is done because the studies are 
exclusively performed in children with chronic or recurrent reversible bronchial 
obstruction. Children with "pure" bronchitis without bronchoconstriction are not 
included. Characteristics of patients such as atopy, are only mentioned if relevant 
for the results. The children had neither detectable infections during the studies nor 
anatomical deformations of the respiratory system. 
The studies are performed in non-smoking children from the age of approxi-
mately 7 years on. The children with asthma are selected from the outpatient 
clinic of the Sophia Children's Hospital according to criteria mentioned in the 
various studies. The healthy children studied came from a school in the neighbour-
hood of the Sophia Children's Hospital. All children and their parents have given 
their consent being fully informed about the study. 
4. List of abbreviations 
BR 
BHR 
BRH 
BRE 
EIB 
PG 
SRS-A 
ECF-A 
cyclic AMP 
cyclic GMP 
H 1 receptor 
H, receptor 
D,O 
FVC 
PF 
FEVI 
MMEF 
MEFV25 
SGaw 
DSCG 
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= bronchial responsiveness 
bronchial hyperresponsiveness = increased bronchial responsive-
ness 
bronchial responsiveness to histamine 
bronchial responsiveness to exercise 
exercise-induced bronchial obstruction 
prostaglandin 
slow reacting substance of anaphylaxis 
eosinophilic chemotactic factor of anaphylaxis 
= cyclic 3'5' adenosine monophosphate 
= cyclic 3'5' guanosine monophosphate 
histamine type 1 receptor 
histamine type 2 receptor 
deuterium oxide 
forced vital capacity 
= peak flow 
forced expiratory volume in one second 
maximal mid-expiratory flow 
maximal expiratory flow at 25 percent of the.forced vital capacity, 
i.e. after 75 percent has been exhaled 
= specific airway conductance 
disodium cromoglycate 
CHAPTERS 2-5 
REVIEW OF THE LITERATURE ON BRONCHIAL 
RESPONSIVENESS 

CHAPTER 2. HISTORICAL VIEW 
The phenomenon of BHR was already observed in the first half of this 
century. Alexander and Paddock (1921) used pilocarpine, while Weiss et al. (1929) 
administered histamine as a stimulus. Both investigators used the intravenous route. 
Dautrebande et al. (1941) demonstrated BHR using aerosolised carbacholcholine. 
Most investigators formed the impression that BHR was related to asthma. 
Tiffeneau (1945) tried to quantify the phenomenon properly using a test in which 
the dose of the agonist that corresponds with a certain amount of bronchial obstruc-
tion was determined ("dose liminaire", later called threshold or provocation dose). 
As stimuli he used acetylcholine, histamine and citric acid. It appeared to him that 
the degree of BHR increases with the severity of asthma (1955, 1958). Other 
investigators reported similar observations using acetylcholine and histamine (Curry 
et al., 1946; Herxheimer, 1951). 
Curry administered the agonist intra-muscularly. Later on inhalation provo-
cation was general accepted as the best route of administration because it gives an 
immediate response and has a low risk compared to injection. 
Parker et al. (1965) used methacholine. an analog of acetylcholine with in-
creased stability. in a fixed dose. Also other agents appeared to elicit reactions 
in BHR i.e. serotonin, bradykinin (Herxheimer & Stresemann, 1961) and 
prostaglandin F2a (Mathe et al., 1973). 
Since 1960 de Vries. Orie and coworkers performed several studies on BR. 
They used mainly histamine, although other agents were applied as well. The 
threshold was used as criterion for BR. Reproducibility, changes in BR during 24 
hours (de Vries et al., l962a), comparison of different stimuli (de Vries et al., 1964, 
1968) and investigation of the mechanism by administration of pharmacological 
agents (Booy-Noord et al .• 1969b) were performed. They noticed "'profiles of BR" 
by studying BR induced by several agents and the effect of blockade in different 
categories of patients with chronic respiratory diseases (Gokemeijer, 1976). At 
present de Vries et al. are studying the role of the ~-sympathetic receptor and the 
effects of ~-blockade with propanolol (Koeter et al., 1981) on BR. 
Studies of the mechanisms involved in BHR have been done mainly in animals 
by several authors notably Widdicombe and coworkers and Nadel and cowerkers 
(paragraph 4.3). 
As the method of measuring BR got a wider application. the experience rose. 
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The impression that BHR was a characteristic of a group of related diseases which 
is called in the Nether lands Chronische Aspecifieke Respiratoire Aandoeningen 
(Cara or CNSLD) was confirmed. In these patients BHR appeared to be frequent, 
whereas it decreased in frequency in patients with chronic bronchitis or allergic 
rhinitis. In normal persons BHR is rare. 
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CHAPTER 3. REGULATION OF THE BRONCHIAL DIAMETER 
3.1. Introduction 
BHR can be considered as a disregulation of the diameter of the bronchi. The 
bronchial diameter is determined by the tone of the bronchial smooth muscle and 
the thickness of the mucosa. at least during tidal breathing. Bronchial obstruction 
in BHR seems to be mainly the result of smooth muscle action because its rapid 
appearance and the immediate effect of ~-sympathomimetics. Mucosal swelling 
and sputum secretion have probably a minor role in BR in most patients. 
The bronchial smooth muscle tone is increased by parasympathetic activity 
and decreased by ~-sympathetic activity, although other factors may also play a 
role. as will be discussed in this chapter. 
3.2. Bronchial Smooth Muscles 
a. General remarks 
Smooth muscle extend from the trachea to the alveolar ducts. It runs circularly 
and spirally (Miller, 194 7). Contraction results in obstruction of the airways. A 
relationship probably exists between the bronchial smooth muscle tone and the 
diameter of the bronchi. Hypertrophy and hyperplasia of the smooth muscle, which 
occur in asthmatic patients (Takizawa & Thurlbeck, 1971), must be of importance 
in BR. An increased amount of muscle is able to develop more tension and can 
presumably narrow the bronchi to a greater extent than muscle present in normal 
amounts. 
b. Receptors 
Contraction and relaxation of the smooth muscle of the tracheobronchial tree 
is dependent on neurogenic and humoral factors. These act through specific re-
ceptors on the bronchial smooth muscle walL 
A review is given by Fleisch (1973). The smooth muscle receptors can be 
divided in two groups according to their receptor mediated responses by an agonist. 
Group I are receptors which give rise to muscle contraction. They consist of 
muscarinic (parasympathetic), a-sympathetic, histamine1 (H1), serotonin. bradykinin, 
prostaglandin F 2a and angiotensin receptors. 
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Group II includes receptors which induce muscle relaxation. The most im· 
portant are ~-sympathetic. prostaglandin E and probably histamine2 (H2) receptors. 
Histamine receptors are discussed in paragraph 3.9. 
Many authors agree that the muscarinic. ~-sympathetic and H 1 receptors are 
involved in physiological and pathological processes. The roles of the other recep· 
tors mentioned is not clear and this is especially true for H 2 receptors. 
The distribution of receptors probably differs among various levels of the air-
way. This is illustrated by the observation of Eyre (1969) in sheep. Histamine 
produced contraction of the smooth muscle of the trachea and central bronchi, but 
relaxed those in the peripheral bronchi. Only the histamine-induced contractions 
of the trachea and the central bronchi could be blocked by a H 1 antagonist. Ahmed 
et a!. (I 980) and Chand et al. (I 980a) also found a difference in reactivity of central 
and peripheral airway smooth muscles to histamine and to carbachol in sheep and 
rhesus monkeys. 
c. Cyclic nucleotides and smooth musc[ejunction 
The importance of cyclic AMP and GMP as modulators of cell action in a 
variety of tissues is well established (Sutherland, 1970). Increase in the level of cyclic 
AMP by the administration of dibutyryl cyclic AMP can induce relaxation of a 
variety of smooth muscles, including that of the bronchi (Krye & Schultz, 1972). 
~-sympathetic agonists stimulate adenylate cyclase and hence cause increase 
of cyclic AMP and relaxation of smooth muscle tone. The intracellular concen-
tration of cyclic GMP has been shown to increase in relation with agents that pro· 
mote smooth muscle contraction~ such as acetylcholine and other cholinergic 
agents, a-sympathetic agonists and histamine (Schultz et al. 1973). However, both 
cellular responses~ increased smooth muscle tone and increased cyclic GMP were 
poorly correlated. Increase in cyclic GMP seemed to be secondary to an increase in 
the cytoplasmatic concentration of calcium (Schultz eta!., 1975). The role of cyclic 
GMP in the mechanism of smooth muscle contraction and relaxation is therefore 
not yet clear (Schulz, 1977). 
The precise model of action of the cyclic nucleotides in smooth muscle con· 
traction is not yet clear. It is thought that cyclic AMP affects the tonus by in· 
creasing the removal of calcium from the cytoplasm. 
Some studies on the involvement of cyclic nucleotides in smooth muscle pre-
parations were performed in vivo. Barnett eta!. (1978) measured in the dog lung in 
vivo the tissue concentrations of cyclic AMP and GMP which were correlated with 
the airway resistance and compliance as parameters of the bronchial smooth muscle 
tone. Their results differ from the results of the in vitro studies. but are difficult to 
interpret because of the complexity of the mechanisms involved in whole tissues in 
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vivo. Matsumura et al. (1976) studied the effect of administration of cyclic 
nucleotides in mice in ,._ hioh the ~-sympathetic function was blocked by propanolol. 
The bronchial obstruction after histamine or allergen inhalation was less after prior 
administration of cyclic AMP. Administration of cyclic GMP was shown to be 
without effect. Atkins et al. (1980) could not find a change in plasma levels of 
cyclic nucleotides in humans after challenge with allergen or methacholine. 
It is concluded that cyclic AMP and possibly cyclic GMP have a role in 
regulation of bronchial smooth muscle tone, although their precise involvement in 
vivo is not yet clear. However, it must be realised that determination of cyclic GMP 
is difficult to perform accurately. Thus many studies are of limited value. The role 
of the cyclic nucleotides is more extensively discussed in relation to mediator 
release (see par. 3.9). 
d. Dose-response relationship 
The log dose-response relationship which represents the tone developed in 
smooth muscle preparations in vitro in relation to the dose of an agonist~ has a 
S-shaped pattern. This indicates a small increase in response in the low dose range, 
followed by rapid increase in the middle dose range, and only a slight increase in 
the high range of doses (Stephens et al., 1968). 
The dose-response curve of bronchial smooth muscle is dependent on the in-
fluences of extra- and intra-cellular factors. In vitro and animal studies show that 
the sensitivity of the muscle to various stimuli increases after surgical or chemical 
denervation. This is seen not only in skeletal muscle, but also in smooth muscle 
preparations of different origins (Fleming et a!., 1973). The increase applies to 
sympathetic- and parasympathetic receptor stimulants, as well as to histamine. This 
supersensitivity results in a smaller dose of an agent required to produce a given 
response than under normal conditions. 
In the literature two main categories of sensitizations are distinguished. First, 
those concerning changes in the effective concentration of agonists at receptors 
(termed prejunctional) which give rise to a horizontal shift in the dose-response curve 
(figure I, type a). 
Secondly, those concerning changes in the responding tissue (muscle cells) 
beyond the initial combination of agonists and receptors (termed post-junctional), 
which are related to change in the magnitude of the response (figure I, type b) 
(Kalsner. 1974; Westphal eta!., 1975). Stephens et al. (1980) showed that a type b 
difference existed in the histamine dose-response curves of sensitized and control 
animal airway smooth muscles. These studies may have some relevance in vivo. 
However~ there is no evidence of a relationship between this phenomenon and BR 
at the present time. 
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The mechanisms of smooth muscle activity in histamine-induced bronchial 
obstruction is discussed in paragraph 4.3.2 and 4.4.2. 
Figure 1. 
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The relationship between the dose of the agonist and the response in 
contraction of bronchial smooth muscle in vitro. 
Sensitizations: type a prejunctional ~f 
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3.3. Sensory receptors 
The sensory receptors are generally considered to be part of the parasym-
pathetic nervous system (paragraph 3.4). These receptors are discussed in a separate 
paragraph because of the recent interest showed in them in the literature. 
The sensory receptors in the respiratory tract play a role in the regulation of 
the bronchial smooth muscle tone. the laryngeal calibre, the mucus secretion and 
the pattern of breathing. Also receptors located outside the respiratory system, for 
instance in the carotid body, may influence the bronchial smooth muscle tone 
(Nadel & Widdicombe. !962a). These receptors may induce additional effects such 
as increase in blood pressure (Nadel & Widdicombe, 1962b). The results of the 
studies in this field are complex and sometimes controversial. which probably 
reflects problems caused by difficult techniques and different animal species (Widdi-
combe. 1977). 
The sensory receptors are situated in the airways and can be identified by 
microscopic and histochemical techniques. Their location has been determined by 
stimulation studies in the nose and pharynx (Kaufman & Wright. 1969; Allison 
et a!.. 1974). larynx (Nadel & Widdicombe. 1962b; Boushey et al., 1974) and 
bronchi (Tomori & Widdicombe. 1969; Widdicombe. 1978). 
The nasal receptors generally cause sneezing and bronchodilatation. but may 
induce bronchial obstruction (Widdicombe, 1977). Receptors in the larynx may in-
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duce coughing. expiratory efforts. swallowing. bronchial obstruction. mucus secre-
tion, laryngeal constriction, hypertension and bradycardia (Phipps & Richardson, 
1976). 
The sensory receptors in the airways can be divided into three classes: 
a. Irritant receptors. These receptors are sensitive to inhaled substances. such as 
carbon dust. sulphur dioxide, ammonia. cigarette smoke. ethyl ether vapour and 
histamine (Simmonsson et a!., 1967; Mills et a!., 1969; Widdicombe, 1975). 
The irritant receptors are also stimulated by pulmonary congestion and oedema. 
anaphylaxis and microembolism (Mills et a!., 1969; Sellick & Widdicombe, 
1969), pneumothorax (Sellick & Widdicombe, 1969) and possibly hypocapnia 
(Coleridge eta!., 1978). 
The localisation of the irritant receptors extends from the trachea to the 
large bronchi. with a concentration at the carina and hili (Mortola et a!., 1975). 
Irritant receptors seem to be identical with the afferent nerve endings which lie 
between the epithelial cells of the mucosa (Widdicombe, 1977). The intercellular 
contact of the mucosal cells is accomplished by tight junctions (Diamond et a!., 
1978). Along with the decrease in tightness of the junctions, as occurs in 
mucosal damage. the irritant receptors become more exposed to the intra-
bronchial lumen. 
Stimulation of the irritant receptors causes rapidly adapting irregular 
discharges in the connecting nerve fiber which are myelinated and afferent in 
origin. The reflex actions of receptors in the trachea and main bronchi include 
constriction of smooth muscle, increase in mucus secretion. cough and laryngeal 
constriction. Those located deeper in the lung cause hyperpnoea rather than 
cough and do not increase secretion (Tomori & Widdicombe, 1969; Fillenz & 
Widdicombe. 1971). 
Other names for irritant receptors are rapidly adapting deflation or expira-
tion receptors. 
b. The stretch receptors. These are stimulated by distension of the lung and 
bronchi. They occur more in the extrapulmonary than in the intra-pulmonary 
airways and they seem to be located in the smooth muscles. After stimulation. 
by maintained inflation of the lungs, their myelinated nerves show a slowly 
adapting pattern of discharge. Their reflex action includes inhibition of inspira-
tion. which is known as the Hering-Beuer inflation and deflation reflex (Widdi-
combe. 1954). and a decrease in tracheal and bronchial smooth muscle tone. 
The stretch receptors are influenced by inhaled CO,. A low airway CO, 
concentration stimulates them (Bartlett & Sant'Ambrogio, 1976). 
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c. The juxta-pulmonary capillary receptors, or in short type J receptors are also 
named alveolar nociceptive. These receptors are assumed to be located especial-
ly in the respiratory bronchioles and alveolar ducts in the proximity of the 
pulmonary capillaries (Paintal, 1973). They are sensitive to mechanical forces 
and assumed to be stimulated by an increase in capillary or interstitial pressure. 
Under normal circumstances they seem to be of little biological significance. 
However. they may be triggered in cases of tissue damage as a result of 
accumulation of interstitial fluid or mediator release. 
Their reflex actions include apnoea or rapid shallow breathing, laryngeal 
constriction, hypotension and bradycardia (Paintal, 1973). The type J receptors 
seem to have a weak reflex bronchoconstrictive action (Karczewski & Widdi-
combe. 1969). 
Recently c-fibres have been described, which have some features in 
common with type J receptors (Coleridge & Coleridge, 1977). 
Because the irritant receptors are supposed to be the main sensory receptors 
involved in BR. some experiments are reviewed which elucidate their physiology. 
Direct stimulation of the receptors has been shown by Sampson eta!. (1975). 
In experiments in dogs, they recorded nerve discharges as a measure of irritant 
receptor activity and intra-tracheal pressure as a measure of the bronchial smooth 
muscle tone. These parameters were related to histamine and acetylcholine inhala-
tions. Acetylcholine caused a larger rise in tracheal pressure than an equimolar 
dose of histamine, but the irritant receptor discharge activity due to histamine was 
higher compared to that by acetylcholine. This discrepancy indicates a direct acti-
vation of the receptors by histamine but not by acetylcholine. After the inhibition 
of muscle contractions by a ~-sympathetic agonist, the tracheal pressure due to the 
inhalation of histamine dropped considerably (81 %), while the receptor discharge 
was only slightly lower (26%) than without a ~-sympathetic agonist. 
Vidruk et al. (1977) extended these experiments in dogs in which a fibre-optic 
bronchoscope was used to determine the location of receptor endings in the bronchi 
and to apply histamine and other stimuli directly on or near the receptor. The result 
was measured by means of the afferent nerve discharge and by observation of the 
bronchial diameter. Histamine stimulated most of the receptors~ whereas acetyl-
choline and buffer solution did not. Isoproterenol had only a slight effect on the 
response to histamine. 
The investigators concluded that smooth muscle contraction Was not essential 
for the stimulation of irritant receptors and that histamine could stimulate them. In 
these studies most receptors could be activated by one or more of the following 
agents: histamine, ammonia, ether and cigarette smoke. Histamine turned out to be 
the most consistent stimulus. It activated approximately 80 percent of the receptors. 
The activity in the afferent nerve began to increase about 10 seconds after the trigger-
ing of the receptor and simultaneously the tracheal pressure increased (Sampson et 
al.. 1975). Responses could repeatedly be obtained from the same receptor site: their 
action was not related to any phase of respiration. 
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Acetylcholine, used as stimulus in these experiments, was unable to activate 
the irritant receptors, although a clearcut bronchoconstricting action was observed. 
Dixon et al. (1979a, 1980a) studied the ability of histamine, acetylcholine and 
serotonin(= 5 hydroxytryptamine) to activate lung irritant receptors and to induce 
reflex bronchoconstriction. All agents given by aerosol and intravenously. produced 
increased discharge of the irritant receptors, increased total lung resistance and in-
duced a fall in dynamic compliance. The changes in lung function due to histamine 
and serotonin, were markly reduced by vagal cooling (a specific afferent fibre 
block). This points to the involvement of the afferent parasympathetic nerve system 
in the mechanism by which the triggered irritant receptors cause bronchial obstruc-
tion. This was not found with regard to acetylcholine. 
Histamine induced irritant receptor activity can be blocked by a HI antagonist 
(chlorpherniramine) and not by a H2 antagonist (cimetidine). This suggests that 
irritant receptors comprise or are linked to a HI receptor (Dixon et al., 1979b). In a 
further study these investigators showed that irritant receptors are sensitized by 
respiratory infections (Dixon et al .. 1979c). 
The permeability of the airway epithelium increases after exposition to ozone 
(Matsumura. 1970). histamine, methacholine (Boucher et al., 1978) and cigarette 
smoke (Simani et al., 1974). This could be concluded from the penetration depth of a 
dye into the intercellular spaces of the airway epithelium in various species. This 
suggests that the tight junctions have loosened and permit penetration for external 
influences towards the irritant receptors. 
Studies with agents that damage the bronchial epithelium, such as ozone, show 
that irritant receptors are more susceptible when the airway epithelium is disrupted 
(Boatman et al.. 1974). The possibility that irritant receptors are intrinsically 
modified by these agents is supported by the observation that their sensitivity to 
intravenous histamine is also increased in states of BHR (Dixon eta!., 1979c). Short 
term inhalation of a low concentration of ozone reveals a marked increase in BR 
to inhaled histamine in healthy dogs (Lee et al., 1977). This was abolished by both 
vagal cooling and atropine. which indicates that afferent and efferent parasym-
pathetic pathways are involved. 
As a bronchodilator aerosol had no protective effect, it was concluded that 
changes in bronchial smooth muscle tone were not involved. However, Linn et al. 
(1978) showed that the reactivity of bronchial smooth muscles increased after very 
high doses of ozone. Similar findings using ozone in atopic and healthy human 
subjects by Golden et al. (1978) and Holtzman et al. (1979) indicate that the path-
ways in humans are the same as in dogs in this respect. These observations are 
consistent with the hypothesis that ozone increases bronchial responses by altering 
the exposure or sensitivity of the sensory receptors. 
Other agents, which can damage the bronchial epithelium, may affect BR as 
well. A viral infection in non-asthmatic individuals temporarily increases the 
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threshold to inhaled histamine (Empey et aL 1976). Hall et al. (1978) did similar 
observations using methacholine. The BHR with methacholine during conditions 
causing epithelial damage has to be explained by other mechanisms than the irritant 
receptors. Other parts of the autonomic nervous system or bronchial smooth 
muscles are candidates in this respect. 
BR also increases after influenza vaccination as was shown by Ouelette et al. 
(1965) in asthmatics. Healthy and asymptomatic asthmatic subjects showed a 
temporarily increased BR to inhalation of nitrates after an acute respiratory infec-
tion by influenza A virus (Utell et al., 1980). 
An inhaled local anaesthetic can inhibit irritant receptors (Dain et al.. 1975). 
However. bupivacaine can also block the efferent nervous pathways as was shown 
in further studies in dogs and cats. This means that the blocking effect of local 
anaesthetics does not necessarily imply the sole involvement of the sensory recep-
tors. but may regard the impact of nervous fibres in general. Cross et al. (1976) and 
Thomson (1979) showed that the cough reflex to either tactile or chemical stimula-
tion was abolished by bupivacaine. Dain et al. (1975) found a significant drop in the 
bronchial response to histamine. in contrast to Cross and Thomson, who did not. 
This difference might be explained either by incomplete blocking or by the relatively 
limited involvement of sensory receptors in histamine-induced bronchial obstruction. 
3.4. Parasympathetic nervous system 
The efferent fibres of the parasympathetic nervous system in the respiratory 
tract run in the vagal nerve. The preganglionic fibres connect the central nervous 
system with the parasympathetic ganglia located in the walls of the airways. and 
then form post-ganglionic fibres. which supply bronchial smooth muscles and 
mucosal glands. These fibres terminate on the endorgans by means of muscarinic 
receptors (El-Bermani & Grant, 1975). The neurotransmitter of the muscarin recep-
tor is acetylcholine. which is inactivated by acetylcholine-esterase. The acetyl-
choline effect can be blocked by atropine and atropine-like substances. 
Many studies imply that the parasympathetic system is the most important 
regulator of the bronchial smooth muscle tone. Electrical stimulation of the vagal 
nerves causes bronchial obstruction as detected by lung function measurements and 
radiologic techniques (Olsen et al., 1965; Nadel et al., 1971). 
The norrnal bronchomotor tone will decrease after abolition of the vagal 
activity by vagotomy (Colebatch & Halmagyi, 1963) or by atropine (Nadel & 
Widdicombe, 1963), and thus results in bronchodilation. Vagal stimulation causes 
bronchial obstruction in the large and small bronchi, but not in the bronchioles 
and alveolar ducts (Colebatch and Halmagyi, 1963; Nadel et al .. 1971). The pattern 
of bronchial obstruction due to electrical stimulation of the vagal nerve is similar 
to that after inhalation of an allergen as was shown by Nadel et al. (1971) and by 
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Kessler et al. (1973), with tantalum bronchography in dogs. 
The evidence that vagal efferent pathways are involved in allergen-induced 
bronchial obstruction is supported by the fact that allergen-induced bronchial 
reactions can be inhibited by blocking of the vagal nerve activity by vagal section 
or application of atropine (Mills and Widdicombe, 1970; Gold et aL 1972; Yu 
eta!., 1972). 
Blocking the afferent parasympathetic fibre by cooling prevents bronchial 
obstruction induced by allergen or histamine inhalation in dogs (Gold eta!., 1972). 
When the antigen aerosol was administered to one lung~ airflow resistance increased 
in both lungs. If the vagus of the challenged lung was blocked by cooling, bronchial 
obstruction was inhibited in both lungs (Gold et al., 1972). 
These results show that efferent and afferent parasympathetic fibers are of 
critical importance for the regulation of the bronchial diameter under resting con-
ditions and after challenge with allergen or histamine and that this reflex spreads 
from its starting point over both lungs. 
3.5. ~-sympathetic system 
The pathways of the sympathetic or adrenergic system have been studied by 
histochemical techniques in several animals (El Bermani, 1978). The description 
in animals conforms in general terms to that in humans (Spencer & Leof. 1964; 
Richardson, 1979). 
The sympathetic pathways of the lung originate from the extra-pulmonary 
stellate ganglia in which preganglionic fibres synapse into postganglionic ones. The 
plexus of sympathetic nerves is associated with the bronchial arteries. 
Direct sympathetic innervation of the bronchial smooth muscles is scarce in 
animals (Mann et aL 1971) and not definitively demonstrated in man. Sympathetic 
fibres terminate on the parasympathetic ganglia (Jacobowitz et al., 1973) and 
probably in the mucosal glands (Spencer and Leof, 1964). 
The role of the sympathetic system in the regulation of the bronchial smooth 
muscle tone appears from the following observations. After section of the sym-
pathetic fibres in dogs, a modest bronchial obstruction appears, which indicates that 
a small degree of sympathetic dilator tone normally exists in the airways (Green & 
Widdicombe, !966; Woolcock eta!., 1969). 
Electrical stimulation of sympathetic fibre is followed by bronchodilation. This 
effect is abolished by ~-sympathetic antagonists (Woolcock eta!., 1969; Minatoya 
& Ludena, 1967). 
Sympathetic blockade, normally followed by bronchial obstruction (Castro 
de Ia Mata et al., 1962), was without effect when the parasympathetic action was 
inhibited (De-Kock, 1970; Me Cullock et al., 1967). 
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After section of the vagal nerves, stimulation of the sympathetic nerves has 
no effect. However. bronchoconstriction after parasympathetic stimulation is in-
hibited by stimulation of sympathetic nerves (Boushey et a!., 1980). 
Although the results of studies on the effect of the sympathetic system on the 
resting tone of the bronchial smooth muscle differ, most investigators assume that 
the magnitude of the effect depends upon the baseline parasympathetic tone and 
that under resting conditions the parasympathetic activity dominates that of the 
sympathetic. 
Woolcock eta!. (1969) tried to relate the action of the sympathetic and para-
sympathetic system to various airway levels. In dogs they recorded the airway 
resistance, as a measure of obstruction in the central bronchi, and frequency de-
pendent compliance as a measure of obstruction in the peripheral bronchi. The 
bronchial obstruction by parasympathetic stimulation after a S-sympathetic anta-
gonist (propanolol) was most pronounced in the central bronchi. They speculated 
that although the parasympathetic tone influences all levels of the airways, it was 
stronger counteracted by the sympathetic action in the peripheral than in the 
central bronchi. 
The sympathetic system consists of a scanty fibre network and of receptors 
which are not connected with the network and react to circulating agonists and 
antagonists. There is good evidence which support the presence of sympathetic 
receptors in bronchial smooth muscles (paragraph 3.2). Although the role of the 
sympathetic system in asthmatic patients seems to be pronounced, the anatomical 
pathways by which this is effected is not clear. Various explanations have been 
proposed. Smooth muscle function may be modified by a change in blood flow due 
to a change in sympathetic tone of the blood vessels. Also an overflow of transmitter 
from nerve endings in the blood vessels may reach the sympathetic system in the 
smooth muscle. Furthermore sympathetic innervation of the parasympathetic 
ganglia (Vermeire & Van Houtte, 1979) may interfere with the parasympathetic 
activity. Additionally circulating catecholamines released by the adrenal glands 
may act on the sympathetic receptors in the bronchial smooth muscle wall. Prob-
ably, several connections between the afferent and the efferent fibres and the sym-
pathetic and parasympathetic system seem to be operative. 
In 1948 Ahlquist proposed to divide the sympathetic receptors into a. and S 
types. according to their response to agonists and antagonists. Lands in 1967 
classified the S-receptors in two autonomous subgroups: S1• with mainly cardiac 
effects, and S,, having mainly bronchial and vascular effects. In the lung S, recep-
tors appear to predominate the S1-receptors. The precise role of S1-receptors in 
asthma is unclear and interconversion between both receptors is not established. 
Also subtypes in a-receptors are distinguished, a, and a2 but this is not discussed 
further on. 
Kunos and Szentivanyi (1968) suggested that a.- and S-receptors are con-
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formations of a single receptor site controlled by the metabolic milieu of the tissue. 
They reported that in frog hearts a reduction in temperature induces conversion of 
~-receptors into a-receptors. The original observation on the effect of temperature 
in shifting the balance of the sympathetic receptors has been extended to include 
similar shifts under a number of conditions associated with low metabolic activity, 
hypothyroidism, hypoxia (Voelkel et aL, 1981), muscarinic. cholinergic stimulation 
and adrenalectomy (Lefkowitz and Hofman, 1980). Although different opinions 
exist and the mechanism involved is unclear, changes between a- and ~-receptors 
may have biological significance. A change from ~- to a-receptors implicate an in-
crease in bronchial obstruction. For further discussion see paragraph 4.4.5. 
In conclusion, the ~,-sympathetic activity seems to be important in the reversal 
of the bronchial obstruction, although the precise mechanisms involved are not 
quite clear. The sympathetic fibres and the catecholamines output of the adrenals 
seem to cooperate. 
3.6. a-sympathetic system 
Presence of a-sympathetic receptors has been shown in the airways of different 
species (Castro de Ia Mata eta!., 1962). In man, Mathe et al. (1971) found evidence 
for bronchial obstruction induced by a-sympathetic agonists in vitro, but only in the 
presence of ~-sympathetic blockade. The stimulation of a-receptors by agonists in 
vivo was demonstrated in human bronchial smooth muscle by some investigators 
(Adolphson eta! .. 1971: Simmonsson eta!., 1972a), but not by others (Stone et al., 
1973). 
a-receptor activity can be demonstrated more easily in the smooth muscle of 
asthmatic patients than in smooth muscles of non-asthmatic persons (Kneussel & 
Richardson. 1978). Bronchial smooth muscle obtained from patients with asthma 
contracted when exposed to an a-sympathetic agonist (noradrenaline). This could be 
blocked by a specific a-blocking agent (phentolamine). In persons without bronchial 
hyperresponsiveness~ a-receptor activity in smooth muscle could only be found after 
pre-treatment with histamine. 
Simmonson et al. (1972a) found in asthmatic patients a large increase in 
a-receptor-induced bronchial obstruction after endotoxin, and much less so in 
patients without asthma. This observation may indicate a role of a-receptors in 
asthmatic reactions after infections. 
The role of a-receptor activation has been evaluated by studying the effects 
of a-agonists and antagonists in propanolol-, histamine- and exercise-induced 
bronchial obstruction. Prime et a!. (1972) found in humans, after blocking the 
~-sympathetic receptors with propanolol, that the administration of phenylephrine 
(an a-sympathetic agonist) caused bronchial obstruction. This could be prevented 
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by premedication with an a-antagonist. Also Patel and Kerr (1975) studied the 
effect of a-receptor blocking drugs in reversible airway obstruction. Inhalation of 
thymoxamine or phentolamine caused a smaller bronchodilatation than produced by 
a B-sympathetic agonist. The combination of the B-sympathetic agonist and the 
a-antagonist was more effective than each given alone. 
Activity of the a-sympathetic receptors seems to enhance the bronchial ob-
struction induced by histamine or exercise as can be concluded from studies in 
which they are specifically antagonized. More details are given in paragraph 4.3.6, 
4.4.6 and 5.3 respectively. 
Henderson et al. (1979) studied the a-sympathetic responsiveness by com-
parison of the constriction of the cutaneous vascular bed and the dilatation of the 
pupillary sphincter muscle by an a-sympathetic agonist (phenylephrine) in healthy 
individuals and patients with asthma and allergic rhinitis. In patients with asthma 
the a-sympathetic response was enhanced. 
It is to be concluded from these studies that a-sympathetic receptors do not 
appear to be prominent, but seem to be subordinate to B-sympathetic receptors. 
However. stimulation of a-receptors results in bronchial obstruction. They may have 
an additional role to the parasympathetic activity. especially in certain conditions. 
such as infections. However~ this is not definitely established. 
3. 7. Non-adrenergic or non-sympathetic inhibitory nervous system 
Several studies indicate the presence of a nervous system that diminishes the 
bronchial smooth muscle tone, but does not belong to the sympathetic system 
(Bando et al., 1973. Coburn & Tomita, 1973; Coleman & Levy, 1974). Electrical 
field stimulation of the trachea of guinea pigs in the presence of sympathetic and 
parasympathetic blockade resulted in a decrease of the obstruction induced by an 
allergen or histamine inhalation (Richardson & Bouchard, 1975). Also in man this 
phenomenon could be demonstrated. The electrical field stimulation-induced relaxa-
tion was neither blocked nor modified by sympathetic blocking agents. which 
indicates the non-sympathetic origin of this mechanism (Richardson & Beland, 
1976). However. nerves have to be involved, because of the blocking capacity of 
tetrodotoxin. 
The system which is thought to be responsible is called the non-adrenergic 
inhibitory nervous system, a similar system in the gastro-intestinal tract has been 
previously described (Crema et al., 1968; Burnstock & Costa, 1973). 
The relevance of the non-adrenergic nervous system is obscure. Because the 
anatomical distribution, the neurotransmitter involved and specific antagonists are 
unknown, the non-adrenergic inhibitory system function is difficult to study. 
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However. the possibility exists that it has an important additional role to the 
~-sympathetic system in the counteraction of bronchial obstruction. 
3.8. APUD-system 
The human tracheal epithelium, like that in other mammals. has been found to 
contain granulated cells with dense cores of 80 to 150 mm in diameter, which stain 
with silver techniques anQ show fluorescence with an amine technic (Lauwerijns 
et al., 1970). These are believed to be part of the APUD system (Cutz et al., 1975). 
They are named APUD for Amine Precursor Uptake and Decarboxylation. 
APUD cells are described to have neural and endocrine functions (Tischler 
et al., 1977). They have the ability to take up, decarboxylate and store 
aromatic-amine precursors, such as 5-hydroxytryptophan and dopa, synthesize 
aromatic-amine or polypeptide-secretory products or both. These cells are 
present in several endocrine organs, the gastro-intestinal tract and the bronchi. 
It has been proposed that their cells represent hypoxia sensitive chemorecep-
tors within the bronchial mucosa. They may produce amines or kinine-related sub-
stances which act upon the pulmonary circulation or modify the caliber of the air-
way lumen by an action on bronchial smooth muscle (Lauwerijns and Peuskens, 
1969). 
As they are relatively numerous and appear well-differentiated in fetal lungs 
(Cutz et a!., 1975), APUD cells may be particularly involved in regulation of fetal 
lung circulation or play a role in the cytodifferentiation of pulmonary epithelium. 
Their role in BR is unknown. 
3.9. Mediator release, cellular aspects 
Mast cells and basophilic leucocytes have the ability to release mediators, 
which can produce the typical signs and symptoms of the acute allergic reaction 
(Lichtenstein & Austen, eds., 1977; Daems, Quanjer & Reerink-Brongers, eds., 
1976; Pepys & Edwards, eds., 1979). 
This process is studied in mast cells obtained from chopped human lung tissue 
or by peritoneal lavage of animals, as well as in basophilic leucocytes. 
The mediator release process is non-cytoxic and is in many aspects similar to 
other secretory processes (Lichtenstein. 1978). Two stages are usually distinguished; 
the first is calcium dependent and the second is energy-dependent. This energy is 
supplied by anaerobic glycolysis. However, recent evidence points to a decrease in 
intra-cellular A TP-cyclic AMP concentrations in conjunction with calcium influx 
into the cell, suggesting a requirement of energy supplied by stores in the first stage 
of the release process (Mongar & Foreman, 1979). 
As in other secretory processes, the mediator release process is modulated by 
the intra-cellular levels of cyclic nucleotides (Sutherland, 1970). 
33 
Once the cell is sensitized fixing the Fe part of the lgE antibody molecule to 
its cell-bound lgE receptor, it is triggered when challenged with. the appropriate 
antigen or anti-lgE. However, other mechanisms may also trigger mediator 
release. In the lgE-induced release of mediators bridging of two cell-bound lgE 
molecules by antigen or anti-lgE takes place (Ishizaka et al., 1973; Ishizaka 1978). 
This leads to the accumulation of monomethylated lipids in the membrane. which 
open the calcium channels (Hirate & Axelrod, 1978). (Figure 2) 
Calcium uptake is required for the release of mediators in response to an 
antigen-IgE interaction at the membrane site (Foreman & Mongar. 1972). The 
calciuminflux results in a fall in intra-cellular concentration of cyclic AMP 
(Mongar & Foreman, 1979). This modifies the cyclic AMP control, resulting in an 
increase in the degree of assembly of the microtubules and the initiation of the 
secretory process (Gillispie & Lichtenstein. 1972). (Figure 3) 
Figure 2. 8 
Ca2+ pore lgE 
Schematic representation of the membrane events of mast cells in relation to the 
IgE receptor. 
Receptor units situated in the outer cell membrane are thought to regulate intra-
cellular processes. ~-sympathetic agonists increase intra-cellular cyclic AMP levels, 
whereas parasympathetic agonists increase intra-cellular cyclic GMP levels. Ade-
nylatecyclase, which is closely linked to the ~-sympathetic receptor, converts 
adenosine triphosphate into cyclic AMP in the presence of magnesium ions. Cyclic 
GMP is formed in a similar fashion by activation of the enzyme guanylate cyclase 
which is triggered by the parasympathetic (cholinergic) receptor. Both cyclic 
nucleotides are inactivated by phosphodiesterases to form inactive 51-AMP and 
51-GMP respectively. Thus the levels of cyclic AMP and cyclic GMP are influenced 
by the membrane-bound receptors on the one hand and the intra-cellular degrading 
enzymes on the other hand. 
In vitro studies with human leucocytes and lung tissue have shown that in-
creased concentration of intra-cellular cyclic AMP induced by ~-sympathetic 
agonists or inhibition of phosphodiesterases, depress mediator release (Lichtenstein 
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Schematic representation of the regulation of mediator release from mast cells. 
& Margolis, 1968; Orange et a!., 1971). This is in contrast to other secretory 
processes where an increase in the intra-cellular cyclic AMP facilitates the secretion 
of a hormone (Sutherland. 1970). 
Besides the S-sympathetic receptor other receptor entities have been described 
which influence the intra-cellular cyclic AMP concentration: 
1. a-sympathetic receptors are supposed to decrease the cyclic AMP concentra-
tion (Orange et al., 1971). 
2. H2 receptors increase cyclic AMP and create a negative feed-back system of 
histamine release. 
3. prostaglandin E2 receptors increase cyclic AMP concentration. 
These receptor-units have been shown to exert their actions on the cyclic 
AMP concentration via the enzyme adenylate cyclase. 
Enhancement of the intra-cellular cyclic GMP concentration without changing 
the intra-cellular cyclic AMP concentration has been shown to increase mediator 
release (Kaliner et al., 1973; Kaliner, 1977). Such an effect could be induced by 
acetylcholine or carbamylcholine via the parasympathetic receptor (Kaliner, 1977). 
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Also H, receptors, which stimulate mediator release are situated on mast cells 
and basophils. The factors and circumstances which determine the involvement of 
the H, or H2 receptors are not quite clear. H, receptors seemed to be linked to the 
cyclic GMP and H2 receptors to cyclic AMP system. (Platshon & Kaliner. 1978) 
Neither parasympathetic nor a-sympathetic stimulation augments mediator 
release from human leucocytes. but these actions do have effects in human mast 
cells. It is not clear whether parasympathetic and a-sympathetic receptors do not 
exist on basophils or are not functional. 
Each mast cell and basophil possesses hundreds of granules containing pre-
formed mediators. During the degranulation process the granules move to the cell 
surface along channels formed by assembly of microtubules and action of the 
microfilaments. Then granular and plasma membranes merge and fmally the 
granules are released (Padawar, 1979). The evidence for the involvement of micro-
tubules in a secretory phase includes the inhibitory effect of the microtubule binding 
agent colchicine upon both human leucocytes and rat mast cells and the enhancing 
effect of the microtubule stabilizing agent D20 upon both systems (Gillespie & 
Lichtenstein, 1972; Gillespie et a!., 1968). Cytochalasin B, which effects micro-
filaments, enhances release from human leucocyte suspensions (Colten & Gabbay, 
1972) and thus microfilaments are likely to be involved in the release process. 
The inhibitory effect of an increased amount of intra-cellular cyclic AMP 
might be linked up with decrease of calcium influx and with inhibition of the 
assembly of the microtubules (Gillespie, 1971). Also impaired fusion of granular 
and plasma membranes are observed as result of an increase in cyclic AMP 
(Kaliner & Austen, 1974a & b). However, the influence of cyclic GMP and the inter-
relationship between cyclic AMP and cyclic GMP in human tissues is not clear. This 
is partly due to the difficulties in accurate determination of cyclic GMP concen-
trations. 
The number of recognized mast cell-derived mediators involved in the patho-
genesis of allergic phenomenon has increased extensively in the past decade. These 
molecules are chemically and biologically diverse. They generate various histologic-
al and physiological phenomena (Wasserman, 1979). These mediators are partly 
liberated from the granules from the mast cells or basophils (primary mediators) and 
partly induced from other sources by the primary mediators. Their biological 
activities are mentioned in table 1. 
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Table I Mediators from mast cells and basophilic leucocytes 
Mediator 
Histamine 
Arachidon acid metabolites: 
prostaglandins 
leucotrienes: 
slow reacting substance 
of anaphylaxis (SRS-a) 
eosinophil 
chemotactic factor 
(ECF-A) 
neutrophil chemotactic 
factor of anaphylaxis 
(NCF-A) 
platelet activating 
factor (PAF) 
bradykinin 
enzymes. such as: 
arylsulfatases 
~-glucuronidase 
supcroxidc dismutase 
heparin 
State in tissue 
preformed 
newly generated 
newly generated 
preformed? 
preformed 
newly generated 
precurser 
preformed 
preformed 
newly generated 
preformed 
Biological activities 
contracts smooth muscle. increases venular 
permeability. stimulates sensory receptors. 
modulates prostaglandin synthesis: sup-
presses mast cell and basophil mediator 
release. modulates chemotaxis. inhibits T 
lymphocytes. 
increases cardiac rate and force of contrac-
tion. augments gastric acid secretion. 
increases vascular permeability. 
contracts smooth muscle. 
contracts smooth muscle, 
increases vascular permeability 
attracts and deactivates Neutrophils 
attracts and deactivates neutrophils 
release platelet amines. aggregate and seques-
ter platelets. 
contracts smooth muscle. increases venular 
permeability. stimulates sensory receptors 
hydrolysis ofSRS-A 
cleaves glucuronide residues 
catabolizes superoxide (01-
induces anticoagulation, inhibits complement 
activation 
Two mediators will be discussed: Histamine, because of its central role, and 
the prostaglandins. because of recently developed insight into their relationship 
with SRS-A. 
Histamine 
Histamine is formed out of histidine. catalyzed by a specific L-histidine 
decarboxylase. Histamine is released from mast cells and basophils in a two step 
process: an expulsion of granules, followed by release of histamine from the 
heparin protein complex of the granule. 
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Histamine is metabolized in several ways. It is methylated in the presence of the 
enzyme histamine-N-methyltransferase and deaminated by histaminase. It is also con 
jucated to deoxyribose. The relative importance of the routes cari vary. The body 
appears to have an amazing capacity to destroy histamine. This is necessary because 
of the potentially lethal effects of histamine. 
In the blood of most species, including man, histamine is mainly present in the 
basophils. The amount of histamine in peripheral blood seems to correlate with the 
severeness of symptoms (Simonet a!., 1977). It is also related to the occurrence of 
bronchial obstruction induced by allergens (Bhat et a!., 1976) or methacholine 
(Atkins et a!., 1980). 
Histamine causes dilation of capillaries in the peripheral organs, resulting in 
pooling of blood in the capillary bed and a fall in systemic blood pressure. It also 
causes a substantial loss of plasma through the capillary epithelium leading to 
edema. Histamine also induces constriction of smooth muscle in organs such as 
bronchioles, uterus, ileum and spleen. Histamine promotes gastric acid secretion and 
is believed to have a role as a synapse transmitter in the central nervous system 
(Calcutt, 1976). 
The existence of two types of receptors, H1 and H2 receptors, was first estab-
lished by Black eta!. (1972). The H 1 receptor functions are inhibited by the classic 
anti-histamines. They are predominantly located in smooth muscle, glands and mast 
cells of the respiratory system and the skin. The H2-receptors are blocked by 
burimamide or cimetidine, but not by the classic anti-histamines. These H2 receptors 
are present in the stomach and also in theJung (Black et a!., 1972). Mast cells and 
bronchial smooth muscles appear to have H2 receptors in addition to H 1 receptors. 
H 1 receptor stimulation produces smooth muscle contraction and vasodilation, while 
triggering of H2 receptors inhibits mediator release and smooth muscle contraction. 
For further discussion of histamine receptors see paragraph 4.4.1. 
Prostaglandins* 
PG's are not stored and the production is induced by the release of other 
mediators like histamine (Orehek et a!., 1973; Grodzinska et a!., !975). Tone in 
airway smooth muscle preparation from guinea pig in vitro has been attributed to 
release of PG (Farmer et a!., 19 7 4 ). 
PG's are formed from arachidonic acid. The enzyme cyclo-oxygenase 
catalyses the formation of endoperoxides, which can be transformed into throm-
boxanes and PG's. Several types of PG's are distinguished: PGF2 and PGD2 
* which are relevant in this respect. 
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(Wasserman et al., 1977), which give bronchial obstruction and PGE,, which induces 
bronchodilation. 
The lipoxy-genase pathway produces a group of intermediates. now called 
leucotrienes. These agents appear to be linked or are identical to SRS-A. This is 
based on similarities concerning leucocyte stimulation, physico-chemical characteris-
tics (Samuelsson et al., 1980a & b) and effects on the bronchial tissues (Hanna et 
al .. 1981). Various leucotrienes have been designated alphabetically. SRS-A from dif-
ferent sources seems to consist of variable amounts of leucotrienes C and D with 
leucotriene D as the main component of human lung SRS-A (Samuelsson, 1980a & 
b). Drazen et al. (1979) postulated that SRS-A is a selective constrictor of peripheral 
airways. Also leucotriene B can be generated and possesses chemotactic activity. It 
may be related or identical to ECF-A. 
Table 2 A simplified diagram of arachidonic metabolites 
phospholipids 
j --phospholipase 
arachidonic acid 
cycle-oxygenase 
pathway /~ lipoxy-genase pathway 
endoperoxides 
thromboxanes and 
prostaglandins 
/]"" 
F2a o, E2 
8 
allytic epoxide intermediate 
(unstable) 
leucotrienes 
c D 
!? 
ECF-A SRS-A 
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3.10. Release of mediators in vivo 
1. Distribution of mast cells 
The majority of mast cells are situated outside the basement membrane of 
the bronchial mucosa and are in close vicinity to bloodvessels and airway smooth 
muscle. Only a few (about 1% in the dog) are situated superficial to the basement 
membrane (Brinkman. 1968; Gold et al., 1977a). Histamine-releasing cells. prob· 
ably mast cells or basophils have been detected in the bronchial lumen of humans 
(Patterson et al., 1977). The number of mast cells per mm3 increases from the 
trachea to the peripheral bronchi. The amount of histamine in lung tissue is closely 
related to the distribution of the mast cells. Both are maximal in the peripheral air· 
ways (Gold et al .. l977a). 
2. Interactions between the release of mediators and other factors involved in 
bronchial obstruction 
It is striking that inhaled allergens can trigger release from mast cells located 
in the bronchial wall. This occurs about 30-60 seconds after the inhalation. Allergens 
are large (about 10 to 20 x 103 Dalton) and little diffusible molecules, which 
hampers a quick penetration into the bronchial wall. After the inhalation of radio-
labelled allergens which was followed by bronchial obstruction in guinea pigs, 
Richardson et al. (1973) could only find allergens on the surface but not in or under 
the epithelium of the bronchial mucosa. 
The bronchial reaction can be initiated by release of mediators from mast 
cells in the airway lumen (Patterson et aL 1977). These mediators may increase the 
permeability of the bronchial epithelium (Boucher et al., 1978). 
Subsequently, submucosal mast cells may be degranulated. and sensory 
endings may be stimulated thus causing a parasympathetic reflex. These mediators 
may also activate bronchial smooth muscle without involvement of nervous reflexes. 
Several observations support the involvement of the nervous system in the 
process of bronchial obstruction after the release of mediators in vivo. After the 
inhalation of allergens in the dog, bronchial obstruction was observed with tantalum 
bronchograms in all airways from the trachea to small bronchi (0.3 mm in diameter). 
The investigators concluded that the reaction was maximal in the peripheral bronchi 
and could be inhibited by cholinergic blockade with atropine (Kessler et al., 1973). 
Under essentially the same circumstances the number of mast cells and the amount 
of histamine decreased in the central but not in the peripheral bronchi (Gold, 
1977b). Thus the bronchial obstruction in the peripheral airways is probably not 
due to local mediator release. but results from a reflex induced action. Although 
histamine and other mediators may be carried via the circulation from the central 
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to the peripheral bronchi. it seems more probable that mediators trigger the para-
sympathetic reflex mechanism (see paragraph 3.4) which results in a generalized 
airway obstruction. 
A further argument for the involvement of the nervous systems in allergen-
induced bronchial reactions is the reduction in bronchial obstruction after blockade 
of the parasympathetic nerve (see paragraph 3.4). 
Mast cell release in vivo may be influenced by the autonomic nervous system. 
Mediator release from mast cells in vitro is modulated by changes in the levels of 
the cyclic nucleotides which are under control of the parasympathetic- and the 
sympathetic membrane bound receptors (see paragraph 3.9). Acetylcholine has been 
shown to induce release of histamine from rat mast cells (Fantozzi et a!., 1978). 
Kiernan (1975) has presented evidence for mast cell degranulation in cutaneous 
axon reflex vasodilatation in the rat. Gold (1977b) could not find degranulation of 
mast cells or release of histamine after methacholine or electrical stimulation of the 
nerves in animals. However, Atkins et a!. (1980) found in humans increase in 
arterial histamine levels after methacholine challenge. If the mast cells can be in-
fluenced by the autonomic nervous system, a mutual relationship exists. This can 
generate vicious circles~ which may explain severe and prolonged bronchial reac-
tions. 
Also the sympathetic activity has an impact upon the bronchial reactivity to 
allergen inhalation. After a ~-sympathetic antagonist the allergen-induced bronchial 
obstruction increases (Ouelette & Reed. 1967; Gold, 1977b). 
It may be concluded that in allergen-induced bronchial obstruction in addition 
to the role of the mast cells in the bronchial walt mediator release from intra-lumi-
nal mast cells. permeability of the bronchial epithelium and a vagally mediated re-
flex are important. The parasympathetic nerves seem to be responsible for modula-
tion and distribution of the signal generated by the mediator release from mast cells 
in vivo. It appears that parasympathetic hyperresponsiveness and ~-sympathetic 
hyporesponsiveness aggravates BR in relation to the inhalation of allergens. 
3.11. Mucus secretion and mucociliary transport 
Mucus is produced by mucosal goblet cells as well as submucosal glands. 
Because of their size and activity submucosal glands are believed to be the major 
contributors to the airway secretion (Reid, 1960). Most studies on mucus secretion 
are done in animals, but great differences between the mechanism of mucus secretion 
in animals and humans are unlikely (Gallagher eta!., 1975). 
Nadel and coworkers (1977) studied the influence of various agents on water 
and active ion transport in the tracheas of various species using a short circuit tech-
nique. radio-isotopes and micropipettes. Parasympathetic and the ~-sympathetic 
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stimulation increased mucus secretion. 
The effect of a-sympathetic stimulation was far greater than that of the ~-sym­
pathetic, parasympatholytic or histamine effect (Marin et a!., 1977). Sputum pro-
duction can also be induced by histamine and prostaglandin F2a (Lopes-Vidriero 
eta!., 1977). 
Mucociliary transport depends on the volume and viscosity of the sputum, on 
the effectiveness of ciliary activity and on the cough reflex. Parasympathetic agonists 
(Corssen & Allen, 1959; King eta!., 1979) and ~,-sympathetic agonists (Santa Cruz 
et a!., 1974) stimulate mucociliary transport in animals and man. After vagal 
blockade by atropine, King et a!. (1979) observed a decrease in mucus collection 
rate. Chronic stimulation of vagal receptors in airways may reflexly stimulate sub-
mucosal glands excessively and may cause hyperplasia of the glands. which may 
even increase bronchial reactions. These phenomena may play a role in the effector 
mechanism of hyperresponsive reactions, although this is not the most prominent 
contributor. Th~ a-sympathetic role in vivo in this respect is unclear, but may be 
important. 
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CHAPTER 4. BRONCHIAL RESPONSIVENESS TO VARIOUS STIMULI. 
PARTICULARLY HISTAMINE 
4. L Introduction 
In this chapter the role of the various factors which determine BR will be 
discussed with emphasis on the effect of histamine. The results of studies in animals 
will be discussed and an attempt will be made to correlate these with results in 
humans. 
The last paragraph will deal with tbe clinical and epidemiological consequences 
ofBR. 
4.2. Methods of measurement of bronchial responsiveness 
In order to determine a relationship between the dose of a bronchial challenge 
agent and the response both variables must be measured accurately. As differences 
in methodology may influence the results. the methods have to be standardized as 
much as possible. 
The following factors are of importance in the registration of BR: 
a. Choice of provocation agents 
Histamine and the acetylcholine derivates, methacholine and carbacholine. are 
currently used in the assessment of BR. Other agents are seldom used. 
In order to obtain a local action and to minimize side effects. provocation 
agents are generally given by inhalation (Curry et aL, 1946; Kang et aL, 1976). 
Witb the exception of exercise (see chapter 5) and hyperpnoea, other 
stimulants are more complicated to apply. Voluntary hyperpnoea is used by some 
investigators to test BR (Kivity & Souhrada, 1981). 
Recently, rapid breathing of cold air has proposed as stimulus in testing BR 
(Deal et a!., 1980). 
Histamine has an important role as a mediator in asthma according to our 
present view. Due to its relatively short lasting action~ histamine is unlikely to 
produce cumulative effects provided intervals of several minutes are allowed 
between inhalations (Orehek et a!., 1976b; study in paragraph 7.1). Histamine 
biphosphate solution, which is commonly used, is relatively stable and has virtually 
no side effects when used according to the methods applied in this country (see para-
graph 6.1). 
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Acetylcholine is the parasympathetic neurotransmitter acting on the muscarinic 
receptor. It is rapidly inactivated by cholinesterase. Methacholine and Carbachol@ 
are parasympathomimetic agents which produce their effects in the same way as 
acetylcholine. Cholinesterases have small effects on carbachol and only slowly in-
activate methacholine. Thus these agents have a relatively long lasting effect and 
thus cumulative dose response curves will be obtained after serial inhalations with 
short intervals. In most patients BR for histamine and acetylcholine are closely 
related (de Vries eta!., 1964; Gokemeijer, 1976; Juniper eta!., 1978). 
b. Delivery of the aerosols 
Challenges usually consist of serial doses of the stimulant, using not more than 
2-fold increments in dose with a controlled time interval between doses. To minimize 
the effects of an acid pH on the airways, it is appropriate to dissolve the agents in an 
aqueous diluent. A pH of 7 can be obtained by the addition of NaCI and 
NaHC03 (ATS News. 1980). 
Most investigators vary the dos<;! of the agonist by increasing the concentra-
tions keeping the volume of each inhalation constant, according to Tiffeneau et aL 
(1955) and de Vries eta!. (1964). 
The dose and distribution in the bronchi will be determined by the character-
istics of the nebulizer used (Ferron eta!., 1976) and also by patient factors like the 
breathing pattern and the presence of obstruction (Orehek et a!., 1977b). The 
distribution of the aerosol is further dependent on the particle size. Small particles 
penetrate deeper and are better retained than large particles. Particles of more than 
4 ll diameter tend to deposit in the delivery system and large airways (Ferron eta!., 
1976). Particles less than 0.4 ll in diameter have decreased deposition and tend to be 
exhaled. It has to be kept in mind that the relatively large particles, which are 
deposited in the central airways, will contain a much higher dose of agonist than the 
relatively small particles (Brain & V alberg, 1979). 
The goal of the distribution pattern has attracted little discussion. One can 
speculate that histamine deposited according to the distribution of the mast cells will 
immitate best the natural situation. Alternatively~ the pattern of deposition may have 
little importance because of the generalizing effect of the reflex mechanisms. The 
last concept is supported by Ryan eta!. (1981a) who found the same bronchial 
reaction when two different patterns of distribution with equal doses were used. In 
another study (Ryan et a!., 1981 b) the nebulizer output, but not particle size 
(between 1.3 and 3.5 !lM diameter) altered the response. 
Several methods of aerosol generation are currently in use: 
I. The continuous flow method with a closed system. The subject inhales the 
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agent containing aerosol continuously. If the subjects inspiratory air flow is at 
least equal to the flow of the aerosol, the amount generated during inspiration 
will be fully inhaled. The dose administered then equals the nebulizer output per 
time multiplied by the product of the subjects inspiratory time and the number 
of breaths during the provocation period. 
2. The intermittent flow method. The aerosol generation is performed by a unit 
which automatically triggers nebulization by the onset of inspiration and limits 
the duration of nebulization for a pre-set time, which should be within the 
first half of inspiration (Chai et a!., 1975; Cropp, 1975a; ATS News, 1980). 
An aerosol given early during inspiration tends to penetrate less deeply than 
when inhaled at the end of inspiration (Riley et a!., 1976). It is, however, not 
established whether this is an important factor to the bronchial reaction in-
duced by histamine inhalation. 
3. The continuous reservoir method. Orehek et a!. (1976b) pointed out that varia-
tions in inspiratory volume~ inspiratory flow and respiratory frequency alter 
the dose of aerosol reaching the bronchi. Inhalation of an aerosol of known 
concentration from a spirometer or a bag-in-box permits the accurate assess-
ment of the amount inhaled. The inhaled dose can be calculated by the stored 
aerosol concentration multiplied by the number and volumes of breaths (Orehek 
et a!., 1977; Utell et a!., 1979). 
The characteristics of the aerosols from the various delivery systems may be 
different. 
c. Condition of the subjects 
Various physiologicaL pathological and therapeutic factors may influence BR. 
I. Breathing pattern. Tidal breathing favors penetration of an aerosol in the 
peripheral airways and forced in- and expiration favors deposition in the central 
airways (Riley et a!., 1976). Breathing patterns applied are tidal breathing for 
some minutes (2') (Cockcroft et a!., 1977a), deep in- and expiration during a 
short time (1/ 2 minute) (Chai et a!., 1976) or a combination (Kerrebijn & 
Neijens. I 98 I). Forced inspiration may induce bronchial obstruction in some 
patients (Nadel et a!., 1961; Gayrard et a!., 1975a; Orehek et a!., 1976b). 
However. inhalation to total lung capacity may sometimes temporarily decrease 
bronchial obstruction (Ankin eta! .. 1979). 
2. Bronchial patency, as indicated by the baseline pulmonary function may in-
fluence the bronchial reponse (Love & Muir, 1976) and thus the assessment 
ofBR (de Vries, 1970; Orehek eta!., 1976b; Gokemeyer, 1976). 
However. the relationship between relative low initial lung function values 
and relative high degree of BR is generally rather weak (Cade & Pain, 1971; 
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Kerrebijn et al., 1977). but it may compromize comparisons of measurements 
in the case of wide differences in baseline bronchial conditions. 
3. Recent exposure to allergens (G6kemeyer, 1976; Zimmerman & Ulmer. 1977). 
respiratory infections and polluted air (see paragraph 4.4.3) may influence the 
response to bronchial provocation. 
4. Drugs administered prior to the test may result in a change in responsiveness. 
5. The circadian rhythm influences BR: the BR is at highest around 4 o'clock a.m. 
and at lowest about 4 o'clock p.m. (de Vries eta!., 1962a). 
These factors are discussed extensively in various reviews (Orie & Sluiter. 1961: 
Orie & Sluiter. !964; Orie & van der Lende, 1970; G6kemeyer, 1976: ATS News. 
1980) 
d. Measurement and calculmion of the response 
Several techniques are used to assess the bronchial response. For routine use 
bronchial obstruction can be registered by means of measurement of the pulmonary 
function. This may be performed with a forced expiration technique such as spiro· 
metry or flow-volume measurement. The PF, FEV1, MMEF or the end-expiratory 
flows (MEFV,) can thus be registered. They are highly reproducible (Cropp, !975a 
& b) but sensitive to forced respirations in some asthmatics. Alternatively. 
determination of airway resistance by body plethysmography is also used. The 
measurement is highly sensitive and requires no full inspiration nor forced expira-
tion. However. its value will be influenced by closure of the glottis which easily 
happens in children. Moreover the equipment is complicated to manage and 
expensive. 
The change in lung function indicating a significant bronchial obstruction, must 
exceed the intra-subject variability and has to be related to carefully obtained 
baseline values. The minimum changes which must be obtained before a test can be 
considered positive depend upon the parameter used, but are arbitrary. An example 
of criteria is given in ATS News (1980). 
Two factors can be calculated from the dose-response curve, according to 
Orehek et a!. (1977). The sensitivity to the provocation agent is determined by the 
dose which corresponds to a significant reaction ("the threshold"), while the reac-
tivity is given by the slope of the curve after the threshold ("the response rate''). 
With standardized methods the results concerning the thresholds are repro-
ducible (de Vries eta!., 1962; Juniper eta!., 1978; Habib et al., 1979). 
Several working committees are charged to produce guidelines for the stan-
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dardization of BR testing to help to obtain comparable results between different 
laboratories. In the U.S.A. the .. Guidelines of the programme directors of the 
Asthma and Allergic Disease Centers (AADC)'' were published in 1975 (Chai eta!., 
1975) and the "'ATS Guidelines for bronchial inhalation challenges with pharma-
cologic and antigenic agents'' appeared recently (A TS News, 1980). In Europe the 
''Working Group on Bronchial Hyperreactivity of the European Society for Clinical 
Respiratory Physiology'" is currently preparing guidelines for standardization 
(Kerrebijn, 1981). 
Because of differences in output and characteristics of the aerosol. use of the 
same nebulizer and inhalation technique would be preferable. Because it seems 
unlikely that this is feasible within a short time, a comparison of the results of a 
limited number of delivery systems and methods is a practical approach which will 
enable us to interrelate the results of various publications better than is possible at 
present. More studies are needed in this respect. 
4.3. Histamine-induced bronchial responses as studied in animal experiments 
4.3.1. Introduction 
Inhaled histamine causes bronchial obstruction by smooth muscle contraction 
produced by a direct effect on the H1 receptors and an indirect effect on irritant 
receptors and reflex mechanisms. 
4.3.2. Role of bronchial smooth muscles 
It has been shown that histamine contracts smooth muscles in vitro in a dose-
dependent way (Schild eta!., 1951; Fleisch et al., 1973) (see paragraph 3.2). This 
also occurs in vivo as is suggested by experiments in guinea pigs and dogs after a 
nervous blockade (Gold et aL 1976; Dunlop and Smith, 1977). 
4.3.3. Role of the epithelium and the sensory receptors 
As histamine activates sensory receptors in the airways and hence induces 
bronchial obstruction via a parasympathetic reflex (see paragraph 3.3 and 3.4), the 
state of the airway epithelium and the receptors may influence the response. 
The activation of irritant receptors by histamine has been demonstrated in 
rabbits (Mills et al., 1969), cats (Armstrong & Luck, 1974) and dogs (Sampson 
& Vidruck, 1975; Dixon et al., 1979a). Also type J receptors may be activated by 
histamine resulting in bronchial obstruction and rapid, shallow breathing (Karczew-
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ski & Widdicombe, 1969). 
BR to histamine increases after epithelial damage by ozone inhalation in dogs 
(Easten & Murphy, 1967: Lee et al., 1977). Also respiratory infection in dogs in-
creases BR to histamine and the rate of discharge of irritant receptors (Dixon et al.. 
1979c). 
Blocking the irritant receptors by a local anaesthetic decreases the histamine-
induced bronchial obstruction in dogs (Dain et al.. 1975). 
Based on the effect of epithelial damage caused by various influences and 
supported by the effect of a local anaesthetic, the sensory receptors are likely to 
play a role in histamine-induced reactions in animals. 
4.3.4. Role of the parasympathetic system 
Reflex bronchial obstruction after histamine aerosols has been studied extensi-
vely in animals. Mills & Widdicombe (1970) found that vagotomy significantly 
reduced the histamine-induced increases in total lung resistance in guinea pigs, but 
had only a small effect on peripheral airway obstruction as detected by changes in 
compliance. Similarly Douglas et al. (1973b) reduced the bronchial obstruction 
produced by aerosolized histamine in guinea pigs by parasympathetic post-
ganglionic blockade with atropine and ganglionic blockade with hexamethonium. 
Studies by Gold et al. (1972) and Dain et al. (1975) support the role of the vagal 
nerve in histamine-induced bronchial obstruction. 
Drazen & Austen (1975) found in the guinea pig that the effect of a low dose 
inhaled histamine on airway resistance and compliance was abolished by atropine. 
With higher doses both a direct effect and a parasympathetic effect seemed to play 
a role. In contrast, Loring et al. (1977) could not detect an effect of atropine on the 
histamine dose-response curves in dogs. However, the delivery of the agents and 
techniques used (see paragraph 4.2), and species differences may explain some of 
the variations in the results of these studies. 
The state of the airway epithelium may also be an important determinant in the 
degree of the vagal component as discussed in paragraph 3.3. 
Thus. it can be concluded that bronchial obstruction after the inhalation of 
histamine is caused by a direct effect on the smooth muscle as well as an indirect 
activation via a parasympathetic reflex. The relative contribution of the direct 
effect gets larger with increasing doses of histamine. These effects are discussed and 
illustrated in paragraph 3.2.d and figure I. 
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4.3.5. Role of the ~-sympathetic system 
A general introduction about this system is given in paragraph 3.5. 
Experimental models of BR have been created in the mouse and guinea pig. 
Increased bronchial sensitivity to histamine and other agents occurred after admi-
nistration of Bordetella pertussis vaccine or B-sympathetic antagonists (Fishel et al., 
1962). In this condition sympathetic functions were decreased, not only inside but 
also outside the respiratory tract. These include the epinephrin-induced vascular 
response, increase in heart rate and blood glucose level. Based on these observa-
tions. Szentivanyi (1968) suggested that an underlying abnormality in bronchial 
asthma is an inherited or acquired abnormality of the B-sympathetic receptor 
function. For further discussion see paragraph 3.5 and 4.4.5. 
The effect of the sympathetic hypofunction in histamine-induced bronchial 
reactions has been studied in various animal experiments. Diamond (1972) found 
an increase in the histamine response after administration of a ~-sympathetic 
antagonist or after cutting the sympathetic nerves in guinea pigs. These observations 
were confirmed by several others (Douglas et al.. 1973b; Drazen. 1978). 
Snapper et al. (1981) found the effect of ~-blockade in dogs to be most pro-
nounced in the peripheral airways. 
Also catecholamines released by the adrenal glands have an influence on the 
bronchial response to histamine. Colebatch & Engel (1974) showed that adrenal-
ectomy increased histamine-induced lung function changes in cats. 
Release of catecholamines. mainly adrenaline, is induced from the adrenal 
medulla by histamine directly in cats and via sympathetic reflex pathways in dogs 
(Staszewsky-Barczak & Vane. 1965). Drazen (1978) studied the effect of adrenal-
ectomy and of a ~-sympathetic antagonist on the bronchial reaction induced by 
intravenous histamine in guinea pigs. The results suggest that the sympathetic 
nervous system modifies the response to histamine. whereas circulating catechol-
amines influence the recovery. 
It may well be that ~-sympathetic hyporesponsiveness is under genetic control, 
as particular inbreds of the mouse have B-hyporesponsiveness whereas others do not 
(Wardley eta!.. 1970). Pauwels eta!. (1980) produced similar findings in rats. 
It may be concluded that the ~-sympathetic system is functioning as a homeo-
static counteracting system. Hyporesponsiveness enhances BR to histamine. 
4.3.6. Role of the a-sympathetic system 
Drazen (1978) found that a-antagonists decrease the histamine response under 
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conditions of ~-blockade. The overall contribution of a and ~ receptors was 
evaluated by determining the effect of chemical sympathectomy with 6-hydroxy-
dopamine on the histamine response. The histamine response decreased after this 
selective destruction of the sympathetic nerves. This effect was dose-related and 
greatest at high doses of histamine. This suggests that the combined a- and ~-sym­
pathetic fibres act to enhance histamine responses. probably by a-sympathetic 
outflow. 
Douglas et a!. (1973b) concluded from their study in guinea pigs that those 
animals with a relatively high BR seem to have the most pronounced hyperrespons-
iveness to a-sympathetic agonists. 
It is concluded from these experiments in animals that a-receptors seem to 
play an additional role in histamine-induced reactions although their influence may 
vary. 
4.3.7/8. Role oft he non-adrenergic inhibitory nervous and APUD systems. 
The role of the non-adrenergic inhibitory nervous system and the APUD 
system have not been studied with regard to histamine responsiveness with the 
exception of that mentioned in paragraph 3.7 and 3.8. 
4.3.9/10. Roleofthemastcells 
The role of the mast cells in histamine-induced bronchial obstruction is 
difficult to assess. It has been studied by stabilizing mast cells with DSCG. DSCG 
has been shown to stabilize mast cells (Cox eta!., 1970: Spataro & Bosman. 1976) 
and a binding site for DSCG on mast cells and basophils has been found (Mazurek 
et a!., 1980). 
In the dog histamine-induced bronchial obstruction was inhibited after both the 
inhalation and intravenous administration of DSCG (Jackson & Richards, 1977). 
However. the authors speculate from their findings that DSCG may also have an 
effect on lung irritant receptors. which complicates the interpretation of these 
blocking studies. 
In a further study DSCG was shown to be without effect on irritant receptors 
(Dixon et a!., !979d), but DSCG reduced action potentials in C-fibre endings 
(Dixon et a!., !980b) and these may be involved in histamine-induced bronchial 
obstruction (Karczewki & Widdicombe, 1969). 
Conclusions of paragraph 4.3 
Based on studies in animals. inhaled histamine seems to activate sensory 
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receptors which cause a parasympathetic reflex bronchial obstruction. The condi-
tion of the epithelium influences the response because the exposure of the sensory 
receptors to the intra-luminal stimuli depends on the integrity of the mucosa. How-
ever. histamine can also produce bronchial obstruction in animals with their para-
sympathetic nerve systems blocked. It is therefore most probable that histamine-
induced bronchial obstruction. results from both a direct non-reflex effect of 
histamine on bronchial smooth muscle and an indirect vagally mediated reflex 
bronchial obstruction. Hyporeactivity of the ~ and hyperreactivity of the a-sym-
pathetic system aggravate the histamine response, but the relative contribution of 
both systems in unclear. The role of mast cells is not defined at this moment but 
their activation and thus contribution to the bronchial response after histamine 
inhalation cannot be excluded. 
4.4. Histamine-induced bronchial responses as sturued in humans 
4.4.1. Introduction 
In order to analyse if the mechanisms of histamine-induced bronchial ob-
struction in animals is similar to that in humans, investigations on the effect of 
agents with various modes of action in histamine-induced reactions will be 
mentioned. 
The effect of histamine-receptor antagonists has been reported in several 
studies. A H 1 antagonist (see paragraph 3.2) diminished histamine-induced bronchial 
obstruction after the inhalation of histamine, but not after methacholine (Woenne 
et al.. 1978; Casterline et al .• 1979). The actions of H 1 and H 2 receptor anta-
gonists were compared on histamine-induced reactions by Eiser et al. (1978) and by 
Nathan eta!. (l979a; 1981). The dose of histamine which caused a 20% decrease 
in FEV1 was higher after the H 1 antagonist chlorpheniramine and lower after the 
H, antagonist cimetidine than the dose without these agents. This suggests that 
H 1 and Hz receptors are present in human airways and have opposite actions. 
However. the effect of the H, receptor dominates. Busse and Sosman (1977). 
Chand (1980) and Nathan et al. (1981) suggest that the H2 receptor deficiency may 
be present in asthmatic patients and be partly responsible for exaggerated res-
ponses. 
Ruffin et al. (1978) compared the effectiveness of central versus diffuse air-
way deposition of histamine aerosols, controlled by a radiotracer method. Histamine 
aerosol deposited predominantly in the central airways was more effective than the 
diffusely deposited histamine. This suggests that the receptors mediating the action 
of histamine are located mainly in the large airways or that the triggering of the 
centrally located receptors can induce a ""complete"" bronchial response. 
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4.4.2. Role of the bronchial smooth muscles 
It is difficult to determine the relative contribution of intrinsic properties of 
the bronchial smooth muscle and extrinsic regulation mechanisms to the bronchial 
obstruction after histamine challenge. As already pointed out, the contribution of 
intrinsic properties may be increased by hypertrophy and hyperplasia of the 
bronchial smooth muscle (paragraph 3.2). 
The similarity of the bronchial reactions after histamine and methacholine (see 
paragraph 4.2) in which different types of receptors are involved. underline the 
importance of the smooth muscle responsiveness. 
The main regulation disturbance seems to be present outside the bronchial 
smooth muscles, as the hyperresponsivity to various stimuli found in vivo was much 
less when bronchial smooth muscles of the same subjects were challenged with com-
parable stimuli in vitro (Simonsson et al .• 1973; Douglas et al., 1973a). 
4.4.3. Role of the sensory recep10rs and the epithelium 
The integrity of the airway epithelium and the sensitization of the sensory 
receptors (see paragraph 3.3 and 3.4) which appear to be involved in the bronchial 
obstructive reaction caused by histamine inhalation in animals (see paragraph 4.3.3), 
are likely to be important in humans. Damage to the airway epithelium by ozone 
exposure in asthmatics (Holzman et al., 1979) and healthy subjects (Golden et al., 
1978). or by respiratory infections (Empey et al., 1976; Laitinen et al., 1976) 
increases BR to histamine. 
The effect of inhibition of sensory receptors by a local anaesthetic, bupivacaine 
was studied in humans by Thomson (1979). He found no protective effect on 
histamine-induced bronchial obstruction, although the cough reflex elicited by citric 
acid aerosol was abolished. However, these results were complicated by the 
bronchoconstrictor effect of bupivacaine. which may have eliminated a protective 
effect. Although Thomson's work does not support a role of sensory receptors in the 
bronchial responsiveness to histamine in humans. the observations based upon the 
effect of epithelial damage strongly indicate their role in this regard. 
4.4.4. Role of the parasympathetic system 
In human studies the results of parasympathetic blocking agents are variable 
and have mainly been performed in asthmatics. Simmonson et al. (1967) showed 
that atropine sulphate abolished the bronchial obstructive effect of histamine. How-
ever, large doses of histamine could not be blocked. In contrast Woenne et al. (1978) 
found only little effect of an inhaled parasympatholytic (ipratropium) on histamine-
induced bronchial obstruction in children. Similarly Casterline et al. (1976) found a 
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minimal effect of an inhaled parasympatholytic (atropine sulphate). On the other 
hand Cockcroft et al. (1977b) and also Thomson (1979) observed a clear protecti.ve 
effect in normal subjects with an upper respiratory infection. The differences in effect 
of parasympatholytics may be partially explained by the relative amount of hist-
amine used. 
Holtzman eta!. (1980) studied the influence of an inhaled ganglionic blocking 
agent (hexamethonium) and muscarinic antagonist (atropine) on the bronchial 
response to histamine in atopic subjects. Bronchial obstruction was prevented by 
both agents in all patients. The inhibitory effect of a ganglionic blocker has been 
previously observed by Booy-Noord eta!. (1969b). 
Hyperresponsiveness of the parasympathetic system was studied by investig-
ating the reaction of the pupillary constrictor muscles to a topically instilled 
cholinomimetic. Parasympathetic hyperresponsiveness was found in all atopic and 
non-atopic asthmatics in contrast to that in normals (Smith et al., 1980). 
It is concluded that the parasympathetic system plays a role in BR to histamine 
in humans, although the evidence is less pronounced than in animal studies. It may 
well be that the parasympathetic action is most pronounced in reactions to relatively 
small amounts of histamine. 
4.4.5. Role of the ~-sympathetic system 
When inhaled. \~-sympathetic agonists have a pronounced protective effect on 
the occurrence of histamine~induced bronchial obstruction as was shown by Caster-
line et al. (1976) with albuturol and Cockcroft eta!. (1977b) with salbutamol. In both 
studies the effect of the ~-sympathetic agonist exceeded that of parasympatholytics 
and other agents. 
As mentioned in paragraph 4.3.5, in 1968 Szentivanyi published his hypothesis 
of hyporesponsiveness of the ~-sympathetic receptor as a basic defect in asthma. 
The function of the ~-sympathetic receptor can be studied in vitro by measuring 
various metabolic responses as well as by determination of plasma or urine cyclic 
AMP levels after a ~-sympathetic agonist. 
Support for the idea of Szentivanyi has been provided by various studies in 
humans. A diminished response to intravenous isoproterenol W agonist) in terms of 
hyperglycaemia and cardiovascular effects was found in asthmatic subjects com-
pared to normals (Cockson & Reed, 1963: Lockey et al., 1967). Ouelette & Reed 
(1967) showed that after pharmacologic ~ blockade ragweed sensitive individuals 
without clinical asthma exhibited increased bronchial sensitivity to inhaled ragweed 
allergens. 
Many studies have been performed to measure pulmonary function with and 
without ~-sympathetic blockade (Bouhuys et al., 1971; Ryo & Townley. 1972: Me 
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Geady et aL, 1968; Turner et aL, 1971). Although the results are variable, in general 
the asthmatics were more sensitive to S-blockade than healthy subjects. 
A S-sympathetic antagonist (propanolol) induced an increased responsiveness 
to histamine and methacholine in asthmatics, in a few patients with allergic rhinitis. 
but not in normal subjects (Zaid & Beall, 1966), Ply-Song-Sang et aL (1978) found 
an increase in BR to intravenous histamine after S-blockade by propanoloL Also 
Orehek et aL (1975b) in normals and Townley et aL (1976) in normal and allergic 
rhinitis subjects showed an increase in BR to acetylcholine after a S-sympathetic 
antagonist. 
The function of the S-sympathetic receptor has been studied in vitro by 
measuring the effects of a S-sympathetic agonist on human leucocytes. S-sym-
pathetic agonist induced changes in intra-cellular cyclic AMP were found to be less 
in asthmatics than in normal controls (Parker & Smith, 1973; Logsdon et aL 1973; 
Haddock et aL, 1975). Parker & Smith (1973) noted that the decrease in re-
sponsiveness was most marked in periods of active asthma and returned towards 
normal during clinical remissions. 
Apold et aL (1977) detected a relationship between the abnormality in the 
plasma cyclic AMP response to intravenous epinephrine and the histamine-induced 
bronchial responsiveness. Evidence was put forward indicating that hyporesponsive-
ness could be simulated by treatment with sympathetic agonists (Nelson et aL, 1975; 
Conolly & Greenacre, 1976; Kalisker et al., 1977; Morris et al .. 1977; Bruynzeel 
et aL 1979), However, S-sympathetic hyporesponsiveness was also demonstrated 
without simultaneous medication (Busse & Lee, 1976; Shelhamer et aL, 1980). 
Apold & Aknes (1977) and Busse eta!. (1980) found a correlation between hypo-
responsiveness of the S-receptor in vitro and BR to inhalation of histamine. The 
~-sympathetic response of leucocytes in vitro was found to be lower in asthmatics 
than in healthy persons (Lemanske et al., 1980). In a further study these investigators 
showed that this decreased leucocyte reaction in asthmatics became even more 
pronounced after incubation with a virus (Busse et aL, 1980). This indicates that 
~-hyporesponsiveness may increase during periods of infection. Thus increased 
bronchial responsiveness~ which is often present in such periods, may be associated 
with decrease of S-sympathetic responsiveness. 
The usage of radiolabe!Jed ligands have made it possible to quantify the num-
ber of S- or a-receptors. Using this technique Brooks et aL (1979) and Kariman 
(1980) found a decrease in the number of S-sympathetic receptors on lymphocyte 
membranes from asthmatic subjects than on those obtained from normals. The 
asthmatics were not being treated with sympathomimetic agents for a long time. 
A relationship was established between the number of S-receptors and the severity of 
the disease. Szentivanyi (!979a, 1979b) measured the number of S-and a-receptors 
in the lungtissue and lymphocytes of asthmatics with reversible airway obstruction, 
and patients without obstruction. The ratio of the number of S· to a-sympathetic 
receptors was much lower in asthmatic patients than in the other group. This sug-
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gests an important role for the B-sympathetic system in bronchial tone regulation. 
Furthermore it indicates that a conversion of B- into a-receptors (see paragraph 
3.5) may be a basic defect in asthma and the hyporesponsiveness of the B-sym-
pathetic system. A B-sympathetic hypofunction may explain partially the increased 
responsiveness of the bronchi. 
4.4.6. Role of the a-sympathetic system 
Few studies have been performed on the role of the a-sympathetic system in 
BR to histamine in human subjects. Kerr et a!. (1970) demonstrated that in 
asthmatics a-blockade with phentolamine and phenoxybenzamine, reduced the intra-
venous histamine-induced bronchial obstruction. Similar findings were observed with 
thymoxamine. a more specific a-blocking drug (Gaddie et a!., 1972: Prime et a!., 
1972). 
These studies indicate that sensitivity of a-receptors may play an additional 
role in the generation of histamine-induced bronchial obstruction. The a-receptors 
are probably stimulated in the course of the sympathetic counteractivation and 
hence produce an adverse effect. 
4.4.7/8. Role of non-adrenergic and APUD systems 
Information about the non-adrenergic inhibitory and apud systems in hista-
mine-induced bronchial obstruction in humans is not available. 
4.4.9/ 10. Role of the mast cells 
As in animal studies, the role of the mast cell system in BR to histamine in 
humans can be approached by assessing the influence of DSCG and by measuring 
the release of mediators. 
As mentioned in paragraph 4.3.9., doubt concerning the mode of action of 
DSCG, makes interpretation of its blocking effect uncertain. Also Harries et a!. 
(1981) suggested that DSCG has an action on irritant receptors or bronchial 
smooth muscle as it blocked sulphur dioxide induced bronchoconstriction in 
asthmatic patients. To date controversy surrounding the mode of action has not 
been solved. The measurement of other mediators such as the neutrophil chemo-
tactic factor, has recently been developed and may reveal a new approach to the 
detection of mast cell involvement (Austen, 1980: Orr eta!., 1980). 
DSCG was found to decrease BR to histamine in some asthmatic patients 
(Kerr et al.. 1970: Pauwels eta!., 1978: Woenne eta! .. 1979), although in other 
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studies this effect was not found (Kang et al.. 1976; Thomson et al.. 1979). These 
differences are difficult to explain. but may be caused by the observed large inter-
subject variability and the use of small study groups. 
Methacholine-induced bronchial obstruction was found to be associated with a 
rise in arterial histamine level (Poon eta! .. 1977; Allen et al.. 1978; Atkins et al.. 
1980). 
It is concluded that a role of mast cells in BR to histamine or methacholine is 
suggestive. but not conclusively proved. 
Conclusion of paragraph 4.4 
Although the studies in humans with agents that influence the histamine-
induced bronchial responsiveness are not quite in agreement with those in animals. 
they generally confirm the concept of the mechanisms found in animal experiments. 
The role of the parasympathetic syst,em is less clear in humans. However. it is most 
probable that histamine produces a sensory receptor plus a parasympathetic reflex 
action, and a direct smooth muscle activation. Their relative contribution may vary 
with factors such as the dose of histamine. the inhalation technique. the state of the 
epithelium and the vagal tone. The mast cells may also be involved. The 
a-sympathetic activity may act as a third system involved in the bronchial response 
to histamine. 
The ~-sympathetic system regulates the counteraction and hypofunction of the 
~-system will result in BHR. The immediate response to histamine is inhibited by the 
sympathetic fibre system. which can be accomplished in several ways (see paragraph 
3.5). Circulating catecholamines from the adrenal medulla become involved after the 
immediate response. The adrenals are triggered by their nervous innervation or by 
circulating histamine. It can be speculated that the non-adrenergic inhibitory system 
may be involved as a second counteracting system. but to date there are very few 
studies to support this idea. 
4.5. Relationship between bronchial responsiveness and diseases and symptoms 
Bronchial asthma 
Asthmatics frequently have greater BR to histamine or methacholine than 
normal subjects (Curry. 1946; Makino. 1966; Itkin. 1967; Cockcroft eta!.. 1977a; 
O"rehek eta!.. 1977). 
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BR to histamine or methacholine varies widely within the group of asthmatics 
and a relationship between the severity of the symptoms and the degree of BR is 
often found. This is illustrated in a number of studies. Makino (1966) noted are-
lationship between a score representing asthmatic symptoms during one year and the 
threshold for histamine or acetylcholine. Cock croft et al. (1977 a) found that the 
severity of BR and asthma were correlated, although a large overlap was present. 
Similar findings were published by Spector & Farr (1975). 
Also occupational asthma is related to BR (Lam et al.. 1979: Cockcroft et al.. 
1979a: Freedman et al.. 1981). 
Several investigators have shown that the degree of BR contributes to the 
occurrence and the severity of the bronchial obstruction caused by some defined 
stimulants. 
There is a relationship between allergen-induced bronchial obstruction and BR. 
This was shown by Kreukniet & Pyper (1973) with cat dander allergen. Killian et al. 
(1976) with pollen and house dust allergen, Bryant & Burns (1976) with house dust 
allergen. Nathan et al. (1979b) with pollen allergen. Cockcroft et al. (1979b) with 
various allergens and Neijens et al. (1979) with cat dander allergen. 
Exercise-induced bronchial obstruction is also related to the degree of BR 
(Kiviloog. 1973a: Mellis et al., 1978: Anderton et al.. 1979: Neijens et al., 1980). 
For a detailed discussion about exercise and allergens in relation to BR is referred 
to the paragraphs 5.4 plus 8.1 and 8.2 respectively. 
A high incidence of BHR is found in patients with chronic bronchitis. but this 
is less pronounced than in asthmatics (G6kemeijer. 1976). Bronchitics have a 
greater responsiveness to acetylcholine than to histamine (G6kemeijer. 1976). 
Allergic rhini1is due 10 pollen allergen 
Subjects with hayfever often have a moderate degree of BR ranging between 
that of asthmatics and healthy individuals. Townley et al. (1965) have compared 
these groups according to their BR to histamine and methacholine. Patients with 
hayfever were considerably less sensitive to methacholine than the asthmatics. With 
histamine the difference was less pronounced. The BR to histamine in the hayfever 
patients was three to four times that of normals. 
Cockcroft et al. (1977a) found the prevalence of BR to histamine in patients 
with rhinitis to be intermediate (22-40%) compared to that in asthmatics ( 69-100%. 
depending on the severity of symptoms). and that in presumed healthy subjects 
(3%). 
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Cystic Fibrosis 
Mitchel et a!. ( 1978) found an increased BR to methacholine in 51% of children 
with cystic fibrosis compared to 98% of asthmatics. However, they found BHR 
in only 20% of cystic fibrosis children, against I 00% of asthmatics when histamine 
was the stimulus. There was a correlation between BR and the pulmonary function. 
but not with allergic rhinitis or allergen skin tests. Thus, BR is not invariably a 
feature of cystic fibrosis. but may be present and relevant in some patients. 
Davis et al. (1980) reported an abnormal sympathetic and cholinergic sensitivity 
in cystic fibrosis patients. 
Cigarette smoking 
Barter and Campbell (1976) showed in a prospective study in smokers that 
the progressive deterioration of the FEV1 correlated with the degree of BR to 
methacholine. They concluded that BR might be a predisposing factor of the 
vulnerability to cigarette smoke, although BR might also be a secondary phenom-
enon. Also Gerrard et al. (1980) found a higher BR to histamine in smokers 
compared to non-smokers. 
Conclusion of paragraph 4.5 
Although BHR is often present in asthma. it is not exclusive to this disease, 
as it may be present in other disease states, which are more or less related. It is even 
found in healthy persons. 
4.6. Course of bronchial responsiveness with age 
Information about the variation of the severity of BR with time not only reveals 
indications about endogenous and exogenous factors, but also of the relevance of 
BR and the benefit of treatment. Murakana et al. (1974) found an increased BR 
to acetylcholine in symptomatic asthmatic patients compared to that in a group of 
patients in remission for at least three years. Both groups did not differ in skintests 
or allergen specific lgE concentrations. However, Townley et al. (1975) found an 
increased BR in a large percentage (82%) of former asthmatics. but this was a 
retrospective study. 
The number of subjects with BHR to histamine increases with age. This was 
found in a population study by van der Lende et al. (1973). In this study no relation-
ship was found between BR and either sex, allergy, eosinophilia, smoking or air 
pollution. However, a relationship was present between BR and the baseline pul-
monary function values. These studies indicate that both exogenous and endogenous 
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factors might be involved in BR. 
Various studies tried to estimate the endogenous component of BR. Falliers 
eta!. (1971) studied identical twins both with asthma. There was a wide variability 
between their bronchial responsiveness to methacholine, sensitivity to allergens and 
the intensity of symptoms, thus dismissing the concept of a genetic influence. 
However. evidence for genetic influence on BR was found by Takino et al. 
(1971) in two families of guinea pigs. Konig & Godfrey (1974) in identical but 
not in non-identical twins and by Guirgis eta!. (1976) using genetic markers. These 
latter two studies were performed in humans. 
It seems that an endogenous component in BR is an important determinant. 
However. exogenous factors may effect BR. More information is needed in this 
respect. 
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CHAPTER 5. BRONCHIAL RESPONSIVENESS IN RELATION TO 
EXERCISE 
5.1. Introduction 
Exercise-induced bronchial obstruction (EIB). synonymous with exercise-
induced bronchospasm or exercise-induced asthma, is characterized by a dyspnoea 
which occurs after a short period of strenuous exercise. This symptom is frequently 
observed in asthmatic subjects, especially in children. Dyspnoea as result of respira-
tory insufficiency is not considered here. EIB can be quantified by lung function 
measurements. which show a characteristic pattern after strong exercise in a 
susceptible person. During a 4 to 10 minutes period of exercise a small but detect· 
able improvement in lung function (bronchodilatation) occurs. this is followed by a 
deterioration (bronchial obstruction) at the end of or shortly after the completion 
of the exercise period. The clinical and physiological abnormalities. regardless of 
severity, are usually most marked during the first ten minutes after exercise and 
decrease over a period of 15 to 45 minutes. 
Thomas Willis noted more than 300 years ago that various forms of exercise 
could provoke asthma. Up until! about 1960 scattered reports appeared on this 
subject. Since then an increased awareness has occurred which started by the obser-
vations of Jones and colleagues (1962. 1963). 
Exercise-induced bronchial obstruction has been studied using various lung 
function techniques in several groups of subjects (paragraph 5.2) and the effects of 
drugs have been investigated (paragraph 5.3). Subsequent investigations have 
extended our understanding of EIB and the influence of protective agents. 
5.2. Factors in exercise testing 
The changes that are produced by exercise are dependent on the type and 
severity of exercise and the condition of the inhaled air. The following variables may 
affect the response to exercise: 
a. A mount of metabolic stress 
When the amount of exercise increases. a linear rise in heart-rate. ventilation 
and oxygen-consumption occurs. Along with oxygen consumption post-exercise 
bronchial obstruction sharply increases. This relationship applies equally to an in-
crease in exercise time or strength of exercise (Godfrey. 1974; Edmunds et al .. 
1978). 
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b. Type of exercise 
Differences in the response to exercise at the same workload have been reported 
in a group of asthmatic children by Anderson et a!. (1971) and Godfrey et a!. (1973). 
Free-range running caused more EIB than treadmill running. Cycling revealed a 
lower drop in lung function than running, while walking and swimming were even 
less effective in causing a post-exercise fall. Sports such as swimming and kyaking. 
which primarily use the arms. are less likely to induce bronchial obstruction. 
The differences in response to exercise were originally thought to be due to 
factors such as the use of different muscle groups. However, doubt about these 
explanations has been raised by several studies. 
Anderson eta!. (1975) have shown that cranking a bicycle ergometer with the 
arms can be as challenging as running provided the oxygen consumption is com-
parable. Arm work produced a greater airway obstruction than leg work but was 
also accompagnied by a greater metabolic load as judged by heart rate (Strauss 
et al.. l977a). If the load on the legs was increased, the differences between arm 
and leg exercise disappeared. The authors concluded that the workload and the mass 
of the exercising muscles determines the metabolic rate and thus the bronchial 
response. Similarly. running and cycling with equal metabolic load. defined by the 
oxygen consumption, revealed no differences in bronchial response to exercise (Fitch 
& Morton. 1971; Miller eta! .. 1975). The bronchial challenge capacity of running 
or walking were compared under equal metabolic conditions by varying the slope 
in order to obtain similar minute ventilation and oxygen consumption. Both tests 
revealed an equally severe postexercise fall in lung function (Kilham et al., !979). 
A linear relationship exists between the oxygen consumption during exercise 
and the leg muscle volume. Maximum oxygen uptake in relation to age could be 
smoothed to a nearly linear horizontal line when corrected for leg muscle volume. 
This was not the case when corrected for lean body mass. Also the differences 
between both sexes. was almost abolished by such a correction (Davies et al., 1972). 
From these observations it appears that metabolic load. assessed by the oxygen 
consumption. depends upon the muscle mass. This may explain to a great extend 
the variability in EIB between persons of different age and sex and between different 
forms of exercise. 
Thus it is most probable that the bronchial reaction after different forms of 
exercise is largely related to the metabolic load. The metabolic load is influenced 
by the strength of the exercise and the muscle mass. But also other factors play a 
role. these include fittness (paragraph 5.3) and environmental factors (paragraph 
5.4). 
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c. Duration of exercise 
The influence of the duration of exercise upon the bronchial response was 
studied by Silverman & Anderson (I 972a). Asthmatic children were exercised on a 
treadmill set at a constant speed (5 km/h) and slope (10%). The duration of exercise 
was randomly varied between 1 and 16 minutes. The severity of exercise-induced 
bronchial obstruction increased with the duration of the test up to 6 to 8 minutes. 
Less post-exercise obstruction occurred in some subjects with exercisetests longer 
than 8 minutes. This was confirmed by Eggleston & Guerrant (1976). 
d. Slope of the treadmill exercise test 
Silverman & Anderson (1972a) studied tbe influence of the slope on the 
bronchial response to exercise. Asthmatic children ran for 6 minutes at a constant 
speed (5 km/h) on various occasions while the slope of the treadmill was varied at 
random between 0% and 20%. The post-exercise fall increased up to a slope of 15%. 
Greater slopes were not associated with a further increase in post-exercise fall. The 
effect of the slope on the workload depends on the body weight of the patient. 
e. Time interval between exercise tests 
Exercise tests performed at 2 hourly intervals on the same day did not show 
significant changes in baseline or post-exercise lung function. according to the study 
of Silverman & Anderson (1972a). James et a!. (1976) repeated exercise-tests in 
astbmatic children at hourly intervals. They observed a progressively less bronchial 
response. The influence on exercise-induced bronchial obstruction by previous 
exercise was extensively studied by Edmunds eta!. (1978). The ability to induce the 
same amount of bronchial obstruction was mainly recovered within 2 hours and 
always fully within 4 hours. 
Thus a refractory period of about 2 hours exist. 
Standardization of exercise tests 
In order to keep the results comparable the exercise tests should be stan-
dardized for the variables mentioned. Several proposals for standardization have 
been published (Silverman & Anderson. 1972a; James eta! .. 1976; Eggleston & 
Guerrant. 1976). 
Since monitoring of the oxygen consumption is seldom available in routine 
laboratories. the metabolic load has mostly to be assessed by the heart rate. An 
increase of the heart rate to 90% of the predicted maximum for age. is comparable 
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to 60-85% of the maximum oxygen consumption (Godfrey, 1974; Eggleston & 
Guerrant, 1976). 
Godfrey (I 974) studied progressive and steady-state exercise tests and found 
that standard steady state running tests gave the most reproducible responses. Sil-
verman & Anderson (I972a) and Godfrey (1975) considered 6 to 8 minutes running 
at steady state sufficient to develop a heart rate of 180 beats per minute in children 
or I 60 beats per minute in adults. This can best be achieved by running on a tread-
mill with a slope. Eggleston & Guerrant (197 6) published a diagram of the relation-
ship between height and treadmill speed required to obtain 90% of the predicted 
maximum pulse rate at a slope of 10 to 15%. Intermittent exercise such as stepping 
or running up and down stairs is a less reproducible challenge. 
Silverman & Anderson (l972a) examined the reproducibility of exercise tests 
by calculation of the coefficient of variation (standard deviation divided by mean 
x I 00% ). Standard running was more reproducible than cycling. If standard running 
was repeated on the same day with intervals of about 2 hours, the coefficient of 
variation was approximately 30%. The coefficient of variation increased to about 
50o/o if the intervals between tests were longer than one week. 
Assessment of the bronchial response to exercise 
The bronchial response to exercise can be quantified by lung function measure-
ments. The largest response will be approximated if measurements are repeatedly 
performed after the completion of exercise. The severity of the response has been 
expressed in different ways. Jones et a!. (1966) have proposed the lability index, 
which is defined as the highest value minus the lowest, divided by the baseline value 
multiplied by 100%. Also the fall in a lung function value as percentage of baseline 
or predicted value. is used. The relationship between the lability index and the fall 
has been considered by Silverman and Anderson (l972a). Both were strongly cor-
related, although a quantitative difference existed. Although the lability index pro-
vides an useful! expression of both phases of the response, the fall in lung function 
seems the most relevant in terms of phenomenon and symptoms. The percent fall 
is commonly used as indication of the severity of the bronchial obstruction after 
exercise. 
Various lung function indices have been proposed as an expression of the 
bronchial response. Cropp (1975b) compared the results of various factors obtained 
by measurement of spirometry and body plethysmography. The measurement of 
SGaw revealed the largest change at any time during the post-exercise period. 
Changes in PF and MMEF were comparable, but were somewhat less than the 
SGaw. The change in the FEV 1 was less marked than in SGaw, MMEF and PF. 
The change in SGaw was significantly, but not linearly correlated with the decreases 
in PF, MMEF and FEV 1• Cropp concluded that the FEV 1 was not the best measure 
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of exercise-induced bronchial obstruction and the use of the MMEF would reveal 
larger responses. However, Kattan et a!. (1978) came to the opposite conclusion. 
They judged the lung function indices by their ability to surpass the intra-individual 
variability and not by the absolute percentage. The flow at 50 and 25% of the VC 
revealed the greatest mean fall, but the PF and the FEV, were the most sensitive 
indices in this respect. 
Occasionally other lung function indices have been proposed such as the 
volume of trapped air (Svenonius eta!.. 1978) but they have no advantage over the 
conventional ones. 
5.3. Protective effects of pharmacological agents on EIB 
Atropine and related parasympathetic blocking agents have little protective 
effect on EIB. Atropine given by injection could not block EIB in the study of 
Chan-Yueng et a! (1971), although Simonsson et a!. (1972b) have shown that 
atropine can have some inhibitory effect. Parasympathetic antagonists by aerosol 
are somewhat more effective. Chan-Yueng (1977) could diminish EIB by Sch 1000 
in the majority of the patients studied. Using a newer variant (ipratropium bromide), 
Thomson et a!. (1978) observed a marked protective effect in 8 from 13 patients. 
Also Godfrey & Konig (1976) found a partial effect. Hartley and Davies (1980) 
studied the same agent in a normal dose (0.1 mg) and a very high dose (I mg) per 
aerosol. They showed that the high dose was more effective than the normal one. 
Thus factors like deposition and dose may play a role in the relatively poor 
effectivity of parasympathetic blocking agents in EIB. 
The blocking capacity of ~-sympathetic agonists in E!B is excellent in most 
patients when given by aerosol (Godfrey & Konig. 1976; Hetzel et a!., 1977; 
Tashkin eta!.. 1977). The effect of oral preparations is variable and less pronounced 
(Morse eta!., 1976; Seale eta!.. 1977). 
a-sympathetic blocking drugs (indoramin and thymoxamine) can partially 
inhibit EIB as shown in the studies of Bianco eta!. (1974), Grosset a!. (1974) and 
Patel eta!. (1976). Beil & de Kock (1978) found in a rather small study, inhibition 
of EIB after a-sympathetic blockade by phentolamine. Also the increase in EIB 
produced by a ~-sympathetic antagonist could be counteracted by the addition of 
phentolamine. These results point to a possible role of an activated a-sympathetic 
receptor and an imbalance in the functions of the a- and ~-sympathetic system in 
EIB. 
The effect of DSCG on EIB has been assessed in several studies. In a pre-
liminary communication Davies (1968) reported that DSCG had a protective 
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effect in 8 adult patients with EIB. More recent studies revealed a nearly complete 
inhibition of EIB in the majority of patients, but with little or no effect in the re-
maining patients (Poppius et aL 1970: Silverman et aL 1972a; Chan-Yueng, 1977). 
DSCG protects more patients than parasympatholytics, such as Sch 1000 (Chan-
Yeung. 1977) and ipratropium bromide (Thomson et a!., 1978). An interesting 
observation about the mode of action of DSCG was demonstrated by Silverman 
& Andrea (1972). who showed that it inhibited EIB if given before exercise but 
not if administered immediately afterwards. 
Xanthine derivatives such as aminophyllin and theophyllin. give protection in 
EIB (Bierman et a!.. 1975b). According to Chryssanthopoulos et a!. (1979a) the 
therapeutic serum concentration seems to have no influence. Kiechel et a!. (1976) 
state that a level of at least 10 f!g/ml is needed. 
Corticosteroids orally or inhaled are of little value in the protection of EIB 
(Konig eta!.. 1974; Hartley et a!.. 1977a; Yazigi eta!., 1978). 
The aerosolized H, receptor antagonist clemastine~ markedly inhibited the 
bronchial response to exercise (Hartley & Nogrady, !980) which suggests an 
important role of histamine in EIB. 
Some reports on other protective agents on EIB are interesting. Diethyl-
carbamazine parmoate. which inhibits the release of slow reacting substance of 
anaphylaxis in the rat, provided some protection against EIB in 15 of the 20 
asthmatic children studied (Sly & Matzen, 1974). Aspirin. given with the intention 
to influence the prostaglandin F la metabolism, had no effect on EIB (Taveira da 
Silva & Hamosh. 1976). The calcium antagonist verapamil inhibited EIB and was 
comparable in effectiveness to DSCG (Patel, 1981). 
The relative potencies of agents were compared in various studies. Godfrey 
& Konig (1976) compared the inhibitory effect on EIB of a placebo. a para-
sympathetic antagonist (atropine), a ~-sympathetic agonist (salbutamol) and 
DSCG all given by aerosol. together with an oral xanthine derivative in asthmatic 
children. The proportion of children who were clearly protected compared to those 
taking the placebo. amounted to I 00% for the ~-sympathetic agonist, 80% for 
DSCG and the xanthine preparation and 60% for the parasympathetic antagonist. 
Also Tashkin eta!. (1977) compared the effectiveness of a placebo, a parasympathe-
tic antagonist (atropine), a ~-sympathetic agonist (isoproterenol), the combination of 
both and DSCG in asthmatic children. Post-exercise bronchial obstruction was 
partially inhibited by each of the agents in progressive order. The combination of a 
~-sympathetic agonist and parasympathetic antagonist revealed a better degree of 
protection than each alone. Our study (paragraph 7.1) reveals comparable results. 
Also psychological procedures, placebo or deconditioning procedures. seem to have 
a benefit in EIB (Heimlich et al., 1966; Khan & Olson, 1977; Godfrey & Silverman, 
1973: Schwank & Scherrer. 1978). 
The effect of training could not be shown (Fitch eta!., 1976), although it may 
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improve the fitness and pulmonary function slightly (Shephard, I 977; Degre et aL, 
1977; Belman & Mittman, 1980). 
The therapeutic effects of inhaled agents in EIB can be summarized as follows. 
The 0-sympathetic agonists are the most effective and parasympathetic antagonists 
are the least effective. The combination of both seems to be additive. The effect of 
DSCG is intermediate. but variable among patients. a-sympathetic antagonists have 
a partial protective potency. 
5.4. Mechanisms in EIB: causes ofhyperresponsiveness to exercise 
In the past the mechanisms of EIB have been obscure, however recent studies 
have provided some insight into that problem. 
Consequences from the pharmacological studies 
Based on the studies with agents to influence EIB (paragraph 5.3) the following 
hypotheses regarding the mechanism involved may be constructed. The reaction of 
the sympathetic system seems very important in EIB. Because of the strong protec-
tive effect afforded by ~-sympathetic agonists, it is possible that a relative hypo-
responsiveness of the ~-sympathetic system (paragraph 4.4.5) or an imbalance 
between ~- and a-receptors in favour of the a-receptors could be important factors. 
The a-receptors. whose antagonists were shown to inhibit EIB. could respond to a 
rise in the norepinephrine level during exercise. An inadequacy of the interaction 
or time scedule between the adrenal response and the sympathetic counteraction 
in the respiratory system, is also a possible explanation for EIB. The plasma levels 
of norepinephrine and epinephrine in relation to exercise were found to be lower in 
subjects with, compared to without EIB (Barnes et aL 1981). 
The poor efficacy of parasympathetic antagonists is surprising in view of the 
importance of the vagus in bronchial obstructions caused by various stimuli in 
animal experiments (paragraph 3.4 and 4.3.4). Insufficient blocking of the para-
sympathetic action might be the explanation for this failure. If the pharmacologic 
blocking is complete in the studies with a partial parasympatholytic effect, other 
factors besides the vagus have to play an important role in EIB. 
The protective effect of DSCG, a drug that is thought to act mainly by stab-
ilizing mast cells. is often put forward as evidence that mediator release from mast 
cells plays an important role in most patients with EIB. Some observations are 
reported which suggest a possible effect of DSCG on the parasympathetic system 
(Jackson & Richards, 1977: Harries et aL 1981) (See paragraph 4.3.9 and 
4.4.9). If this mode of action should be proven, the interpretation of DSCG blocking 
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studies will have to be adapted. 
Also the refractory period after EIB is consistent with the concept of a release 
of stored mediators. However. the evidence for mediator release in relation to EIB is 
not conclusive. Various investigators have looked for histamine in the peripheral 
arterial blood after exercise. Ferris et a!. (1978) found a remarkable increase. 
Charles et aL (1979) measured a peak in the histamine concentration immediately 
after exercise which was however unrelated to the degree of bronchial obstruction. 
Me Fadden et aL (1979: 1980) could not detect an increase in relation to exercise. 
Thus. although mediator release from mast cells is likely to occur in EIB direct prove 
is lacking. 
Physiology of exercise 
Heavy exercise is accompanied by hyperventilation. hypocapnia and lactate 
acidosis (Godfrey. 1974: Wasserman. !978). These indices have been thought to 
play a role in EIB. Although no causal relationship could be observed between EIB 
and hypocapnia. lactate acidosis. acidaemia or change in the arterial oxygen tension 
(Silverman et aL. !972b). various detailed studies have been performed which 
further deny such a relationship. 
Hyperventilation has been thought to be a cause of E!B because of hypocapnia 
(Herxheimer, 1946). Hypocapnia, down to 20 mm Hg, usually induces airway 
obstruction (Newhouse et aL, 1964). Experiments with the administration of CO, 
during exercise revealed variable results (Chan Yeung et aL 197!: Vassalo et aL 
1972: Fisher & Hansen, 1976). 
Me Fadden et aL (1977a) studied the role of hyperventilation under isocapnic 
conditions using a partial rebreathing technique. This did not produce any measur-
able change in lung function. When the pCO, was lowered to about 20 mm Hg. 
a moderate bronchial obstruction appeared which was not comparable to that in 
EIB. Another study with hyperventilation under isocapnic conditions, obtained by 
adding C02 to the inspired air. showed that hyperventilation produced the same 
degree of bronchial obstruction as exercise, irrespective of the concentration of 
CO, (Zeballos et aL 1978). These authors claimed that their results differed from 
these of Me Fadden (1977a) because of differences in the humification of the 
inspired air. Thus it would seem that although hyperventilation is involved in the 
mechanism of EIR the C02 wash out is not a causative factor. 
In order to examine if acidosis contributed to EIB. sodium bicarbonate was 
infusing during and after exercise to prevent acidosis, but this porcedure could not 
influence the occurrence of EIB (Strauss et aL. !977b ). The possible role of lactate 
was considered by lactate infusions in resting subjects in a quantity exceeding that 
after exercise. No bronchial obstruction appeared and it was concluded that lactic 
acidemia per se does not cause EIB. 
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Condition of inhaled air during exercise 
Several observations highlighted the importance of the condition of the inhaled 
air in EIB. 
Weinstein et al. (1976) studied the effect of humification and found thai 
exercise-induced bronchial obstruction was more severe when subjects breathed dry 
air compared to humified air. This observation has been confirmed by Bar-Or 
et al. (1977) in a climate chamber where a high relative humidity (90%) revealed a 
diminished bronchial response compared to a low relative humidity (25%). Also 
Chen & Horton (1977) could virtually prevent EIB by having their patients inhale 
air at high humidity and body temperature. Cold air at subfreezing level sub-
stantially enhanced the bronchial response to exercise. but not without exercise 
(Strauss et al.. 1977c). In a further study Strauss et al. (1978) compared temper-
ature and humidity and their interaction with EIB. Heating the air from room to 
body temperature had no clear effect on the bronchial response. When the 
humidity was increased in combination with room temperature. the degree of 
bronchial obstruction diminished. The lung function changes could be completely 
prevented by fully saturated inhaled air at room temperature. In patients having 
EIB. when breathing with their mouth open. nasal breathing virtually abolished 
the post-exercise bronchial obstruction. This may be explained by the humidifying 
and heating capacity of the nose (Shturman-Ellstein et al.. !978). 
During hyperventilation with exercise the evaporation capacity is easily sur-
passed. especially when mouth breathing is used and the inspired air is relative dry 
and cold. The drier and colder the air. the more evaporation at the airway mucosa 
will occur. An excellent relationship was found between the condition of the inspired 
air, i.e. the temperature and the humidity, and the degree ofE!B (Deal eta!., 1979a; 
1979b; Me Fadden & Ingram. 1979). Patients with EIB are more sensitive to air-
way cooling. than healthy subjects without EIB, as hyperventilation associated with 
exercise produced similar degrees of airway cooling in both groups (O'Cain et al.. 
1980). 
The mechanism by which these triggers act, is not clear. In order to study the 
involvement of the airway sensory receptors, oropharyngeal anaesthesia has been 
applied. A two percent lidocaine spray diminished the decrease in lung function after 
exercise in contrast to saline, but this effect was variable (Me Nally et al., 1979). 
However. using hyperventilation with cold air as an equivalent of exercise. Fanta 
et al. (1980) could not inhibit bronchial obstruction with lidocaine. 
The condition of the inspired air is now believed to be important in the trig-
gering of exercise reactions. but its precise mechanism in inducing bronchial ob-
struction is not yet known. 
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Based upon the available information the mechanisms which lead to BR can 
be constructed as follows: 
Bronchial obstruction can be generated by a parasympathetic reflex or mediator 
release. probably in a variable interaction. The counteraction depending on the 
sympathetic response, may be impaired by an imbalance between a- and ~-recep­
tors. The relationship between the severity of the bronchial responses to exercise 
and the responsiveness to inhaled histamine (paragraph 5 .5) would suggest that in 
both phenomena comparable mechanisms are involved. However. some differences 
do exist. The pronounced protective effect of DSCG and the refractoriness both 
point to an involvement of mast cells in exercise. which is less clear in the 
responsiveness to histamine. Airway epithelium and sensory receptors are probably 
involved in the responsiveness to histamine. but are not proven to be involved in 
responsiveness to exercise at the present time. (Deal et aL 1978) 
5.5 Relationship between EIB and bronchial responsiveness to inhaled histamine 
The bronchial reaction due to exercise and BR have similarities. as was 
suggested by Simonsson et a!. (1972b). They observed that most subjects with 
EIB. also had increased BR to other stimuli. such as hyperventilation and cold air. 
Kiviloog (1973a) found that in most patients the severity of the bronchial obstruc-
tion due to exercise. was related to BR to methacholine. Schachter eta!. (1978) cor-
related the degree of EIB with various data obtained from case histories. The in-
cidence of upper respiratory tract infections. the bronchial reactions to tobacco 
smoke and to cold weather were related to EIB in descending order. This was not 
the case with a history of allergy. A strong correlation was found between the 
severity of the bronchial response to exercise and to histamine in children (Mellis 
eta!.. !978; Neijens eta!.. 1980) and adults (Anderton eta! .. 1979). as well as to 
methacholine in adults (Eggleston. 1979). 
These findings and those in paragraph 5.2 suggest that EIB is dependent on two 
factors: an increased responsiveness of the bronchi in addition to the type and 
strength of the exercise stimulus. 
A difference between the bronchial responses to exercise and histamine was 
shown by Schoeffel et a!. (1980) and Ruffin et a!. (1981 ). They showed that the 
bronchial response to repeated histamine challenges. with intervals of 40 minutes. did 
not diminish to the same extent as exercise tests performed with the same intervals. 
They concluded that the refractoriness to EIB (James eta!.. 1976; Edmunds eta!.. 
1978; Schnall & Landau. 1980) was much less pronounced with histamine chal-
lenge. 
In the opinion of various authors (Kiviloog, !973a; Editorial Thorax, !979) 
and of our group (see paragraph 7.1) EIB may be considered as an expression of BR. 
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CHAPTERS 6-8 
The Studies 

CHAPTER 6. STUDIES TO THE METHODS OF MEASUREMENTS 
6. I. Bronchial responsiveness as a function of inhaled histamine and the methods 
of measurement 
H. J. Neijens. M. Hofkamp, H. J. Degenhart and K. F. Kerrebijn 
Summary 
Methodical factors in the determination of bronchial responsiveness to hist-
amine were studied in two groups of asthmatic children. In the first, dose-response 
relationships of inhaled histamine and the provocation dose defined as the threshold 
(PD) were calculated by various methods. using different techniques of analysis of 
the dose-response relationship. These PD correlated strongly. but their absolute 
values varied. A 15% decrease in FEV, was a suitable criterion for the PD (PD,). 
Other fixed criteria (PD20 and PD,) revealed PD values which had an arithmetical 
relationship with PD, and produced no advantage. However, the PD calculated on 
the basis of the intra-subject variability had a considerable variation with those using 
a fixed criterion. The response rate (slope of the dose-response curve) is unrelated 
to the threshold. 
The time-response relationship was analysed in group two. Bronchial obstruc-
tion after the inhalation of the PD and the proceeding dose lasted for about 15 
minutes. Nevertheless no accumulative effect was found giving sequential histamine 
concentrations inhaled at three minutes intervals. 
Introduction 
Increased bronchial responsiveness (BR) is a hallmark of asthma (3.17). The 
severity of the bronchial obstruction induced by several triggers, such as allergens 
L This study is supported by the Netherlands Asthma Foundation. 
2. Presented at the meetings of the Hyperreactivity Group of the Netherlands Asthma Foundation. 
Lcusden. The Netherlands. september 24the, 1980 and of the Working Group on Bronchial Hyper~ 
reactivity of the European Society for Clinical Respiratory Physiology. G6teborg, June 3rd. 
1981. 
3. Accepted for publication in The Bulletin Europeen de Physiopathologie Respiratoire/Clinica\ 
Respiratory Physiology. 
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(2.11.14.15) and exercise (12.13.16) is related to the degree of BR. Determination of 
the presence of exaggerated BR is increasingly used to establish or diagnose asthma 
and to estimate its severity. BR is determined by measuring airflow limitation in-
duced by agents like histamine or acetylcholine (3.17) and recently a test using cold 
air and hyperpnea has been proposed (4). Most laboratories use a method in which 
the agents are inhaled in increasing concentrations. From the dose-response curves 
the histamine provocation dose (PD) or threshold is delineated. which is the con-
centration at which a defined bronchial obstruction appears (18) and a response 
rate can be calculated. Repeated measurements give reproducible results when 
performed within a couple of days in the same individual (9, 10), but are influenced 
by differences in methods and criteria of judging the response. 
We have compared the PD from the dose-response curves using several 
analysis techniques, and various criteria for defining significant bronchial obstruc-
tion. We have also studied accumulative effects of sequential doses of histamine 
and its influence on the threshold and response rate. 
The time-response relationships after histamine inhalations have also been 
measured. 
Methods 
I. The histamine challenge was performed by inhalation of hist-
amine biphosphate solution in saline in sequential concentrations 
(doses '/,. I, 2. 4. 8, 16, 32 and 64 g.l-1) (18). At the beginning and twice 
during the inhalation each patient performed a submaximal vital capacity 
manoeuvre. after which they inhaled the aerosol at slow tidal volume breathing 
(12-15 per minute) for 30 seconds. The time between the inhalations was 3 
minutes. unless otherwise mentioned. 
Histamine was nebulised by a Doppel Inhaler (Wiesbaden) (flow 6 Lmin- 1) 
the characteristics of which are described elsewhere (6). Saline solution was in-
haled before histamine in order to exclude non-specific responses. Before and 
after every inhalation the lung function was measured by flow-volume curves. 
The forced expiratory volume in the first second (FEY 1) was indicated by a 
time signal and used for the results. Each measurement was performed three 
times in an optimal way. The highest is taken as the result. Changes were 
expressed as a percentage of the baseline. 
2. The dose-response relationship was studied in 18 patients (group I, II boys and 
7 girls, mean age 13.2 years with a range from 8 to 16.4 years). After the con-
centration which caused a decrease in FEY, ? 15% (PD 15) was achieved. three 
successive concentrations were inhaled, each after an interval of one hour to 
avoid accumulative effects. This was not performed if severe bronchial ob-
struction occurred. The dose-response relationships were calculated by linear 
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Figure I. A smoothed dose-response curve (patient number 8) reflecting the change in FEY 1 re-
sulting from inhalations of sequential concentrations histamine biphosphate plotted on 
a ~log scale. 
a= the change in FEY 1 which is the criterion for the provocation dose. 
b =the point of maximal inflexion 
c =the histamine concentration which corresponds to a given change in FEY 1• i.e. the 
provocation dose or the threshold. 
total = analysis using every response obtained 
partial = analysis using the responses from where they deviate from baseline. 
and square regression equations. 
Log dose response curves were constructed as follows (Figure !): 
A. by calculating a linear regression equation using every response obtained 
("total dose-response curve"); 
B. by calculating a square regression equation using every response obtained~ 
C. by calculating a linear regression equation using the responses from where 
they definitely deviate from baseline ("partial dose-response curve ·•); this 
was visually determined; 
D. by handdrawing the best fitting parabolic curve through all responses. 
PD according to A. B. C and D were defined as the calculated concentration 
from the corresponding dose-response curve according to a certain degree of 
bronchial obstruction. 
E. PD 15 was defined as the lowest administered concentration after which at 
least a significant bronchial obstruction e>ccurs ("stepmethod"). 
75 
PD., were compared with the PD producing a 20 (PD20) and 25% decrease 
(PD,) using methods B and E. Similar calculations were done to the PD using 
a decrease in FEV 1 of twice the coefficient of variation of the baseline values 
(PD,,), which reflected the intra-subject variability (9.10). 
The point of maximal inflexion is defined as the histamine concentration 
at which the dose-response curve bends maximally (Figure 1). This point is 
approximated by the histamine concentration (x) and the response (y), where the 
radius of curvature (K) is minimal. 
3. The time-response relationship after the inhalation of histamine was studied in 
group II (18 patients, 10 boys and 8 girls, mean age 11.6 years with a range of 
9.4 till 13.9). After the PD., (according to method E) was reached. the FEY, 
was repeated every five minutes until its value was about 5 percent below the 
baseline value. 
The concentration of histamine which was defined as the PD and the pre-
ceding concentration C'subprovocation dose= sub PD) were again administered 
at intervals of two hours ("single PD 15 and sub PD 15). After each dose there-
covery of the FEY, was recorded as before. 
The changes in FEY 1 after the inhalation of the single PD 15 and sub PD 15 
were compared to those after the PD., and sub PD 15 in complete sequence of 
doses (series). 
4. The patients were selected from the outpatient clinic for respiratory disease of 
the Sophia Children's Hospital in Rotterdam. In the two weeks prior to the study 
the patients were in a stable condition according to the clinical history and had 
not received cromoglycate or oral corticosteroids. Other drugs were withdrawn 
three days prior to the study. Patients and their parents were fully informed 
and they gave their consent for the study. 
Results 
The results in group I are given in Table I. The baseline FEY1 and the PD 15 
calculated according to the various methods are shown in Table 2. The trend in the 
differences of the PD 15 according to the various methods is significant (Friedman's 
test P < 0.001), i.e. the trend in the median values reflects the trend in the values of 
most individuals. 
In most patients the pattern of the dose-response curves is curvilinear (a 
second degree polynomial). The first part of the curve increases slightly and is in 
most patients followed after a point "of maximal inflexion by a rapid increase (the 
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Table I. Changes in FEV 1 after the inhalation of saline and histamine hi phosphate. expressed as 
percentage of the baseline value for height. 
Histamine concentration (G.L- 1) 
Patients 
Saline 0.25 0.50 2 4 8 16 32 64 
+5 0 -2 -19 -49 -20 -74 
2 0 - 3 -5 -32 -14 -16 -70 
3 +7 -10 -5 - 2 -48 -53 -63 
4 0 - 2 -2 -21 -12 -21 -29 -26 
5 +5 -3 + 2 -39 -46 -53 -63 
6 -5 7 -4 7 -16 -23 -52 -41 -41 
7 0 0 0 -10 -40 -42 -61 
8 +2 0 0 5 -12 -23 -32 -44 
9 0 -4 -6 8 -II -18 -42 -24 -47 
10 0 0 0 0 -10 -17 -49 -47 -57 
II -I - 3 -2 - 2 - 7 7 -46 -35 -59 
12 +I 0 -2 - 2 0 5 -38 -43 -27 -59 
13 -I - 5 -5 - 7 7 8 -27 -30 -75 
14 -3 + 3 +2 + 2 3 9 -19 -31 -34 -47 
15 +I + 3 0 + I 0 0 -27 -27 -65 
16 +3 + 5 +3 6 6 6 -13 - 9 -30 -78 
17 -2 + 2 +4 + 4 2 + I 9 -16 -37 -52 
18 +2 + 6 +5 + 2 0 2 2 - 3 -29 -52 
response rate) (Figure 1). The curvilinear pattern is highlighted by the square re-
gression equations using every response obtained which describe the dose-response 
relationship better than the linear regression equations with significantly better cor-
relation coefficients (F-test) in 12 of the 18 patients (Table 3). The methods differ 
in their ability to take the point of maximal inflexion into account. Methods B 
(square analysis of the total curve) and C (linear analysis of the partial curve) are 
superior in this respect. Method B is a simple and accurate procedure and is there-
fore considered as the reference method. 
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Table 2. Histamine PD 15 calculated by different methods. 
Methods 
Baseline 
Dose-response curve 
FEY I 
Patients Total Partial By hand Step 
% 
Linear Square Linear 
Predicted 
A B c D E 
97 0.7 0.9 0.7 
2 84 0.8 1.4 0.8 
3 69 0.7 1.0 1.2 1.! 
4 88 1.7 1.3 1.6 2.6 
5 58 0.9 0.9 1.2 1.3 2 
6 92 I. I !.I 1.4 2.1 2 
7 81 1.3 2.0 1.9 2.5 2 
8 74 1.8 2.7 2.0 2.2 4 
9 102 1.6 2.2 2.2 2.6 4 
10 84 2.5 2.5 2.5 2.4 4 
II 85 1.8 3.5 3.5 4 8 
12 93 2.6 4.4 4.0 6.6 8 
13 92 1.8 4.6 4.3 6.1 8 
14 105 4.0 6.3 5.6 6.1 8 
15 76 3.0 6.0 7.4 8 8 
16 78 3.8 9.4 9.4 15.3 8 
17 77 5.7 1!.5 10.8 13.3 16 
18 80 8.7 14.6 11.6 25.2 32 
Median 1.7 2.4 2.1 2.5 4 
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Table 3. Correlation coefficients of the linear and square regression equations of total dose-
respons curves. (Method A and B). 
Patients 
Power of regression equations 
Linear Square 
0.84 0.85 
2 0.85 0.8I 
3 0.89 0.90 
4 0.88 0.89 
5 0.94 0.94 
6 0.89 0.89 
7 0.87 0.96* 
8 0.97 0.99* 
9 0.88 0.92* 
IO 0.94 0.97"' 
II 0.87 0.93"' 
I2 0.85 0.90* 
13 0.8I G.96t 
I4 0.96 0.99t 
I5 0.8I 0.97t 
I6 0.75 0.92t 
I7 0.88 0.99t 
I8 0.82 0.94t 
Significances of the improvement in correlation (F-test). 
[
•P<0.05 
tP < O.OI 
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The relationship between the PD 15 witb the various methods are shown in log: 
log diagrams on a 'logarithmic scale (Figure 2). Although the relationship between 
the PD 15 according to metbod A and the reference method B correlated well 
(r = 0.93, p < 0.00 1), values differ slightly. The distance between the regression 
line and the line of identity represents the difference between the results by both 
methods, which may be estimated by the slope a of the regression equation y = ax + 
b. In this case the slope is 0. 7 6 indicating that tbe PD 15 with method A are lower 
than those with the reference method (B) and this is more pronounced in high than 
in low PD 15 • These differences can be explained by the curvilinear pattern of the 
dose-response relationship. 
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Figure 2. Comparison of the PD 15 obtained by various methods. 
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Calculated regression line---: line if y = x ----- :Method A: linear analysis 
of every response obtained: Method B = square analysis of every response obtained: 
Method C = linear analysis of a part of the responses: Method E = step. 
PD2o-
2so--o 
histamine concentration (g.l-1 ) 
32 
16 CRITERION 
8 
-15% -20% -25°/o 
4 
2 
0.50 l PD (g.!"') 
0.25 0.5 1 2 4 8 16 32 
histamine concentration (g.l- 1 ) 
PD15 
Figure 3. PD~0 and PD~5 (y-axis) compared with PD 15 (x-axis). 
Method B. 
Regression line ify = x ---. 
Regression equations: 
LINEAR TERMS: 
~log Y~0 = 0.3946 + ~log (x 1 ~ + 0.3608) r = 0.99. P < 0.00 l 
F ~ 693.17 
:logY :s = 0. 7270 + :log (x 15 + l.l599) r = 0.88. P < 0.00 I 
F ~ 56.38 
LOGARITHMIC TERMS: 
Y:o = 0.96 X 15 + 0.59 
Y:5 = 0.95 X 15 + 1.01 
1.5 2.0 
4 5.7 7.7 
16 21.4 27.6 
The PD., with method C and method B correlate well (Figure 2, r = 0.97, 
P < 0.001). The regression line is almost the same as the line of identity (y = x), 
which indicates that the PO with both methods is nearly identical. The PD 15 with 
method E and with the reference method B are also related (Figure 2. r = 0.94, 
P < 0.001). The slope !.II of the regression line indicates that the PD15 with 
method E is somewhat higher than those with method B. 
We have analysed the extent to which PD is influenced by changing the 
criterion for bronchial obstruction. 
In Figure 3 the PD is compared from either a 15%, and 20% or 25% decrease 
in FEY,. The values are calculated according to method B and reproduced on a 
logarithmic scale. The regression lines represent the interrelationship of the PD 
according to the various criteria. The slopes of the regression lines are almost I, 
indicating a parallelism with the line of identity which means constant differences 
in logarithmic terms ('log g.l-1) throughout the threshold range. The effect of change 
of criterion is small and about similar over the whole range as shown by the slope 
and the high correlation coefficients. The changes in linear terms (g.l-1) can be 
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PD2o 
histamine concentration (g.l- 1 ) 
32 • 
16 
8 
4 
2 
-
2 4 8 16 
histamine concentration (g .1- 1) 
PD15 
32 
Figure 4. PD~0 compared to PD 15 using the step method (E). Regression line ify = x ---. 
calculated from the equations which describe the PD20 in relation to the PD 15 : 
2log y200 0.3946 + 2log (x15 + 0.3608) and in the case of the PD25 compared to the 
PD 15 : 2log y25 0 0.7270 + 2log (x15 + 1.1599). In the table next to Figure 3 
examples of PD values in linear terms according to the various criteria are given. 
Because method E is often used their PD20 is compared to the PD 15 (Figure 4). 
In 9 of the 18 patients no difference is seen, in 6 patients the PD 15 is I concentra-
tion lower and in 3 it is 2 concentrations lower than the PD20• The comparison of 
PD 15 with PD2" (Figure 5) gives in most cases lower values ofPD2" than PD 15 with 
a wider scatter than between the fixed criteria. 
PD2x cocff. var. 
histamine concentration (g.l- 1) 
32 
16 
8 
4 
2 ,_ 
1 
0.50 
• 
• r = 0.72, P<O.Ol 
y = 1.22x- 1.53 
0.25 t 
0.25 0.5 1 2 X 4 8 16 32 
histamine concentrat-ion (g.l-1 ) 
PD15 
Figure 5. Comparison of the PD 15 (method B) with the PD~~v· 
Regression line if y = x,..-- -
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The bronchial responsiveness to histamine is not only estimated by the con-
centration which gives a certain degree of bronchial obstruction. but also by the 
response rate (see Figure 1). 
The response rate is assessed by the slope of the linear regression equation of 
the partial curve (method C). Figure 6a shows the relationship between the PD, 
(method B) and the response rates. As no relationship exists (r = 0.12, not signifi· 
cant), it can be concluded that the response rate is independent of the PD. Figure 6b 
shows the relationship between the PD, and the point of maximal inflexion (see 
Figure 1). 
response rotc point of maximo I inflexion 
(Slope) hi5tomine concentration (g.l- 1 ) 
21 
18 
15 
12 
9 
6 
3 
r=O 12 r=0.80. P<O.Ol 
n .s. y=0.46x- 0.31 
. . 
0 2 4 6 8 10 12 14 16 0 2 4 6 8 TO 12 14 16 
histamine concentration (g_l- 1) 
PD,5 
Figure 6. Comparison of the PD 15 (method B) with the response rate (the regression coefficient 
of method C) and the point of maximal inflexion in two separate graphs. 
A significant. positive relationship exists between the histamine concentrations 
defined as the PD 15 and those corresponding with the point of maximal inflexion 
(r = 0.80, P < 0.001). It appears that the PD, is predominantly defined by the 
point of maximal inflexion and not evidently by the response rate. This also holds 
in the case of PD20_ 
The results from the patient of group II are shown in Figure 7. The FEY, after 
each of the histamine inhalations~ including the PD 15 given as a series, and after the 
single sub PD, and the single PD, is shown as well as the increase in FEY, with 
time (recovery). Although the decrease after the series is somewhat larger than that 
after the single doses, the difference do not reach significance (student T test, P 
< 0.1). 
On average the FEY 1 is returned till about 5% below the baseline value after 
15 minutes. In this respect there is no difference in the recovery after the series or 
after a single dose (test according to Gebelein and Ruhenstroth-Bauer (8).: P < 0.1). 
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decrea5e in FEV1 
% ba5eline in a series singly given 30 I b c I d 0 it I 25 t 
I 
I it I 20 I I I 
t I I I I 15 I t t I 
t 
I t I 10 I I I 
t 
I ? I 
+ 
I 
5 I I 
+ 
I ?1 I 
0 ~I I 
0 5 10 15 0 5 10 15 0 5 10 15 
time after inhalation (min.) 
Figure 7. Mean recovery ( ± sem) of the change in FEY 1 in 18 patients. with time after the in~ 
halation of histamine in a series or singly given. a = after the histamine concentration 
prior to the PD 1 ~. b = after the PD 15• c = equal to a but singly given. d = equal to b 
but singly given. 
Differences in the recovery rate: b- d. not significant. c- d. P < 0.01 (test according to 
Gebelein and Ruhenstroth-Bauer (8) ). 
Although the rate of recovery after the sub PD 15 and the PD 15 as single doses 
differs, the recovery time is about equaL This indicates that the recovery time does 
not necessarily depend on the drop in the FEV 1, In each patient the baseline values 
of the three tests were approximately equaL It can therefore be assumed tbat the 
results were not influenced by differences in the basic condition. 
Discussion 
The dose-response relationship of histamine in the bronchi plotted on a semi-
logarithmic scale has curvilinear features (second degree polynomial) as in many 
biological systems. This pattern has similarities to the in vivo equivalent of the left 
part of the S-shaped curve which reflects the bronchial smooth muscle strength in 
vitro caused by an agonist (1). 
It is widely accepted that the bronchial reaction induced by histamine is short 
lasting. However, we have shown that it usually takes at least 15 minutes before 
the FEV1 reapproaches the baseline value after inhalation of the PD15 or the 
sub PD 15 (figure 7). Giving histamine concentrations in a series with a few minutes 
interval could have an accumulative effect, but this is improbable, because it would 
predominantly effect the response rate, which has no measurable impact on the 
PD 15 (figure 6). These theoretical considerations were confirmed by our observations 
84 
Table 4. Values and percentage decrease in PD 
model of a typical dose-response curve. 
%cumulation PD 1 ~ 
(G.L 1 ) %deer 
0 4.3 
10 4.1 5 
15 4.0 7 
20 4.0 7 
30 3.9 10 
change in FEV1 
in relation with accumulation in a simufared 
PD~o PD~s 
(G.I.:I) %deer (G.l:ll %deer 
6.7 
6.1 
5.9 
5.9 
5.5 
/PD25 
9.9 
9 8.7 
12 8.3 
12 8.3 
18 7.5 
Degree of accumulation 
Concentration of 
inhaled histamine 
12 
16 
16 
24 
Difference in 
that the drop in FEV1 induced by tbe PD 15 after a series or that after a single dose 
were approximately equal (figure 7). To avoid an eventually occurring strong 
response rate. we have taken hourly intervals with concentrations above the thres-
hold. 
The influence of accumulation has also been analysed in a typical curve in 
which accumulation is simulated increasing there response rates (Table 4). An 
influence of accumulation on the threshold may be assumed if the criterion for tbe 
threshold is 20% or more and the increase in the response rate is at least 20%. 
Although differences in PD 15 between individuals can be defined by all methods, 
the absolute values may vary. The PD can therefore be calculated most accurately 
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with methods that take the curvilinear pattern into account. This can best be done 
by a square analysis of every response obtained (method B) or a linear analysis of 
the responses from the point where they definitely deviate from the baseline (method 
C). As this point may be difficult to define, we prefer method B as the reference 
method. The commonly used stepmethod (E) generally gives higher values than the 
reference method. This is the consequence of the method, which defines the PD as 
the lowest administered concentration after which the chosen criterion is exceeded 
or at least reached. The difference increases with rising PD, because the histamine 
concentrations are administered in a geometrical series. A disadvantage of method 
E is that the drop in FEY 1 may differ considerably between individuals with the 
same PD (Figure 4). 
The linear analysis of every response obtained is attractive because of its sim-
plicity, but gives mostly lower values than the reference method (Table 2, Figure 2). 
With rising PD the differences incr~ase, because the higher the histamine concen-
tration at which the point of maximal inflexion is situated, the more inaccurate 
a straight line fits the curvilinear pattern. The PD 15 determined from a curve 
constructed by hand is mostly higher than those with the reference method (table 2). 
Although this line is influenced by subjective variances, it will tend to have a 
sharper inflexion than that of the reference curve. Thus the point of maximal in-
flexion and consequently the PD will rise to a higher value. 
If the criterion for significant bronchial obstruction is changed from !5 to 20 
or 25%, the PD values increase (Figure 3). Quantitatively the difference is not only 
dependent on the change in the criterion, but also on the value of the original PD. 
In linear terms a change from 15 to 20% increases the PD values over the whole 
range with approximately 30% and in the case of a change in criterion from 15 to 
25%, with approximately 60%. In the case of the stepmethod a change in criterion 
influences the PD in a variable way. 
A different approach for the PD determination is the calculation of the intra-
subject variability of the FEY 1 prior to the inhalation challenge, and to define twice 
the coefficient of variation. The PD thus defined is also related to, although gene-
rally lower than, that by the !5% criterion. However, they had a considerable 
scatter. This is due to the difference in intra-subject variability in the population. 
A comparison of the biological significance of both methods will have to clarify 
whether the intra-subject variability is a better criterion for. bronchial obstruction 
than the commonly used fixed ones. 
As in studies by Orehek ( 17) and Habib (9) we found no relationship between 
the PD and the response rate. This can be understood from animal studies in which 
the influence of components which contribute to the mechanism of bronchial 
obstruction on the dose-response relationship was studied (7). The greater the 
excitability of the parasympathetic nerve the more the dose-response curve is shifted 
to the left in a parallel way. The authors stated that bronchial smooth muscle tone 
was related to the response rate. This is in agreement with the findings in guinea 
86 
pigs from Orazen and Austen (5). 
We concluded that a good estimation of the bronchial responsiveness to 
histamine could be obtained by calculating the PO 15 from the total dose-response 
curve using a square analysis. Linear analysis of the responses which definitely 
deviate from baseline could also be used, but this was liable to subjective choice of 
the responses taken for analysis. A 15% decrease in FEV 1 was a suitable criterion to 
delineate PD. Other criteria such as 20 or 25% could be used, but they have no 
advantage over a 15% decrease in FEV" as the PO's according had an arithmetical 
relationship. Although the PD calculated on the basis of the intra-subject variability 
is related to that with a fixed criterion, the values showed a considerable scatter. 
We have shown that the administration of histamine inhalations as a geometrical 
series with at least three minutes intervals until! the PO was reached produced no 
accumulative effects. Insight in the dose-response relationship could be augmented 
if after the PD 15 , the response of three successive concentrations were measured 
unless severe bronchial obstruction occured. Hence the PO could be calculated more 
accurately and the response rate could be determined. The stepmethod was easy to 
use and gives a fair estimate of the PD. However. results could not easily be com-
pared with those obtained with other methods and different criteria. 
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CHAPTER 7. STUDIES OF THE METHODS OF MEASUREMENTS 
7 .1. Exercise-induced bronchoconstriction as an expression of bronchial hyper-
reactivity: a study of its mechanisms in children 
HermanJ. Neijens M.D .. Taco Wesselius M. D .• Karel F. Kerrebijn M.D. 
Abstract 
The mechanism of exercise-induced bronchoconstriction (EIB) was studied by 
observing the protective effects of several aerosolized agents in a double-blind, 
randomized trial. 
EIB is affected not by the placebo, but by all of the agents (P < 0.001). Block-
ing the parasympathetic system had the weakest effect; whilst ~ 2 adrenergic 
stimulation produced the strongest effect which was significantly different from the 
parasympatholytic (P < 0.02). The effect of the mast cell stabilizer was found to be 
intermediate. However, in some of the patients the mast cell stabilizer had a stronger 
effect than the ~ 2 adrenergic agonist. 
The effect of the parasympatholytic and the mast cell stabilizer varied amongst 
patients. Their combined effect approached the degree of E!B. 
EIB was related to the bronchial hyperreactivity induced by histamine 
(P < 0.05). Their possible mechanisms are discussed. 
INTRODUCTION 
Bronchial hyperreactivity to non-specific stimuli is one of the hallmarks of 
bronchial asthma1"'. This implies the occurrence of bronchoconstriction after the 
inhalation of physical or chemical stimuli (allergens excepted) to a degree or at a 
concentration which would have no effect on healthy people. The degree of hyper-
reactivity is often estimated by the bronchial sensitivity to histamine, acetylcholine 
or methacholine. 
1. This study is supported by the Netherlands Asthma Foundation (grant nr. 279) and Boehringer 
Ingclheim Ltd. Haarlem who also supplied the agents. 
2. Presented at the meetings of the Dutch Paediatric Association. Noordwijkerhout. The Nether-
lands, september 8th. 1979 and of the British Paediatric Respiratory Group. Nothingham. Eng-
land. September lith. 1979. 
3. Published in Thorax. 1981; 36: 517-522. Reprint with permission of the publisher. 
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A strong correlation has been found between tbe bronchial sensitlVlty to 
histamine and exercise-induced bronchoconstriction (E!B)3_4_ 5 • Some authors4 
consider EIB an expression ofhyperreactivity. 
The mechanism of ElB is currently only partially understood. The parasym-
pathetic nervous system~ activated by sensory fibres situated in the mucosa of the 
large airways ("irritant receptors'") seems to play a role, because aerosolised para-
sympatholytic agents' or local anaesthetics 7 may diminish or abolish EIB. Several 
studies' point to the important influence of rapid ventilation with cold, dry air as 
the initiating stimulus which may trigger irritant receptors. ~ 2 adrenergic agonists 
block E!B6, whieh suggests that the sympathetic nervous system also plays a role. 
Disodium cromoglycate often gives protection against ElB9• This may indicate that 
mediator release from mast cells or from related histamine containing cells in the 
bronchial lumen 10 is also involved. Some authors suggest that cromoglycate may 
influence EIB in other ways5-s-11 • None of these suggestions have, however, been 
substantiated5• Therefore, we have assumed that the effect of cromoglycate is 
brought about by mast cell stabilisation". 
We measured the protective effect of various agents in a group of asthmatic 
children who also had EIB. A (3 2 adrenergic agonist, a parasympatholytic agent as 
well as a mast cell stabilizer were all tested as aerosols. In this way the contribution 
of the various parts of the autonomic nervous system and of mast cells in the 
mechanism of EIB has been studied. 
We present a hypothesis to define the role of these systems in EIB. The 
bronchial sensitivity to histamine was also measured and related to the protective 
effect of the agents. It is concluded that the mechanisms of bronchoconstriction 
induced by exercise and by histamine have much in common. 
Methods 
I. 25 Asthmatic patients were studied, 12 did not fulfill all the criteria, therefore 
the results of the remaining 13 patients were analysed. This group consisted of 
9 boys and 4 girls and their ages ranged from 9 to 151/ 2 years witb a mean of 
125/ 12 years. The patients were selected from tbe outpatient clinic of the Sophia 
Children's Hospital in Rotterdam (The Netherlands). The criteria were the initial 
forced expiratory volume in 1 second (FEV 1) )o 60% of tbe mean expected value 
for height and the exercise-induced decrease in FEV, )o 15% of the initial value 
in the basal tests on each of tbe 3 consecutive days (see 4). For each patient 
these values had to be reproducible, i.e. tbeir coefficient of variation (~ standard 
deviation as percentage of the mean) was less than 15%. 
In the 2 weeks prior to the study the patients were in a stable clinical condition 
and had not received cromoglycate, beclomethasone, oral corticosteroids or 
(32 adrenergic agonists. Other drugs were withdrawn 3 days prior to tbe tests. 
2. The exercise test was done on a Jaeger treadmill following tbe method of 
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Eggleston and Guerrant". The slope was 10° and the running time about 
6 minutes. The speed was increased to give a pulse rate of about 175/min. This 
was reached with speeds between 5 and 12 km/hour. 
3. Bronchoconstriction was detected by lung function measurement using a Finivess 
flow-volume equipment. The FEY 1 was registered by a time signal. The results 
were based upon the FEY 1 values. The maximal expiratory flows at 25% of the 
forced vital capacity were also analysed. but no essential differences were found 
compared to the FEY 1 values, consequently they are not mentioned further. 
Pulmonary function tests were measured at the following times: before, im-
mediately after and 5, I 0, 15 and 20 minutes after the exercise tests. At every 
measurement the flow-volume curve was recorded three times and the highest 
FEV 1 values were taken for the results. 
The change in FEY 1 was expressed as a percentage of the initial value. The 
criterion taken for bronchoconstriction was a decrease in FEV 1 ):: 15%. 
4. The study was done on 4 consecutive days. On the first day an exercise test was 
done after the administration of a placebo. On each of the 3 following days an 
exercise test was performed twice. At 9 a.m. it was done without a protective 
agent (basal test). At I 0.40 a.m. a protective agent was given. The test was 
repeated 20 minutes thereafter. A two hour interval between tests would avoid 
interest influences 14. The temperature and humidity of the air in the room where 
the tests took place. were rather constant at approximately 22° and 70% re-
spectively: they were. however~ not controlled. 
5. On each of the test days, one of the following protective agents was given in a 
random order. 
- oxytropium bromide (parasympatholytic), 0,02 mg per dose aerosol (2 puffs) 
- disodium cromoglycate (mast cell stabilizer), 20 mg as aquous solution per 
ultrasonic nebulizer (Monaghan 670). By using a solution we avoided cromo-
glycate acting by a hygroscopic effect alone 11 • 
- fenoterol (~,adrenergic agonist), 0,4 mg per dose aerosol (2 puffs). 
The inhalation was performed as follows: after a submaximal expiration, the 
patient inspired synchronously with the aerosol, the mouth being kept closed 
over the inhaler opening. During this inspiration the tongue was kept on the 
floor of the mouth. After inspiration the breath was held for 5 seconds. The 
technique was learnt using a placebo. 
The doses were chosen so that a maximal effect in pharmacological terms 
could be expected 15- 16- 17. 
6. The histamine threshold was measured by means of the inhalation of histamine 
acid phosphate in increasing concentration (doses I, 2, 4, 8, 16, 32 and 64 
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mg/ml) 18• At the beginning of the inhalation each patient performed a sub· 
maximal vital capacity manoeuvre, after which they inhaled the aerosol at tidal 
volume for 30 seconds. The time between the inhalations was 3-5 minutes. 
The histamine concentration which caused a decrease in FEY 1 ?:: 15% of the 
initial value was called the histamine threshold. With this technique the histamine 
threshold in healthy children is) 32 mg/ml. 
7. Statistics. 
An analysis of variance was done in order to detect any influences of day- or 
agent sequence on the initial FEY1 (every day at 9 a.m. and during the day) and 
the decrease of the FEY 1 induced by exercise without protection (basal tests). 
The results concerning the effects of the protective agents and the comparison 
between them were analysed by calculating means and standard errors and 
hence paired student T tests. The relationship between the decrease in FEY 1 
without agents and the degree of protection by each agent (figure I) as well as 
the histamine threshold (figure 4) were analysed by lineair regression equations. 
from which p-values were derived. 
The patient groups were divided according to the greatest effect by paired 
comparison between the three agents. These patient groups were compared 
according to the initial FEY 1, the decrease in FEY 1 induced by exercise without 
protection and the histamine threshold. The differences were analysed by 
Wilcoxon tests. The 5% level was considered as the level of significance. 
Results 
In the basal tests no correlation existed between the day - and agents sequences 
on the one hand and the initial FEY 1 and the decrease in FEY 1 in the basal tests 
on the other hand (Analysis of variance). This makes the influence of variables other 
than the protective agents on the results improbable. The initial FEY 1 values at 
9 and II a.m. did not change significantly. except after the administration of the 
~ 2 adrenergic agonist when they were just significantly higher (0,02 < P < 0,05). 
Table I shows the mean change in FEY 1 after exercise without and with pro· 
tection for the group as a whole. The decrease in FEY 1 without protection is 
32.4 ± 3.0% and the results after the placebo are not significantly different from 
those without. 
After the administration of the protective agents there was either less decrease 
in FEV 1 or even an increase was observed. The results following all protective 
agents were significantly different from those without (P < 0.001). The degree of 
protection. defined as the difference between the decrease in FEY 1 with and without 
agents, was significant for all of them. 
If the effects of the protective agents are mutually compared, there appears 
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Table l. Mean changes in FEV 1 after exercise without and with the placebo and each of the 
protecting agents. 
Decrease in FEV 1 Degree of t Difference 
induced by exercise protection between agents 
Agents 
Mean ± S.E.M. P~value Mean .±_ S.E.M. P-value P-value 
Without 
-32.4 ±3.0 
Placebo 
-27.5 ±3.2 N.S. 
Parasympatholytic 
-12.5 ±4.7 < 0.001 16.6 ±4.1 < 0.01 
rN.S. r 
Mast cell stabilizer 6.7 ±2.1 < 0.001 25.8 ±4.1 < 0.001 I 1<0.02 
~~Adrenergic agonist + 1.5 .:t:5.2 < 0.001 32.5 ±5.4 < 0.001 
N.S.i 
Mean ± S.E.M. are expressed as percentage of the initial values. 
·J· Difference of change in FEV 1 with and without agents. 
only a significant difference between the parasympatholytic and the ~' adrenergic 
agonist (P < 0.02). 
In figure I the decrease in FEV 1 for every patient without protection is com-
pared with the degree of protection given by each of the three agents in a separate 
graph. The degree of protection ranged up to 20% in the case of the parasympa-
tholytic, 50% in the case of the mast cell stabilizer and 60% in the case of the ~' 
adrenergic agonist. It appears to be greater the more pronounced the decrease in 
FEV 1 without protection. A relationship exists between those factors. In the formula 
y = ax + b. a indicates the slope. The greater the slope, the greater the degree of 
Degree of protection (%of initio! value) by: 
Parasympatholytic Mast cell stabilizer ~2 adrenergic agonist 80 y=O.l6x+7.72 80 y=0.73x+l .40 80 y=0.90x+4.24 
r = 0.14 r = 0.65 r = 0.50 
60 60 60 • • 
• • 
3 
40 40 • • 40 • 
• • . . 
• 
20 •• 20 • • 20 • ••• • . . • • & 
• • • ••• • • • 0 0 0 
0 20 40 60 0 20 40 60 0 20 40 60 
:lecreosc in FEV, induced by exercise without agents(% of the initial values) 
Figure I. Comparison per patient of the decrease in FEV 1 induced by exercise without agents 
and the degree of protection given by several agents. The degree of protection is the 
difference between the decrease in FEV 1 with and without agents. 
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protection. The parasympatholytic gives a slope of 0.16, the mast cell stabilizer 0. 73 
and the~' adrenergic agonist 0.90. 
From the fact that the degree of protection was related only to the degree of 
bronchoconstriction without protection (Figure I) and not to the degree of broncho-
dilatation after the ~' adrenergic agonist without exercise (Figure 2), it is to be 
concluded that the agents were not effective in EIB by initial bronchodilatation but 
by influencing the mechanism. 
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Figure 2. Changes in FEY 1 without exercise by the !3~ adrenergic agonist in patients in whom the 
mast cell stabilizer (b) respectively the 13~ adrenergic agonist (c) gave the best degree of 
protection in EIB. 
A check was made to see if some of the patients reacted differently to the 
group as a whole. For each patie~t the protective agent which gave the best degree 
of protection was determined by paired comparison between the agents (Figure 3). 
The parasympatholytic showed superior protection in 3 .patients when compared 
with the mast cell stabilizer and in I patient when compared with the ~' adrenergic 
agonist. The mast cell stabilizer gave the best protection in 4 patients compared with 
the~' adrenergic agonist. 
For each patient these differences in the protection were expressed in quanti-
tative terms as the quotient of the degree of protection of the agents compared. 
whereby the strongest one is situated in the upper part. Nearly all quotients are 
markedly greater than I. which points to the fact that the differences in degree of 
protection are relevant. For median values see the figures in the columns of 
Figure 3. 
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Figure 3. The number of patients according to the best degree of protection in EIB by paired com-
parison of the agents. 
a - parasympatholytic~ b - mast cell stabilizer; c - ~~ adrenergic agonist. 
Equal effects were not found. 
The difference in effect is for each patient expressed as the quotient of the degree of 
protection by the agents compaired. The medians of the quotients are shown in the 
columns. They indicate that the division of the patients into groups is not based on 
marginal differences in effect of the agents compared. 
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Figure 4. The degree of protection in EIB given by the parasympatholytic and the mast cell 
stabilizer. illustrated as accumulated effects. compared with that of the ~~ adrenergic 
agonist and the exercise-induced decrease in FEY 1 without protection. 
Both the degree of protection and the decrease of FEY 1 are expressed in percentages of 
the initial FEY 1• 
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In Figure 4 the comparison is shown between the decrease in FEY 1 induced 
by exercise without protection and the degree ofpro\ection oftbe parasympatholytic 
and the mast cell stabilizer. The accumulated degree of protection of both agents 
appears to be about equal (difference less than 10%) in 9 patients and higher in tbe 
otber 4 patients compared to tbe decrease without protection. Figure 4 also shows 
great individual differences between the accumulated degree of protection given by 
the parasympatholytic and mast cell stabilizer and tbe degree of protection given 
by the ~' adrenergic agonist. 
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Figure 5. Relationship between the histamine threshold and the exercise-induced decrease in FEY 1• 
Figure 5 shows that tbe relationship between the decrease in FEY 1 induced by 
exercise without protection and the histamine thresholds is significant (P < 0.05). 
No relationship could be detected between the decrease in FEY 1 induced by exercise 
and the initial FEY 1 (r = 0.40. not significant). 
In Figure 6 tbe patients are grouped according to tbe agent which gave tbe best 
protection by paired comparison. 
No significant differences between tbe groups existed in the initial FEY,, 
decrease in FEY 1 after unprotected exercise and histamine thresholds (Wilcoxon 
tests). 
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Figure 6. The initial FEV 1• the decrease in FEV 1 after exercise without protection and the histamine 
threshold in patient groups divided according to the best protection in EIB by paired 
comparison of the agents. 
a= parasympatholytic: b =mast cell stabilizer; c = ~~adrenergic agonist. 
Median ------
Differences between the groups are not significant (Wilcoxon tests). 
Discussion 
In this study the protective effect of a parasympatholytic, a mast cell stabilizer 
(cromoglycate) and a~' adrenergic agonist on EIB was found to be significant. 
We have assumed tbat a maximal bronchodilatating effect has been provoked 
by tbe technique and with tbe doses used and that the same was true for the protec-
tive effect on EIB although this is difficult to prove. 
Although tbe time between administration of the parasympatholytic and the 
exercise test was a little short and bronchodilatation could have occurred during 
the recovery time, we do not think this could have influenced the results to a 
meaningfull degree. 
The results were not influenced by variables other than the protective agents. 
They are in accordance with those of several other authors6-r9'""2o _ One of them, 
Tashkin19 found tbat although aerosolized atropine had some protective effect, it 
could not be differentiated from placebo effect. 
Based on Figure 1 and 2, it would seem justifiable to conclude tbat all pro-
tective agents had their effect on EIB mainly by influencing its mechanism during 
and after exercise and that this could not be explained by initial bronchodilatation. 
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It was found that individual differences existed between patients. From the 
fact that the degree of protection in some patients given by the parasympatholytic is 
greater than that of the mast cell stabilizer,_ it may be concluded that in these individ-
uals activation of the vagus is more important than activation of the mast cell 
system. In contrast to the results of the patientgroup in general, some patients 
attained a greater degree of protection from the mast cell stabilizer than from the 
~' adrenergic agonist. 
In these patients it can be assumed that mediator release from mast cells is 
relatively important in the mechanism of ElB. It seems that blocking of histamine 
release from their mast cells by triggering the ~' adrenergic receptors is only of 
limited value in contrast to the effect of cromoglycate. Also, ~' adrenergic relaxation 
of their bronchial muscles is of relatively little importance in the blocking of the 
EIB response. 
Although this might indicate hyporesponsiveness of their ~' adrenergic recep-
tors, this does not seem to be so because the bronchodilatation induced by the 
~2 adrenergic agonist under resting conditions in these patients was not less than in 
the others (Figure 2). 
Our findings that the degree of protection given by the parasympatholytic 
together with the mast cell stabilizer seems to be in accordance with the degree of 
bronchoconstriction without protection can be explained in two ways: 
L A combined action of the parasympathetic nerves and the mast cells in EIB may 
occur. Which system dominates could not be predicted from the initial lung 
function values, the bronchodilatation induced by the agents without exercise nor 
the bronchial sensitivity to histamine (Figures 2, 6). Me Fadden et al." could 
also distinguish subgroups in their population with ElB. This is important in 
view of the treatment as well. 
2. A complete stabilisation of the mast cell, resulting in blocking of mediator-
release, only occurs if besides the cromoglycate sensitive receptors the para-
sympathetic receptors of the mast cell are blocked as welL 
If it turns out that cromoglycate has effects outside the mast cells, the inter-
pretations of blocking studies like this has to be reviewed. Possibly the blocking 
effect of cromoglycate could then partially be explained by an action on bronchial 
smooth muscle or irritant receptors. The important place of the mast cells in EIB 
is however supported by the facts that EIB is followed by a period of latency" and 
that several authors22-:!3 found a rise in arterial histamine concentration after 
exercise. 
The degree of bronchoconstriction induced by exercise has a strong relation-
ship with the bronchial sensitivity to histamine as shown in this and other 
studies'_,. This indicates that the mechanisms induced by both stimuli may be 
related. There is no difference in the bronchial sensitivity to histamine in patients 
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with EIB in whom the autonomic nervous system dominates compared to those in 
whom the mast cells are of major importance. 
Thus one might suspect that both these systems play a role in the mechanism 
leading to bronchoconstriction after histamine inhalation. Although the reaction to 
histamine could be confined to the direct stimulation of the histamine receptors of 
the bronchial muscle cells'\ this is probably not the case. Jackson et aL 25 showed in 
rats that the autonomic nervous system was stimulated by the histamine aerosol, 
since the bronchial response decreased after dissection of the vagus nerve. Studies 
of Dixon et aL 26 indicate that this may be due to stimulation of irritant receptors. 
It seems probable that histamine-induced vagal stimulation also triggers mast cells, 
because the mast cell stabilizer cromoglycate diminishes the bronchial response to 
histamine in a part of the patients27--28. 
Thus large similarities exist between the mechanisms by which histamine and 
exercise induce bronchoconstriction. This justifies the view that EIB can be regarded 
as an expression of bronchial hyperreactivity. 
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Appendix to paragraph 7.1 
The degree of protection by an agent has been defined as the difference in 
change of lung function with and without an agent. The change in lung function is 
the difference between the lung function before and after a challenge with a stimulus. 
in this case an exercise test. The agent given may produce an initial bronchial dilata-
tion as well as protection during and after the challenge. Thus the degree of protec-
tion reflexes both influences. These are impossible to differentiate in a reliable way. 
This holds for the sympathomimetic and the parasympatholytic agents, but not 
forDSCG. 
It is striking that the protective effect of the parasympatholytic is relatively 
low if it is compared to the large influence of the parasympatholytic activity in 
animal experiments. However, the possibility exists that the blocking capacity of the 
parasympatholytic used, may not be optimal as suggested recently. Hartley and 
Davies (1980) showed that a very high dose of a parasympatholytic protected much 
better against exercise-induced bronchial obstruction than a normal dose. although 
the drug-induced bronchial dilatation by both were comparable. 
The protective effect of DSCG was not related to the degree of atopy in the 
patients studied. 
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7.2 Site of maximal flow-limitation in bronchial responsiveness due to exercise 
Herman J. Neijens M.D., Gianfranco Gargani M.D., Adrie van Kralingen, 
Nellie van Weezepoel, Karel F. Kerrebijn M.D. 
Abstract 
The change in the site of maximal flow-limitation with time in exercise-induced 
bronchoconstriction was studied in 16 asthmatic children by repeated measurements 
of maximal flow-volume curves in air and helium-oxygen (80/20). Bronchocon-
striction shortly after exercise is determined by flow-limitation in the more peri-
pheral airways in nearly all of the patients. Then bronchoconstriction fades away, 
while the site of maximal flow-limitation returns towards the central airways. Both 
variables have a significant relationship (P < 0.05), which differs with time and 
among patients. 
The degree of protection by the ~-sympathetic agonist is more pronounced 
(mean 28%) than that of the parasympatholytic (mean 3%), and its action increases 
along with the degree of shift in the maximal flow-limitation towards the periphery. 
The implications for the mechanism involved and the therapy are discussed. 
Introduction 
The mechanism of exercise-induced bronchoconstriction (EIB) is not fully 
understood (4). Me Fadden and Ingram (II) and also others (17) stressed the 
importance of hyperventilation with relatively cold and dry air. Several blocking 
studies in EIB have been done (8, 15, 18), which have given information about the 
role of the sympathetic, the parasympathetic and the mast cell systems. However, 
relatively little is known about the site of flow-limitation after exercise. 
Me Fadden et al. (12) used the density dependency method to analyse the site 
of maximal flow-limitation in EIB in adults. They concluded that flow-limitation in 
a number of their patients was located in the central airways and in others in the 
peripheral airways. Parasympatholytics were found to be most effective in patients 
l. This study is supported by the Netherlands Asthma Foundation (grant nr. 279). 
2. Presented at the meetings of the European Paediatric Respiratory Society, Baden near Vienna. 
Austria. October lithe. 1980 and at the congress "'Small airways in relation to chronic 
obstructive pulmonary disease", The Hague. The Netherlands. January 31st. 1981. 
3. To be published in Progress in Respiration Research 1981. 17. in press (the paper of the Baden 
Meeting) and in the European Journal of Respiratory Disease, in press. 
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with central flow-limitation, whilst in patients with peripheral flow-limitation ~-sym­
pathetic agonists were most appropriate. This method is based on the principle that 
in the peripheral airways laminar flow exists which is not dependent on the density 
of the gas, whereas turbulent flow which occurs in the larger, more centrally located 
airways is gas-density dependent according to Despas et al. (3). This means that the 
flow will increase if breathing is performed, instead of with air. with a gas of lower 
density. In healthy individuals the limitation of expiratory flow is determined by 
the diameter of the central airways. Therefore the expiratory flow after exhaling a 
low density mixture is larger than with air and the difference will be approximately 
50% if 80% Helium - 20% oxygen (He/02) is used. If the site of maximal flow-
limitation is located in airways with a turbulent flow, the difference between both 
gases will be unchanged. However, if the flow is largely limited by airways in which 
it is laminar, the difference will be smaller. Although density independent flow 
occurs preferentially in more peripheral regions of the airways than density depen-
dent flow does, the precise site were flow changes from being predominantly density 
independent to density dependent is unknown (14). 
In a previous study we found that the majority of asthmatic children is better 
protected against EIB by a ~-sympathetic agonist than by a parasympatholytic (15). 
We herewith report results of measurements of the relationship between broncho-
constriction and density dependency with time after exercise in asthmatic children. 
Also the degree of protection by either a ~,-sympathetic agonist and a para-
sympatholytic agent and its relationship to the pattern of flow-limitation will be 
evaluated. 
Methods 
1. Lung function was measured by flow-volume curves using Finivess equipment. 
These were obtained with air and with a low density gas after a wash-in of 
He/0, until the end-tidal nitrogen concentration was < 5%. At every measure-
ment the flow-volume curve was recorded three times and the highest values 
according to the method of Peslin et a!. (16) were taken. The maximal expiratory 
flow-volume curves with He/02 were adapted to those in air with the aid of a 
computer; The forced vital capacity in He/02 was equalized to that in air 
superimposing the curves at total lung capacity. Hence the flows were adapted 
accordingly. Flow at 50% of the vital capacity in air ( VJ so air) and He/02 
( VJ so He/0,) were taken for the calculations. VJ so He/02 minus VJ so air is ex-
pressed as a percentage of VJ 50 air and used as a measure for the density depen-
dency. 
2. The exercise test was done on a Jaeger treadmill according to the method of 
Eggleston and Guerrant (6). The slope is 10° and the running time about 6 
minutes. The speed was increased to give a pulse rate of > 175/min. This was 
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reached with speeds of between 7 and 12 km/hour. 
An exercise test without a protective agent (basal test) was done on each of 
two consecutive days at 9 o'clock in similar ways. On each day an identical 
exercise test was performed, four hours later, this interval would avoid intertest 
influences (5). The second test was done 30 minutes after administration of a 
protective agent. The temperature and humidity of the air in the room where 
the test took place. were rather constant at 22° and 70% respectively: they 
were. however. not controlled. 
3. On each of the test days, one of the following protective agents were given in 
a random order. 
- oxytropiumbromide (parasympatholytic), 0.08 mg per dose aerosol; 
- fenoterol (~ 2-sympathetic agonist), 0.4 mg per dose aerosoL 
The inhalation was performed as follows: after a submaximal expiration, 
the patient inspired synchronously with the aerosol, the mouth being kept closed 
over the inhaler opening. During this inspiration the tongue was kept on the 
floor of the mouth. After inspiration the breath was held for 5 seconds. The 
technique was learnt using a placebo. 
The doses were chosen so that a maximum effect in pharmacological 
terms could be expected. The influence of the protective agents on E!B is 
expressed as the degree of protection, which is the difference between the 
bronchial obstruction in the exercise test with and without agent. 
'-lso air and 'if50 He/02 were measured prior to the exercise. After exercise 
the same measurements were repeated in the following schedule: '-!150 air at 1, 5, 
13 and 22 minutes; 'It, He/02 at 4, 9 and 19 minutes after exercise (Figure 1). 
In the figure all measurements in air are connected by a continuous line and 
those in He/02 by a dotted line. The distance between the measured point and the 
corresponding point on the other line was considered as the density dependency. 
To determine the density dependency with time. mean values of paired measure-
ments have been taken: at 4 and 5 minutes, 9 and 13, as well as 19 and 22 minu-
tes. As reference for 'It 50 air the data of Zapletal et aL (20) were used. 
4. 16 asthmatic children were studied; their ages ranged from 86/, to 141/ 12 years 
with a mean of 12 10/ 12 year. The patients were selected from the outpatient clinic 
of the Sophia Children's Hospital in Rotterdam (The Netherlands). 
5. The criteria for selection were: 
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L the baseline 'It 50 air ;;, 50% of the mean predicted value for height; 
2. a decrease after exercise ;;, 20% of the baseline value on each of 2 con-
secutive days: 
'llso 
L.seC~ 
9 
' 
• 
I Exercise 
t 
before 
' 
I I 
13 19 22 min 
11 20!, 
evaluated in the results 
Figure 1. Design of the study and method of calculation. T evaluated in the results. 
3. for each patient these values and the density dependency had to be repro-
ducible. i.e. their coefficient of variation ( = standard deviation as percentage 
of the mean) was ,;;; 15%; 
4. in the 2 weeks prior to the study the patients had to be in a stable clinical 
condition and without cromoglycate, beclomethasone, oral corticosteroids or 
~,-sympathetic agonists. Other drugs were withdrawn 3 days prior to tbe 
tests. 
Informed consent was obtained from tbe parents after full information about 
the investigations had been given. 
Results 
In Figure 2 the mean values for all patients are given for both days. The base-
line values of ~50 air are 74.1 ± 4,3% (mean± SEM) respectively 73,8 ± 3,4% of 
the reference value. The decrease in ~50 air is 39,2 ± 3,5% respectively 40,3 ± 3,9% 
at 4'/, minutes. 32,3 ± 3,9% and 29,3 ± 3,4% at 11 minutes and hence 23,5 ± 5,4% 
and 21.4 ± 17,9% at 201/ 2 minutes after exercise. 
The mean density dependency, which is also shown in Figure 2, is 42,8 ± 3,6% 
respectively 42.4 ± 3,1% before exercise, 16,8 ± 1,9% respectively 16,2 ± 2,8% 
at 41/, minutes, 29,4 ± 4,6% respectively 23,6 ± 3,2% at 11 minutes and finally 
4 7.6 ± 3, I% respectively 43, I ± 2,8% at 201/, minutes after exercise. 
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Figure 2. Vi ~ 0 air (-------) and density dependency (- -.--1 before and after exercise in mean ± sem 
on 2 consecutive days. in I6 patients. 
In Figure 3 the decrease in Vt50 air and the density dependency are compared 
for every patient at 41/ 2 (3a), II (3b) and at 201/ 2 minutes (3c). The relationship 
between both factors is significant at the 5% level (Spearman rho). Shortly after 
exercise (41/ 2 minutes) a strong bronchoconstriction accompanies a low density 
dependency and vice versa (figure 3a). At a relatively long time after exercise (201/ 2 
minutes) a slight or moderate bronchoconstriction is associated with a high density 
dependency. At II minutes after exercise (figure 3b) an intermediate situation exists. 
In order to compare the density dependency relatively late after exercise (at 
201/ 2 minutes) with the pre-exercise value, both are displaced on a x-y diagram 
(figure 4). In most patients the density dependency late after exercise is higher than 
prior to exercise. 
The relationship between the degree of the bronchoconstriction and the density 
dependency with time is plotted in ax-y diagram for each patient in the way shown 
in Figure 5. Four types of pattern can be distinguished (Figure 5). The pattern type 
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Figure 3. Relationship between Xtso air and density dependency at 4 1/ 2 minutes (A). 11 minutes 
(B) and 201/ 2 minutes (C) after exercise. Test of Spearman is used for significance. 
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Figure 4. Comparison of the density dependency before (y-axis) and at 20 minutes after exercise 
(x-axis). x = y, line of identity. 
V50oir 
%baseline 
100 
80 
60 
40 
20 
10 20 
a 
30 40 50 60 70 
density dependency 
Figure 5. Relationship of bronchoconstriction and density dependency with .time of a typical 
patient. 
108 
a before exercise; 
b 4 1/~ minutes after exercise; 
c 11 minutes after exercise: 
d 201/: minutes after exercise. 
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Figure 6. Patterns of the relationship between bronchoconstriction and density dependency with time 
as shown in figure 4 for each of the patients on two consecutive days( .. ). 
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Figure 7. Relationship between the degree of protection defined as the bronchoconstriction (de-
crease in ir50 air) after exercise with and without the ~z-sympathetic agonist (left graph) 
or the parasympatholytic agent (right graph) (x-axis) and the density dependency after 
exercise without protection (y-axis). All values are at 4 1/ 2 minutes after exercise. 
~ mean degree of protection. 
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mostly obtained is that of a safety-pin with its opening to the right (pattern a). 
Patterns b and c seem to be closely related to a. All patterns reflect a simultaneous 
decrease in flow and density dependency. Thereafter the density dependency nor-
malises while bronchoconstriction, at least in part, persists. In pattern b low density 
dependency persists for a while. In pattern c the bronchoconstriction and the density 
dependency return to baseline simultaneously. Pattern a was observed in 6 patients 
on both days and in 8 patients on one of the two days. Pattern b was seen in two 
patients on both days and in another two on one of the days, while pattern c was 
present in 5 patients on a single day. A completely different pattern (d) was seen 
only once illustrating bronchoconstriction immediately after exercise in combina-
tion with an increase in density dependency. 
The mean degree of protection by the agents, defined as the decrease in i-50 air 
after exercise with and without protection, is 28% with the ~-sympathetic agonist 
and 3% with the parasympatholytic drug (Figure 7). A high degree of protection at 
4 1/ 2 minutes by the ~-sympathetic agonist is associated with a low density depen-
dency and the reverse. This relationship is significant at the 1% level. The degree of 
protection by the parasympatholytic agent is not related to the density dependency. 
Discussion 
From these data conclusions can be drawn only if we accept that: 
1. density dependency occurs if flow-limitation is determined by airways with a 
laminar flow. 
2. density dependent airflow occurs preferentially in more central regions and 
density independent airflow in more peripheral airways. 
These assumptions are not in contradiction with the recent theories on wave 
speed limitation (2) and on mechanics of increased maximal expiratory flow during 
He/02 breathing in dogs (14) and human lung (1, 13). 
Therefore the following conclusions can be drawn from this study. Shortly 
after exercise bronchoconstriction is most pronounced while the site of maximal 
flow-limitation has moved towards the periphery. Thereafter bronchoconstriction 
fades away while the site of maximal flow-limitation rapidly returns to the central 
airways. Because, in most patients, the density dependency at 201 I 2 minutes after 
exercise is larger than the value before exercise, the site of maximal flow-limitation 
may be located more centrally than before exercise. The combination of broncho-
constriction soon after exercise with localisation of the site of maximal flow-limita-
tion in the central airways (type d) is rarely seen, in contrast to the study of 
Me Fadden et al. (13) in adults. 
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The wavelike pattern, in which the site of maximal flow-limitation initially 
moves towards the periphery and hence returns to the more central airways, is in 
agreement with findings by several investigators in animal studies. In the generation 
of EIB. the parasympathetic and the mast cell system seem to be involved (4). 
Kessler et a!. (9). in studies on dogs, used electrical stimulation of the vagal nerves 
as well as allergen inhalation and found the constriction to be maximal in the 
peripheral airways (1-8 mm diameter), but not detectable in the smaller ones. 
Woolcock et al. (19) found that the sympathetic action exceeds the parasympathetic 
influence most in the peripheral airways. If recovery from EIB is caused for an im-
portant part by a sympathetic counteraction, it could be expected from these 
findings that it would first become obvious in the peripheral airways. This could 
explain why the \)150 He/02 increases more quickly than the \)150 air improves. 
The variation observed in the pattern of recovery of the density dependency 
is unexplained. but may be due to variability of the measurements as well as to 
physiological factors. lf the latter is true the differences in pattern (Figure 6) could 
be explained at least in part by variability in sympathetic counterregulation. 
In order to exclude the occurrance of peripheral airway obstruction due to 
frequent forced expirations shortly after exercise, identical measurements were per-
formed without exercise in some of the patients, which did not reveal a decrease in 
FEV 1, or a change in density dependency. 
We found, like Me Fadden et a!. (12) that the protective effect of the B-sym-
pathetic agonist increases with a more peripherally located site of maximal flow-
limitation. 
Similar to others (7) we found a relationship between the degree of broncho-
constriction and the density dependency (Fig. 3). No patients were observed in whom 
bronchoconstriction and a high density dependency went together after 41/ 2 min. 
This indicates that in none of the individuals the site of maximal flow-limitation was 
located in the central airways immediately after exercise. We could therefore not 
evaluate the effect of the parasympatholytic agent in this pattern of reaction like 
Me Fadden et al. did (12). 
Because EIB may be considered as an expression of bronchial hyperreactivity 
( 4, 15), the wavelike pattern of bronchoconstriction might also occur in other reac-
tions due to hyperreactivity such as after histamine challenge. Studies to analyse 
this are in progress. 
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7.3. The correlation between increased reactivity of the bronchi and of mediator 
releasing cells in asthma 
H. J. Neijens, H. J. Degenhart, R. Raatgeep and K. F. Kerrebijn. 
Depariment of Paediatrics, Subdepartment of Respiratory Diseases, Erasmus 
University Medical School, Sophia Children's Hospital, Rotterdam, the Nether-
lands 
Summary 
The hypothesis that increased reactivity in asthma is not always limited to 
the bronchi but also exists in the mediator releasing system was investigated in 
forty-five asthmatic children, approximately half of whom had exercise-induced 
bronchoconstriction (EIB). The bronchial threshold to histamine was measured as 
an indicator of the reactivity of the bronchi and the histamine release from leuco-
cytes without adding allergen (spontaneous histamine release) was considered as an 
indicator of the reactivity of the basophilic leucocytes. There was a significant cor· 
relation between the histamine threshold and spontaneous histamine release and 
between these and EIB. These findings support the hypothesis. 
Introduction 
Many asthmatic patients show exercise-induced bronchoconstriction (EIB) 
(Bierman, Kawabori & Pierson, 1975). These patients often have bronchial hyper-
reactivity to histamine and acetylcholine (Kiviloog, 1973). Because of the protective 
action of sympathomimetics, parasympatholytics (Godfrey & Konig, 1976) and 
disodium cromoglycate (Davies, 1968), it can be assumed that both the autonomic 
nervous system and mediator release play a role in the mechanism of E!B. 
When measuring histamine release from leucocytes in asthmatic patients 
sensitive to cat dander allergen, we noticed that histamine was sometimes released 
in incubations without allergen (Neijens et al., 1979). 
I. This study is supported by the Netherlands Asthma Foundation (grant nr. 238). 
2. Presented at the meetings of the British Paediatric Respiratory Group. Canterbury. England. 
September 29th. 1978 and the International Symposium: '"The Mast cell, its role in health and 
disease", Davos. Switserland, April 25th. 1979. 
3. Published in: .. The Mast cell, its role in health and disease". Pepys J and Edwards AM eds. 
Pitman Medical, London, 1979. 322-325. (the paper of the Davos Meeting) and in Clinical 
Allergy 1980: 10:535-539. Reprint with permission ofthe publisher. 
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We called this phenomenon "spontaneous histamine release". Spontaneous 
histamine release is considered as a measure of the reactivity of leucocytes. In this 
study we have investigated the hypothesis that in asthma increased reactivity is not 
limited to the airways but also exists in other systems such as mediator-releasing 
cells. We have investigated this in patients with EIB. Because it is difficult to obtain 
live human pulmonary mast cells, leucocytes have been studied. 
Materials and methods 
Forty-four asthmatic children (thirty-one boys, fourteen girls), who were under 
treatment in the outpatient department for respiratory diseases of the Sophia 
Children's Hospital in Rotterdam were investigated. Their mean age was 10-7 years 
with a range of 6·2-14·2 years .. They had been in a symptom-free period for at least 
4 weeks. Treatment was stopped 48 hr before the investigations, which were carried 
out between 09 h 00 min and II h 00 min. Histamine threshold was measured in the 
asthmatic children by means of inhalation at a flow of 6 !/min of histamine di-
phosphate in increasing dose concentrations of I, 2, 4, 8, 16, 32 and 64 mg/ml (de 
Vries et a!., 1964). At the beginning of the inhalation each patient performed a 
submaximal vital capacity manoeuvre after which they inhaled the aerosol at tidal 
volume for 30 sec. With this technique the bronchial threshold to histamine in 
healthy children is;:;, 32 mg/ml. 
On the morning before the histamine threshold measurement, venous blood was 
withdrawn, with the patient at rest, some minutes after venapuncture to minimize 
variations caused by the procedure (Simon et a!., 1977). Spontaneous histamine 
release was determined by measuring the amount of histamine released from I ml 
of leucocyte suspension incubated without allergen using the method of May et a!. 
(1970). Histamine release was also measured after adding 20 )!I anti-IgE (Behring 
Werke 400 000 IU/ml) in order to estimate allergen-induced histamine release. The 
leucocyte suspension was in contact with open air. The histamine release measure-
ments were done in all asthmatic and in thirteen healthy persons comparable in age 
and sex but without a history of asthma or eczema. All measurements were done in 
triplicate and the values given are the average of these. The standard deviation of 
triplicate measurements was 0-5 )!g/1. The number of basophils was counted in 
duplicate by the method of Moore & James (1953). The bronchial reaction to 
exercise was measured in the asthmatic children by running up and down stairs for 
at least 5 min and was performed on the day after the histamine threshold. Exer-
cise was considered satisfactory if the pulse rose above 175 beats a minute. Lung 
function was assessed by spirometry before, immediately after and at 5, 10, 15, 20 
and 30 min after exercise. A decrease in the forced expiratory volume in 1 sec 
(FEV1) below 85% of the initial value within 15 min of the run was considered as 
bronchoconstriction. Most of the parameters were found to be distributed abnor-
mally as appeared from tests for skewness and kurtosis, therefore the statistical 
treatment of the data was done with non-parametrical tests. 
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Results 
Figure 1 shows that the spontaneous histamine release is higher in patients with 
EIB than in either those without EIB (Fisher exact test, P < 0-02) or than in healthy 
children (P < 0-05). The medians of the three groups were respectively 2-4, 1 and 
I ~g/L No relationship between other parameters and spontaneous histamine release 
could be detected. The basophil counts in the respective groups were 31 ± 25, 
37 ± 16 and 20 ± 16/ml (mean± s.d.). Anti-IgE induced histamine release in these 
groups was, respectively, 9-0 ± 7-2, 7-5 ± 5-4 and 4-6 ± 3-0 ~g/1 (mean ± s.d.). 
Initial FEY 1 and spontaneous histamine release were also not related (Spearman 
p = 0-03, not significant). 
It can be seen in Fig. 2 that the relationship between the histamine threshold 
and the decrease after exercise is very significant (Spearmanp = 0-60, P < 0-001). 
In patients with EIB the histamine threshold is significantly lower than in patients 
without EIB (x2 test, P < 0-005). The medians were 4 and 16 mg/ml respectively. 
spontaneous 
histamine release 
---median 
1'9/11 
: 
:j 
'~ ~--~- ----.·.----
0 J . 
healthy f--'-"-"cg'?.:cC.HC.v::.c _ _l__.!:PC:::'::.It.:_lv__:cc_--1 
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~--- p < 0. 05 ---'o 
Figure 1. Spontaneous histamine release in asthmatic children. divided according to their sensitivity 
to exercise. and in healthy children. Fisher exact test. Separation of the groups at 
I · 5 J.lg/llevel. but this was not critical. 
----.Median. 
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Figure 2. Relationship between histamine threshold and exercise~induced decrease in FEY 1 in 
asthmatic children. Spearmanp = 0- 69: P < 0-001. 
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Figure 3. Relationship between the histamine threshold and spontaneous histamine release in rela· 
tion to bronchoconstriction. Spearman p between spontaneous histamine release and 
histamine threshold= 0-30: P < 0-025. e, Exercise. positive: o. exercise. negative. 
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Figure 3 shows that fourteen out of the seventeen patients with a histamine 
threshold of ,;;; 4 mg/ml also have a spontaneous histamine release of:). 1-5 ~g/1; 
13 of these have ErB. Eight of the twenty-eight patients with a histamine threshold of 
:). 8 mg/ml have a spontaneous histamine release of:). 1·5 ~g/1; two of these have 
EIB. Six of the twenty patients in whom the histamine threshold is :). 8 mg/ml and 
the spontaneous histamine release< 1-5 ~g/1 have EIB. 
From Fig. 3 it also appears that a correlation exists between the degree of 
spontaneous histamine release and the histamine threshold (Spearman p = 0-30, 
P < 0.025), whereby the reaction to exercise was not taken into account. 
Discussion 
The results of this study indicate that leucocytes from asthmatic patients with 
EIB often have a greater spontaneous histamine release than leucocytes of both 
asthmatic patients without EIB and healthy children. This indicates that the leuco-
cytes of a number of patients with EIB in the absence of a known ttigger but under 
carefully standardized conditions, have a greater releasing capacity per unit time. 
This could not be explained by a difference in the number of basophils, nor by a 
difference in allergen-induced histamine release as judged by anti-IgE induced 
release in patients with and without EIB. 
Further the state of the asthmatic disease was not relevant because all patients 
had been in a symptom-free period for at least 4 weeks and no relationship existed 
with the initial lung function values. 
Findlay & Lichtenstein (I 978) showed that leucocytes of patients with intrinsic 
asthma released a greater amount of histamine after adding deuterium oxide com..: 
pared to those of healthy subjects. This may indicate a difference in releasability. 
May (1976) found that leucocytes of patients with food allergy often had high 
spontaneous histamine release. Podleski and Grimes (1978) demonstrated hyper-
reactivity in lymphocytes of patients with obstructive airways disease. 
Like others (Mellis et a!., 1978; Eggleston, 1979) we found that the decrease in 
FEY, after exercise is strongly correlated with the histamine threshold. The hist-
amine threshold reflects the degree of bronchial hyperreactivity of non-allergic 
stimuli (de Vries et a!., 1964). The degree of spontaneous histamine release cor-
relates well with the degree of bronchial hyperreactivity as is shown in Fig. 3. This 
supports our hypothesis that in asthmatic patients hyperreactivity may not only be 
present in the bronchi but also in the mediator releasing system. 
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7.4 Release of histamine from leucocytes and its determinants in vitro in 
relation to bronchial responsiveness to inhaled histamine and exercise in vivo. 
H. J. Neijens. R. Raatgeep, H. J. Degenhart & K. F. Kerrebijn 
Summary 
The hypothesis studied is that an increased responsiveness in asthma is not 
limited to the airways. 40 asthmatic children were analysed for their bronchial res-
ponsiveness (BR) to exercise. 20 patients revealed bronchial obstruction after exer-
cise while the remainder did not. These parameters were compared to the responsi-
veness of leucocytes, which was determined by their histamine "releasability''. 20 
healthy children served as controls. Release of histamine induced by calciumiono-
phore aided calcium influx was significantly higher in both groups of asthmatics 
than in the healthy children (P < 0.005). Similar findings were obtained by induction 
of microtubule aggregation due to deuterium oxide (D20). The S-shaped dose-
response relationship with D20 was shifted to the left in the patients with BR to 
exercise compared to patients without (P < 0.025). The slope was increased in both 
patient groups compared to the healthy children (P < 0.01). It is concluded that the 
mean "releasability" of histamine from leucocytes is higher if BR increases. The 
histamine release due to both stimulants correlated well (P < 0.01). This suggests 
that the "releasability" is determined by the responsiveness of the microtubules. To 
a large degree this may also apply to allergen-induced histamine release, as was 
revealed from studies with anti-IgE. The differences in histamine release found in 
relation to BR due to exercise were also present if the patients were divided 
according to BR due to histamine. A significant relationship existed between the 
degree of BR to histamine and the responsiveness of the microtubules (P < 0.02). 
Introduction 
Increased bronchial responsiveness (BR) also called bronchial hyperreactivity, 
can be observed in many asthmatic patients (Boushey et a!. 1979). Increased BR 
is characterized by the occurrence of bronchial obstruction due to various stimuli 
with a dose which does not have such a result in persons with a normal responsive-
ness (Kiviloog, 1973; Neijens eta!. 1979). 
l. This study is supported by the Netherlands Asthma Foundation (grant nr. 79.31). 
2. Presented at the meeting of the European Paediatric Respiratory Society, Berne. Switserland. 
September 25th. 1981. 
3. Published as an abstract in Paediatric Research l98L in press. Complete paper submitted for 
publication. 
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Dysregulation of various systems, such as lysozymatic release from leucocytes 
(Busse et al. 1979) and pupillary reflexes (Smith et al. 1980) has been reported in 
relation to asthma. We have studied histamine release from basophilic leucocytes 
to investigate cell dysfunction in asthmatic children with increased BR. ln a pre-
vious study we (Neijens et al. 1980) and others (Findlay and Lichtenstein, 1980) 
found a correlation between the mean histamine release from leucocytes and the 
degree of BR. 
Our present study questions in which parts of the release prqcess dysregula-
tion occurs. Therefore the influx of calcium into the cells was stimulated with the 
calcium ionophore A 23187 (Siragarian et al. 1975). This may increase the release 
of histamine from basophilic leucocytes. The influence of zinc on the calcium-
induced histamine release was studied (Kazimierczak & Maslinski, 1974). Micro-
tubules are thought to be important in the expulsion of mediator containing 
granules which are necessary for the release of mediators (Padawar, 1979). The 
effects of induction of microtubular aggregation due to deuterium oxide (D,O) 
(Gillespie & Lichtenstein. 1972) was analysed. 
Methods 
1. Design of the study 
The study was done on two consecutive days. On the first day a venepuncture 
was done and the provocation dose of inhaled histamine was determined. On the 
second day an exercise test was performed. 
2. The asthmatic children were selected from the out-patient clinic of the Sophia 
Children's Hospital in Rotterdam. based on the following criteria: 
1. The patients had to be in a stable clinical condition for at least 3 weeks 
prior to the study. 
2. The ability to perform lung function tests in a reproducible way. 
3. All drugs withdrawn at least two days before the study. None of the patients 
was treated with hyposensitization therapy. 
The healthy children were without present or previous symptoms, chronic 
rhinitis. hayfever or eczema and revealed no bronchial obstruction after exercise. 
3. Measurement of histaminerelease 
A sample of 20 ml venous blood was taken with the patient at rest at 8.30 a.m. 
From this sample 1 ml suspensions of leucocytes were prepared and incubated 
with and without one of the following agents: 
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- D,O, 20, 40. 60, 70 and 80% in combination with cytochalasine E (2.1 o-5 M), 
with appropriate pH correction. 
- Calciumionophore A 23187, 0.56 x J0-6 M (0,3 mg. 1-1) and 2,80 x J0-6 M 
(1.5 mg.l- 1) with and without Ca'+ (I0-3 M) or znH (ZnSO, 1,5.10-5 M). 
- Anti-lgE, 20 111 of a 400.000 IU/ml solution (Behring Werke) in combination 
with Ca2+ (!0-3 M). 
Release of histamine was measured after one hour"s incubation, using the 
method of May et al. (1970). All measurements were done in triplicate and the 
values given are the average of the three. The numbers of Jeucocytes and 
basophils were counted in the samples, according to the method of Moore and 
James (1953). 
4. The bronchial responsiveness to histamine and exercise was determined as 
described previously (Neijens et al. 1980). 
The patients were divided according to their reaction after exercise: patients 
with a bronchial obstruction after exercise, i.e. a decrease in the forced expira-
tory volume in the first second of > 15% of baseline and those without this 
phenomenon. The groups were indicated as bronchial responsiveness to exercise 
positive (ERE +) and negative (ERE -) respectively. The healthy children 
formed the third group.Tbe patient groups comprised 20 children, the healthy 
group 22, and all groups were comparable with regard to age and sex. All the 
subjects and their parents were fully informed about the methods and the aims 
of the study before they gave their consent. 
5. Statistical analysis 
Most of the parameters appeared to have an abnormal distribution, therefore 
the statistical treatment of the data was performed with non-parametric tests. 
The differences in results between the three groups were analyzed with a test for 
multiple comparisons (Conover, 1980). Correlations of the parameters were 
calculated according to Spearman. The regression lines were determined using 
the median values of the regression equations of each pair of subjects, accord-
ing to the method of Nimmo and Atkins (1979). The slopes and intercepts of 
these lines were compared with the patient groups using Wilcoxon tests. 
The 5% level was considered as the level of significance. 
The steepness and the parallel shift of the individual regression lines is 
expressed as a single value by determination of the "median response", i.e. the 
histamine release which is the median value of all responses after each of the 
sequential D 20 series in an individual. The medium D 20 response is used in 
table I, figure 2 and 3. 
Results 
The median values of the numbers of leucocytes and basophils as well as the 
histamine release are shown in table 1. No significant relationship exists between the 
number of these cells and the degree of histamine release. 
In Figure I the mean amount of histamine released by sequential D,O con-
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Table 1 
Group Number of cells 
Leucocytes"' Basophils 
10'/!11 iMI 
+ 24.9 26.0 
(n ~ 20) (8.9 - 56.3) (10.0 -74.0) 
BRE 
26.2 28.5 
(n ~ 20) (5.2- 44.5) (3.0- 77.0) 
healthy children 21.4 27.5 
n = 20 (8.9 - 42.5) (6.0- 70.0) 
in the leucocyte suspension. 
BRE =bronchial responsiveness to exercise. + and-. see methods. 
Histamine release due to 
0 20 (median response) 
!J.g. L-1 
6.4 
(1.7- 23.0) 
4.5 
(0.8- !5.3) 
2.8 
(1.4- 5.3) 
Histamine release is the median response after all doses ofD20 for each patient. 
All results are expressed as median value with the extreme values between brackets. 
No significant relationship exists between the number of cells and the amount of histamine release. 
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Rdc:tse due to 60. 70 
-
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-
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Figure I. Histamine release from leucocytes in vitro as a function of the percentage deuterium oxide. 
The results are expressed in mean + SEM for each of the three groups of subjects. 
I -
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centrations is illustrated for each group of subjects. The mean release with 60, 70 
and 80% D,O is significantly higher in the patient groups than in the healthy indi-
vidual group (P < 0.0025). The dose-response relationship is evaluated by the 
regression line of the responses at 40 and 60%. The slope in groups BRE positive 
and BRE negative is significantly steeper than in the healthy individual group (P < 
0.01). Between BRE positive and BRE negative patients the slopes do not differ, but 
the intercepts of their regression lines with the y-axis differ significantly (P < 0.025). 
It is therefore concluded that the mean dose response curve in asthmatic children 
with an increased BRE was shifted to the left compared to the asthmatic children 
without BRE. The regression lines of the asthmatic children are rotated anti-
clockwise compared to that of the healthy subjects. Changes can be taken into 
account by the median response (see methods, statistical analysis). 
histamine (SJg. 1- 1 ) 
16 
14 
12 
10 
8 
6 
4 
2 
0 
I?'.ZI asthmatics, bronchial re5ponsiveness to exercise+ 
e;:sJ. asthmatics, bronchial responsiveness to exercise-
D healthy controls 
Figure 2. Mean histamine release (±SEM) from leucocytes in vitro with and without various agents 
in three groups of subjects. 
Results after the calcium ionophore with calcium are significantly higher in BRE+ sub~ 
jects than in BRE- subjects (P <0.005) and healthy children (p < 0.005). These differ-
ences in the presence of zinc are also significant (P < 0.0 1). 
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The mean release of histamine with the calcium ionophore A 23!87 alone or 
combined with calcium or zinc is shown in Figure 2. In all groups the release of 
histamine increases markedly after the addition of calcium to the calcium ionophore. 
There is no significant difference in release with 0.3 and 0.5 mg r-r calcium iono-
phore. The mean release by the calcium ionophore plus calcium is greater in the 
patients with BRE than without BRE (P < 0.005) and than in the healthy children 
(P < 0.005). The difference between the release in the patients without BRE and the 
healthy controls does not reach significance. If zinc is added to the combination of 
calcium ionophore and calcium the histamine release decreases. However, the 
differences between the groups persist (P < 0.01). 
Figure 3 shows the anti-IgE induced release of histamine for the three groups. 
lt is highest in the patients with BRE, intermediate in those without BRE and lowest 
in the healthy children. The differences between all groups are significant at the 
5%leveL 
For each group the histamine release after the calciumionophore plus calcium 
and the release after 0 20 are compared in a xy-graph (figure 4 a.b.c.). The cor-
hi~tamine {!Jg.l-1 ) 
14 
12 
10 
8 
6 
4 
2 
0 
onti-lgE 
Co 
ezl asthmatic~, bronchial responsiveness to exercise+ 
E:5J asthmatics, bronchial responsiveness to exercise-
0 healthy controls 
Figure 3. Mean histamine release (± SEM) from leucocytes in vitro with and without anti-IgE plus 
calcium in three groups of subjects. 
The results are significantly different between all groups (P < 0.05). 
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Figure 4. Comparison of the histamine release due to calcium ionophore plus calcium (calcium 
influx) and that due to D20 (median response) in three groups of subjects 
{
a= asthmatics, BRE+ 
graph b =asthmatics. BRE-
c = healthy subjects 
The relationships are significant in groups of BRE+ and BRE- subjects (P < 0.01). In the 
healthy children a correlation cannot be expressed because of mathematical reasons. The 
slope of the median regression line is significantly steeper in the BRE- patients than in 
the ERE+ patients (P < 0.02). 
relation is significant (P < 0.01) in both groups of patients, but not in the healthy 
children. The slopes of the regression line in the patient groups differ significantly 
(P < 0.02), decreasing with a higher bronchial responsiveness. 
Figure 5 shows the correlation between the histamine release after 0,0 and 
anti-lgE in the same way as in Figure 4. The correlation is again significant in the 
patient groups (P < 0.01), but not in the healthy children. The difference be-
tween the slopes in the patient groups with and without BRE is significant 
(P < 0.01), decreasing with a higher bronchial responsiveness. 
The patients are also divided into 2 classes according to their histamine pro-
vocation doses, as a measure of BR to inhaled histamine. This in vivo parameter of 
BR is related to the release of histamine in vitro. The relationships approximate to 
those found in the case of BR to exercise. They are therefore not given in this paper. 
In Figure 6 the histamine provocation doses and the 0,0 induced histamine release 
are compared as continuous variables. They are significantly related (P < 0.02). 
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Figure 5. 
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The relationships are significant in the patient groups (P < 0.01). but not in the healthy 
children (see legend of Figure 2). 
The slope of the median regression line is significantly steeper in the BRE- than in the 
BRE+ patients (P < 0.01). 
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Figure 6. Relationship for each patient between the bronchial responsiveness to histamine (histamine 
provocation dose) and the histamine release in vitro due to D::P (median responses). The 
relationship is significant (Spearman. rho -0.40. P < 0.02). 
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Discussion 
In a suspension of leucocytes the release of histamine without activation of the 
IgE-receptor can be induced by influx of calcium (by means of a calciumionophore) 
and also by activation of the microtubular aggregation (by D20). This is in agree-
ment with results in other studies (Gillespie et a!. 1968; Findlay & Lichtenstein, 
1980). The histamine release is greater in asthmatics with than without ERE, and 
the release in asthmatics exceeds that in healthy subjects. This indicates that an 
increase in BR is associated with an increase in the releasability of basophilic leuco-
cytes. 
Relatively low concentrations of zinc which are in the range of those found in 
normal plasma, inhibit the calcium-induced histamine release. Probably it has its 
effect in the first part of the mediator releasing process, for instance on the influx of 
calcium. since the mediator release after the activation of the microtubules is not 
inhibited by zinc (preliminary observations). It may well be that a change in the 
plasma zinc concentration will influence the mediator release in vivo, but there is as 
yet no data confirming this suspicion. 
The influx of calcium leads to the release of mediators via a series of events 
(Lichtenstein, 1975). The histamine release after stimulation of an initial step in the 
sequence (calcium influx) correlates highly with that due to the activation of a step 
later on in the sequence (induction of microtubular aggregation). It seems that the 
responsiveness of the total intracellular sequence is determined by the degree to 
which the microtubules can be activated. 
The histamine release after anti-IgE is related to the D 20 induced release in a 
similar way. This indicates that at least in part the allergen-induced mediator release 
is also determined by the degree to which the microtubules can be stimulated. 
It is widely accepted that the activity of the microtubules is mainly regulated 
by the intracellular cyclic AMP concentration (Mongar et a!. 1979). However, this 
may well have other effects on intra-cellular processes which lead to mediator release 
(Smolen et a!. 1980). Although therefore the "releasability" seems to be determined 
to a large extent by the state of the aggregation of the microtubules, this may not be 
only factor involved. 
Besides the dysregulation of the mechanisms which determine the bronchial 
diameter and the increased responsiveness of basophilic leucocytes, dysregulation of 
other systems is also described in asthma. Hyperresponsiveness of the pupillary 
reflexes was found in asthmatic patients in relation to a cholinergic agent (Smith 
et a!. 1980) and to an a-sympathetic agonist (Henderson et a!. 1979). The latter 
study also showed a hyperresponsiveness of the cutaneous blood flow to an a-sym-
pathetic agonist in asthmatics. In leucocytes hypofunction of receptors which 
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counteract mediator release, such as the ~-sympathetic (Lemanske et a!. 1980) and 
the histamine and prostaglandin E1 receptors (Busse et a!. 1980) was found in 
asthmatics. The bronchial smooth muscle had a greater contractibility in asth-
matics than in normal subjects (Stephens et a!. 1980). The cyclic AMP concen-
tration in bronchial smooth muscle was found to be depressed in relation to the 
presence of asthma in dogs (Rinard et a!. 1979). Thus in asthma a generalised 
dysregulation seems to be present, which is apparent both inside and outside the 
respiratory system. 
This study leads to the conclusion that the dysregulation which exists in 
basophilic leucocytes in association with a dysregulation of bronchial responsive-
ness, may be determined by an identical factor, such as the level of the cyclic 
nucleotides. Studies to investigate this in more detail are in progress. 
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Appendix to paragraphs 7.3 and 7.4 
The releasability is not related to atopy. We found that the variability in 
histamine release between persons was independent of the total IgE concentration 
as well as to the allergen specific lgE concentration to house dust. cat dander and 
grasspollen allergen. 
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CHAPTER 8. STUDIES OF THE RELATIONSHIP BETWEEN BRONCHIAL 
RESPONSIVENESS AND THE BRONCHIAL REACTION TO 
STIMULANTS WHICH PROVOKE SYMPTOMS IN DAILY 
LIFE 
8.1 Relationship between the bronchial responsiveness to inhaled histamine and 
the degree of bronchial obstruction after exercise 
Exercise is a commonly observed cause of bronchial obstruction in part of the 
asthmatic children. The relationship between bronchial obstruction after exercise and 
inhaled histamine was analysed in the studies 7.1 and 7.3. 
From study 7.1, figure 5 and from study 7.3, figure 2 are shown: here called 
figure I and 2 respectively. 
Figure 1. 
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Figure 2. 
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In both studies a positive relationship was found to exist between the degree of 
bronchial obstruction after a standardized dose of exercise and tbe bronchial 
response after inhaled histamine. This indicates a parallelism in the response of tbe 
airways after both stimuli. The higher the BR to histamine, the higher the risk of 
the occurrence of dyspnoea after exercise and the more severe the reaction. 
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8.2 Study on the significance of bronchial hyperreactivity in the broncbus 
obstruction after inhalation of cat dander allergen 
H. J. Neijens, M.D., H. J. Degenhart, Ph.D., H. C. Raatgeep, and K. F. Kerrebijn, 
M.D. Rotterdam, The Netherlands 
from the Department of Paediatrics, Subdepartment of Respiratory Diseases, 
Erasmus University, Medical School, Sophia Children Hospital. 
Abstract 
The role of bronchial hyperreactivity in the process that leads to bronchial obstruc-
tion after inhalation of an allergen was investigated. In 30 asthmatic children 
selected because of a positive skin test to cat dander allergen, we measured the 
histamine threshold, the reaction after allergen inhalation, the allergen-specific IgE 
concentration in serum, the lowest allergen concentration to which the intra-
cutaneous skin test was positive (skin titer), and the histamine release of leukocytes 
after challenge with allergen. These variables were correlated with each other. The 
highest correlation was found between the inhalation reaction and the combination 
of the histamine threshold and either the allergen-specific IgE or the skin titer. 
Inhalation was only positive with a decreased histamine threshold ( < 8 mg/ml). 
With a low histamine threshold, a positive reaction to inhalation is likely to occur 
at an allergen-specific lgE concentration of~ 2 U/ml or at a skin titer of<, 2.5 x 
JO-' )lg/ml. 
Introduction 
It is a common finding that in many asthmatic patients with known allergies 
bronchial obstruction does not always occur after contact with the allergen. This 
points to the fact that, besides allergen-specific antibodies, other factors are im-
portant for such a reaction to appear. Our hypothesis was that one of these factors 
might be a bronchial hyperreactivity, defined as a decreased threshold of the 
bronchial tree to inhaled bronchoconstrictor agents such as histamine, acetyl-
I. This study is supported by the Netherlands Asthma Foundation (grant nr. 238). 
2. Presented at the meetings of the European Society for Clinical Investigation, Rotterdam. The 
Netherlands. April 21st. 1978. the Dutch Paediatric Association. Tilburg, The Netherlands. 
May 27th. 1978. and the European Paediatric Respiratory Society. Badgastein. Austria. May 
31ste, 1978. 
3. Published in the Journal of Allergy and Clinical Immunology. 1979.64: 507-515. Reprint with 
permission of the publisher. 
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choline, chemical irritants, and smoke. In this study we investigated the role of the 
bronchial threshold to histamine in the process that leads to bronchial obstruction 
after inhalation of an allergen. Therefore, the correlations between the reaction to 
inhalation of cat dander allergen, the bronchial threshold to histamine, the allergen-
specific IgE concentration in serum~ the intradermal skin test, and histamine release 
from leukocytes with and without allergen were investigated. The results show that 
bronchial obstruction after allergen inhalation is highly dependent on the presence 
of an increased bronchial sensitivity and allergen-specific lgE. 
Methods 
Thirty asthmatic children were studied. They were selected because of a positive 
skin test against cat dander, indicating the presence of cell-bound antibodies, as well 
as the presence of circulating cat dander-specific IgE antibodies as measured by 
means of a radioallergosorbent test (RAST). Twenty also had a positive history of 
bronchial obstruction after contact with cats. In some of the children, however, 
these symptoms appeared only from time to time. Informed consent was obtained 
from all parents after full information about the investigations was given. The mean 
age was 10.4 yr with a range of 7 to 15 yr. There were 15 boys and 15 girls. The 
study was done during a period in which they had experienced few or no respiratory 
symptoms during the previous 4 wk. During the study the children were admitted to 
the hospital. Two days before and during the study no medication was given. 
Procedures were performed between 9 and 12 a.m. in order to avoid the influence of 
circadian rhythm. The same batch of cat dander allergen was used in all investiga-
tions. 
Allergen 
Cat dander allergen was obtained from Dr. R. Voorhorst in Leiden and from 
Diephuis Inc. in Groningen. Both products were mixed by us, lyophilized, and kept 
at -25° C. Freshly prepared mixture in physiologic saline was used. 
Skin test 
An intracutaneous skin test was done with four different concentrations 
(2.5 x IO-', 2.5 x I0-1, and 2.5 x 101 )lg/ml). In each skin test a control was 
performed using the solvent. The volar aspect of the forearm was used, and injec· 
tions were at least 3 em apart to avoid induction. 1 The reaction was considered 
positive if the diameter of the wheal was > 5 mm after 20 min. The lowest con· 
centration of allergen to which a positive reaction occurs is called the skin titer. 
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Allergen-specific IgE antibodies 
The concentration of allergen-specific IgE was measured by the RAST' 
using CNBr-activated Sepharose 4B as solid phase. To 1 m1 packed activated 
Sepharose. 5 mg allergen was added. Fifty microliters serum or serum dilution was 
incubated with 0.5 ml of a 1% suspension. Alter overnight incubation, the 
Sepharose beads were washed, and 1251-labeled anti-IgE antibodies, isolated as 
described', were added. Alter another overnight incubation, Sepharose-bound 
radioactivity was determined. The counts found were converted to international 
units (IU) IgE by comparison with a dose-response curve obtained by incubation of 
dilutions of an IgE standard serum with Sepharose-coupled anti-IgE antiserum. 
The best correlation with the inhalation reaction could be obtained if the 
allergen-specific IgE concentration was expressed as the natural logarithm. • 
Inhalation test 
Inhalations were done with concentrations of 2.5 x 101 and 2.5 x 102 J.ig/ml 
of the allergen solution. These concentrations were established from the results of a 
preliminary test which are not shown here. 
The nebulizer used is the Doppelinhaler (Bliime1, Wiesbaden) with an airllow of 
6 L/min. The characteristics of this inhaler have been described elsewhere.' The 
allergen was inhaled for a maximum of 10 min (first for 1 min; for a furtber 4 min 
if there was no reaction within 15 min; and for another 5 min if 15 min thereafter 
still no reaction occurred). The forced expiratory volume in 1 sec (FEY 1) was 
measured prior to, immediately after, and at 1, 8, and 24 hr after the inhalation. The 
inhalation test was considered positive when the FEV 1 diminished to less than 85% 
of the initial value. 
The best of five successive measurements was taken. A distinction was made 
between an immediate reaction taking place witbin l hr after inhalation and a 
delayed reaction between 4 and 24 hr afterwards. During the inhalations the sub-
jects breathed slowly and somewhat more deeply than normal. 
After an immediate reaction, an isoprenaline aerosol was inhaled to prevent the 
development of an asthma attack. Patients with an isolated delayed reaction on the 
lower dose were retested with the higher dose, which in all of them resulted in an 
immediate reaction. 
Histantine release from leukocytes 
The quantity of histamine released from 1 mi of a leukocyte suspension was 
* In all calculations and illustrations. except in Table II and Figure I. allergen specific IgE stands 
for the natural logarithm of the allergen - specific IgE concentration. 
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measured after incubation for I hr with the allergen solution following the modified 
method of May et al.5 The applied allergen concentrations were 2.5 x IQ-3, 
2.5 x ro-z, 2.5 x I0-1• and 2.5 !-1&/ml. The concentrations were chosen after the 
histamine release in five patients was measured with allergen concentrations in a 
geometric series composed of 10 steps, ranging from 2.5 x 10-7 to 2.5 x 102 [!g/ml. 
Every result is the average of three duplicate measurements. 
The maximum release was determined by heating 1 ml of the same leukocyte 
suspension for 30 min at 100° C. The histamine release is expressed as percentage 
of the maximum release. 
Bronchial hyperreactivity 
This was measured by means of the inhalation of histamine biphosphate in 
increasing concentrations (doses of 1, 2, 4, 8, 16, 32, and 64 mg/m1).6 Histamine 
was nebulized with the Doppelinhaler (flow of 6 L/min). At the beginning of the 
inhalation patients performed a submaximal vital capacity (VC) manoeuvre, after 
which they breathed at tidal volume for 30 sec. The histamine threshold was 
measured on the day prior to the inhalation test. The lowest concentration after 
which a positive reaction appeared was considered the threshold; for a positive reac-
tion the same criteria were used as in the inhalation test. The strength of the reaction 
was not taken into account.7 The effect was measured immediately after stopping 
the administration of histamine. The time between inhalations was about 5 min. In 
adults the reproducibility of the threshold is good when it is repeated at the same 
hour on successive days.6 This also applies to children.* With this technique the 
bronchial threshold to histamine in healthy children is 32 mg/ml. 
In children this value is not age dependent. Because logarithmic transformation 
did not improve the correlation coefficient with other variables~ the histamine 
threshold is handled as milligrams per milliliter to facilitate the legibility of the 
results. 
Statistical methods 
In the correlation calculations all variables were processed as if they were 
continuous. This method, although not quite correct, offers from a mathematical 
point of view important advantages over the method which considers variables 
as discontinuous. The results obtained by these two methods do not differ to any 
important extent. s 
Single and multiple correlation analyses and regression formulas were cal-
culated for the different variables (see Table VI). The inhalation reactions have 
been expressed both as a differential score (made up of the concentration of the 
* Unpublished observations from this laboratory. 
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Table I. Results of the tests 
Inhalation reaction Histamine release(% maximum) 
2.5 X 101 s.5 X 102 Allergen~ 
"g/ml "g/ml Hista- specific IgE With allergen ()..tg/ml) 
mine With 
After After After After thres- Skin out 
0-I 8-24 0-1 8-24 hold nlog titer 2.5 X 2.5 X 2.5 X 2_5 aller-
Patient* hr hr hr hr (mg/ml) U/ml U/ml ("g/ml) I0-3 IQ-2 I0-1 2.5 gen 
I + + 4_5 90.0 2.5 x ro-1 34 20 
2 -1.2 0.3 2.5 X lQI 0 
3 + 4.3 76.0 2.5 x ro-z 53 21 
4 + 2 5.5 245.0 2.5 1I 15 
5 + + 2 2.4 I LO 2.5 x ro-2 45 2 
6 + + 2 1.1 3.0 2.5 X IQ-2 5 0 
7 + 4 1.1 3.0 2.5 X 101 55 4 
8 4 -1.2 0.3 2.5 X 101 0 
9 + + 4 4.9 137.0 2.5 X IQ-2 31 6 
10 + 8 4.2 64.0 2.5 X IQ-! 88 6 
11 + 8 4.6 99.0 2.5 X I0-2 73 2 
I2 + 8 1.4 4.0 2.5 X I0-2 29 2 
I3 + + 8 4.4 79.0 2.5 X I0- 1 15 17 
14 16 1.1 3.0 2.5 x w-' 18 6 
I5 16 -1.2 0.3 2.5 x w-' 10 0 
I6 32 1.8 6.0 2.5 X JO-l 41 2 
17 64 0.9 2.5 2.5 2 2 5 
18 64 -1.2 0.3 2.5 4 4 7 
19 64 4.2 70.0 2.5 x w-' 34 5 
20 64 0.8 23.0 2.5 25 20 
2I 0 LO 2.5 5 4 
22 4 2.0 7.0 2.5 9 3 
23 + 8 3.8 46.0 2.5 x w-' 65 57 
24 8 0 LO 2.5 15 6 
25 8 0 LO 2.5 5 4 
26 32 3_5 33.0 2.5 X IQ- 1 18 3 
27 32 0 LO 2.5 6 3 
28 32 0 LO 2.5 X 101 20 16 
29 64 0 LO 2.5 6 4 
30 64 1.4 4.0 2.5 X IQ- 1 7 8 
• Patients 1 to 20. positive history: Patients 21 to 30. negative history. 
allergen in the nebulizer and the type of the reaction) and as a positive/negative 
score (see Table IV). 
In the multiple correlations the inhalation reaction (the dependent variable) was 
compared with the other variables (independent variables), both singly and in several 
combinations. The significances of the multiple correlation coefficients are calculated 
as follows': 
F 
n-k-1 R' 
k 1-R2 
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W Table II. Relation between inhalation reaction and histamine threshold, allergen·specific IgE, skin titer, and histamine release. 
00 
Histamine Allergen- Histamine release(% maximum) 
Inhalation threshold specific IgE 
reaction (mg/ml) (U/ml) Skin titer (~tg/ml} With allergen Without allergen 
Dose 
(~g/ml) Type+ n <(8 16 ;<:32 )21 6-20 2-5 <2 2.5 X lQ-l 2.5 X lQ-I 2.5 2.5 X 10 1 )40 20-39 ~;;19 > 15 6-15 0-5 
2.5 X 101 E 3 3 1 1 1 3 1 I I I 2 
D 2 2 2 2 I I I I 
2.5 x !Ol E 7 7 5 2 4 1 1 1 5 I I 2 2 3 
D 0 0 
Negative 18 6 2 10 3 2 3 10 3 3 9 3 I 3 14 2 4 12 
-
* E =immediate reaction; D =delayed reaction. 
Table III. Correlation coefficients between single variables in linear terms. 
Histamine release 
Histamine Allergen-
threshold specific IgE Skin titer With allergen Without allergen 
Inhalation reaction 
Histamine threshold 
Allergen-specific IgE 
Skin titer 
Histamine release 
The variables are used as follows: 
Inhalation reaciion 
0.60t 
-0.24 
2.5 x 101 !J.g/ml allergen: immediate reaction. score 4. 
delayed reaction. score 3. 
2.5 x 10z ).J.g/ml allergen: immediate reaction. score 2. 
delayed reaction. score I. 
no reaction. score 0. 
0.55* 
-0.13 
0.64t 
OA6t 
-0.26 
0.601" 
0.50* 
0.23 
0.04 
0.39 
0.23 
0.35 
Hisramine rhreshold is the concentration histamine biphosphate after which FEV 1 decreased to below 
85% of the initial value. 
A!!ergen-speciflc !g£ is the natural logarithm of the serum concentration in U/ml. 
Skin titer 
2.5 x 10-~ !J.g/ml allergen. score 4. 
2.5 x I0- 1 !J.g/ml allergen. score 3. 
2.5 ).J.g/ml allergen. score 2. 
2.5 x 10 1 Jlg/ml allergen. score I. 
Negative reaction. score 0. 
Hisramine release is expressed as percentage of the maximal release. 
; O.Ql ,;:; p <0.05. 
* 0.001 ~ p < 0.01. 
+ p < 0.001. 
where n = number of observations, k = number of independent variables, and 
R = correlation coefficients. 
The significances which were derived from these F values have been obtained 
partly from a standard table of F distributions, 10 and partly calculated. We looked 
for non-linear relationships by trying out other mathematical expressions. Only if 
quadratic terms were added to linear terms did some of the correlation coefficients 
increase significantly as shown by the F test modified for two correlation coeffi-
cients. The p values of the differences between correlation coefficients (Table V) were 
calculated by z-transformations according to FisherY The 5% level has been 
considered the level of significance. 
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Results 
The results are summarized in Table !. Table II shows the relationship 
between the inhalation reaction after allergen provocation, the histamine threshold, 
the allergen-specific IgE concentrations, the skin titer, and the histamine release 
with and without allergen. In this table the variables are arbitrarily divided into 
classes. After inhalation of cat dander allergen in 2.5 x I 01 ~g/ml concentration, 
bronchial obstruction occurred in five out of 30 patients. Three of these developed 
an immediate reaction and two a delayed reaction. The 25 patients who did not 
respond after inhalation of the allergen in the lower dose were tested with inhalation 
of 2.5 x 102 ~g/ml. An immediate reaction developed in seven patients, and none 
showed a delayed reaction. 
Inhalation tests were only positive with a histamine threshold of <( 8 mg/ml. 
Within the group of patients with a low histamine threshold only six out of I 8 had 
a negative reaction after cat dander inhalation. In a positive inhalation test the con-
centration of the allergen-specific IgE was always greater than or equal to 2 U/ml; 
in eight out of I2 patients it was greater than 20 U/ml. In a negative inhalation 
test the concentration of the allergen-specific IgE was higher than 2 U/ml in eight 
patients out of I 8. In nine out of I 2 a positive inhalation test was found with a skin 
titer with a low allergen concentration (2.5 x 10-2 ~g/ml), while in only three out 
of I8 the same skin titer was found together with a negative inhalation test. In six 
out of I 2 patients with a positive inhalation test there was a high allergen-induced 
histamine release ~ 40o/o of the maximum release). In patients with a negative 
inhalation reaction we found such a high allergen-induced histamine release on one 
occasion. a medium release (20o/o to 39o/o) on three occasions and low release 
( <( I 9%) on I 4 occasions. 
For further analysis of the correlation between the variables a correlation 
matrix has been constructed (Table Ill). This shows the following: 
I. The results of the inhalation test. expressed in the differential score as described 
in Table Ill, show a significant correlation with the histamine threshold, the 
allergen-specific IgE concentration. the skin titer, and the allergen-induced 
histamine release. 
2. The histamine threshold does not show any correlation with the histamine 
release with and without allergen or with the skin titer. 
3. The allergen-specific lgE concentration is correlated equally with the inhalation 
reaction, the skin titer. and the histamine release with allergen. There is no 
correlation with the histamine release without allergen or with the histamine 
threshold. 
4. The skin titer shows a significant correlation with the histamine release with 
allergen but not with the histamine release without allergen. 
In order to determine the correlation between more than two variables, multiple 
correlations have been calculated. Table IV (first and second columns) gives the 
results of the multiple correlation calculation with linear terms. The combinations 
of the histamine threshold with the allergen-specific IgE, skin titer. or histamine 
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release with allergen show significantly higher correlation coefficients with the in-
halation reaction than each of the variables alone (Table V). The combination of 
the histamine threshold with the allergen-specific IgE concentration gives the best 
correlation with the inhalation reaction. Combinations of more than two factors do 
not significantly increase the correlation with the inhalation reaction. When quad-
ratic terms were introduced together with linear, only the combination of the hist-
amine threshold with the skin titer and with the allergen-induced histamine release 
showed significant improvement in the correlation coefficients at the 1% level. 
The relationship between the reaction to inhalation, the histamine threshold, 
and the allergen-specific IgE concentration is shown for each patient in Fig. 1. 
Where the histamine threshold is 16 mg/ml or more. all inhalation reactions are 
negative. Where the histamine threshold is low, a positive reaction to inhalation is 
likely to occur a( an allergen-specific IgE concentration of;> 2 U/ml. The same is 
true at a skin titer with ,;; 2.5 X 10-1 ~g/ml. 
Discussion 
In formulating the conclusions to be drawn from this study, a posrtlve in-
halation reaction (scores 2. 3, or 4 from Table Ill) has been considered as indicative 
of clinically relevant allergy and the histamine threshold as a parameter of bronchial 
hyperreactivity. 
From Table Ill it can be seen that a statistically significant correlation exists 
between the histamine threshold and the reaction to inhalation of cat dander 
allergen. The inhalation reaction shows a significant correlation not only with the 
histamine threshold, but also with the concentration of the allergen-specific IgE, 
the skin titer. and the allergen-induced histamine release. The allergen-specific lgE 
concentration is correlated with the occurrence of the inhalation reaction but not 
with the degree of the reaction. 
From Tables IV and V it appears that the correlation between the inhalation 
reaction and the combination of the histamine threshold and the allergen-specific 
lgE concentration or skin titer is higher than with each separately. 
From the fact that the correlation coefficients of the inhalation reaction with 
the combinations of the histamine threshold with skin titer or histamine release in-
crease when quadratic terms are added to the linear ones. it can be concluded that 
the correlations between these factors are not rectilinear. Also, the allergen-specific 
IgE concentration gives the best fit in the correlation calculations if expressed as a 
natural logarithm. These facts point to nonlinear correlations~ which are often found 
in biologic systems. 11 
The calculations of the regression formulas and correlation coefficients were 
simplified using normal procedures for continuous variables, despite the fact that 
several variables had only discrete values. This method, although not quite correct. 
offers from a mathematical point of view important advantages over methods 
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Table IV. Correlation between the inhalation reaction as a dependent variable and several indepen-
dent variables singly and in groups. 
Histamine threshold 
Allergen-specific IgE 
Skin titer 
Histamine release 
Histamine threshold + allergen-specific IgE 
Histamine threshold + skin titer 
Histamine threshold + histamine release 
Histamine threshold + allergen-specific IgE 
+ skin titer 
Histamine threshold + allergen-specific lgE 
+ histamine release 
Histamine threshold + skin titer 
+ histamine release 
• Expressed in the same way as in Table III. 
Inhalation reaction 
Linear plus 
Linear terms quadratic terms 
Positive Positive 
Score* or negative·!· Score• or negativet 
-0.53t -0.56t --D.61 § --D.62§ 
0.60 11 0.69 11 0.60§ 0.69:j: 
0.55:/: 0.51:/: 0.62§ 0.57§ 
0.46§ 0.6311 0.49 11 0.64§ 
0.7311 0.8011 0.78 11 0.8211 
0.7211 0.71 11 0.7911 0.77 11 
0.63:/: 0.7211 0.7411 0.82 11 
0.76 11 0.81 11 0.8211 0.8411 
0.7311 0.83 11 0.78 11 0.8611 
0.7611 0.79 0.8211 0.8511 
+ Positive: scores 1-4 (Table III): negative: no reaction after allergen inhalation: all other variables 
are expressed as in Table Ill. 
§ 0.01 ::;;; p < 0.05. 
: 0.001 ,;; p < 0.01. 
11 p < 0.001. 
which consider variables as discontinuous. Moreover, the results obtained do not 
differ to any important extent. 12 
The correlation coefficients give limited information about the kind and range 
of the individual variations of the relationship found, especially if the regression 
model contains multiple linear and quadratic terms. This may limit its value when 
drawing conclusions from this data. In order to investigate the validity of the cor-
relation coefficients for our conclusions, regression equations were calculated based 
on all patient data (see Table VD. Using these we predicted which inhalation reaction 
would occur in each child from his histamine threshold, allergen-specific lgE con-
centration, and skin titer. The predicted reaction was compared with the observed 
one. The results can be summarized as follows. Based on the histamine threshold 
and the allergen-specific IgE concentration, in 14 out of the 30 patients a correct 
prediction of the differential inhalation score could be made. The inhalation reac-
tions in terms of positive or negative could be correctly predicted in 25 of the 30 
patients. Based on the histamine threshold and the skin titer, a correct prediction 
of the differential score could be made in 13 of 30 patients. The predictions in 
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terms of a positive or negative inhalation reaction were correct in 26 of the 30 
patients. These results indicate that in our studies conclusions can be drawn from the 
correlation coefficients. 
Bryant and Burns13 found, along with a low bronchial threshold for Dermato-
phagoides pteronyssinus allergen, a lowered histamine threshold. In monkeys who 
were allergic to Ascaris and who had a positive inhalation reaction with this aller-
gen. Patterson et al. 14 found a higher bronchial sensitivity for carbacholine than in 
monkeys with a negative inhalation reaction. G6kemeyer15 found a significant cor-
relation between the histamine threshold and the dose of house dust allergen which 
provoked bronchial obstruction after inhalation. 
The histamine threshold could be influenced by the allergen-specific IgE con-
centration. This is unlikely, however, because no relationship between histamine 
threshold and the allergen-specific IgE concentration or the skin titer was found 
(Table III). Also, G6kemeyer15 found no relationship between the histamine thres-
hold and the skin titer. Rademaecker et al. 16 found that a stronger reaction of the 
bronchial tree to histamine occurred in monkeys passively immunized with grass 
pollen reagins. In guinea pigs, Popa et alY found no influence of sensitization 
with antibodies against egg -albumen on the bronchial threshold. After inhalation 
of this allergen, a temporarily increased bronchial threshold was found. Bryant 
et al.18 found no correlation between the histamine threshold and the number of 
allergens with which a positive prick test was obtained. He also failed to find a 
relationship between the histamine threshold and the total IgE. 
The histamine threshold and the initial lung function are not necessarily in-
dependent of each other. 19• 20 Table VII shows that a slight difference exists between 
the group of patients with a positive and a negative inhalation reaction and between 
patients with a decreased and a normal histamine threshold as to their initial FEY 1• 
These differences are not statistically significant. We therefore assumed that the 
relationship between the inhalation reaction and the histamine threshold was not 
based on differences in the extent of bronchial obstruction at the start of the test. 
G6kemeyer15 found a slight but significant decrease of the histamine threshold 
some days after a positive response to provocation with house dust. It is improb-
able. however, that the lowered histamine threshold in our patients was caused by 
an allergic reaction. According to their history they had not suffered from symp-
toms at least 4 wk prior to the examination. 
The results of this study support our hypothesis that a decreased bronchial 
threshold to inhaled bronchial constrictor agents is essential for an inhalation re-
action to an allergen to occur in allergic patients. 
In some asthma patients there is a permanently decreased bronchial threshold, 
while in others the bronchial threshold is normal or changing. 21 The fact that 
bronchial obstruction after inhalation of allergen seems to occur only with a 
decreased bronchial threshold can explain why patients from this last category do 
not always show symptoms after contact with the allergen. This can be confirmed 
by repeated bronchial provocation tests in the same patient in periods with a normal 
and a decreased threshold to histamine. This is currently under study. Up to now 
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we were able to reinvestigate the patient marked in Fig. I with an asterisk 2 wk 
after an asthma attack. The histamine threshold was 8 mg/ml, and the child showed 
a delayed reaction after inhalation of 2.5 x 101 ~g/ml and an early reaction after 
2.5 x 102 ~g/ml. The initial FEV1 was 108% on the first and 72.5% on the second 
occasion. The skin titer and specific lgE were unchanged. 
Clinical asthma based on the history does not always concur with the inhalation 
reactions. There may be several reasons for this. Apart from changes in reactivity 
with time, the impression of the patient concerning symptoms caused by contact 
with a particular allergen might be incorrect. 
It seems improbable that the inhalation reaction was influenced by measure· 
men! of the histamine threshold, because histamine challenge gives a reaction which 
only lasts minutes. 
It appears that on the basis of the serum concentration of the allergen-specific 
lgE or the skin titer, the reaction occurring after inhalation of allergen can only be 
predicted with moderate accuracy in the individual patient. For a more reliable pre· 
diction the bronchial threshold should be determined. If this is increased (a hist-
amine threshold < 8 mg/rnl using our method), and at the same time an elevated 
concentration of circulating or cell-bound allergen-specific lgE is present, bronchial 
obstruction after allergen inhalation is very likely. If the bronchial threshold hist-
amine is normal (> 32 mg/rnl), an increased allergen-specific lgE concentration 
does not produce bronchial obstruction after inhalation. Both antibody and bron· 
chial threshold determinations are feasible in most outpatient departments and in 
most patients. 
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o* 
0 
0 
0 
0 
0 
0 
0 8 8 
2 4 8 16 32 64 
Histamine threshold ( mg/ml) 
Figure I. Coherence of histamine threshold and allergen-specific IgE with inhalation reaction for 
each patient. Group A (positive history of bronchial reaction after contact with cat): 
• inhalation reaction positive, o inhalation reaction negative. Group B (negative history): 
• inhalation reaction positive. o inhalation reaction negative. 
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Table V. DiO"erences between the correlation coefficients in Table IV. 
Histamine 
threshold 
Allergen-specific 
lgE Skin titer Histamine release 
Histamine 
threshold 
+ al!ergen-
specific lgE 
Histamine 
threshold 
+ skin titer 
Histamine 
threshold 
+ histamine release 
Score• Pos/Neg• Score• Pos/Neg"' Score• Pos/Neg"' Score• Pos/Neg"' Score Pos/Neg Score Pos/Neg Score Pos/Neg 
Histamine threshold 
+ allergen-specific IgE 
Histamine threshold 
+ skin titer 
Histamine threshold 
+ histamine release 
Histamine threshold 
+ allergen-specific lgE 
+ skin titer 
Histamine threshold 
+ allergen;specific IgE 
+ histamine release 
Histamine threshold + skin 
titer + histamine release 
0 =Not significantly different 
I ~ O.Ql ( p < 0.05. 
2~0.00l(p<O.Ol. 
3~p<0.001. 
3 
2 
2 2 2 
2 2 3 
2 2 
"' Inhalation reactions expressed as in Table IV; all other variables are expressed as in Table Ill. 
0 0 0 2 
0 0 
0 2 
Table VI. Regression equations calculated from measurements in 30 patients. 
Inhalation reaction 
expressed as*: 
Pos/Neg • 
Score • 
Pos/Neg • 
Score • 
Pos/Neg • 
Score • 
Pos/Neg • 
Score • 
Pos/Neg • 
Score • 
Pos/Neg • 
Score • 
* See Table III. 
Regression equation with following variables 
0.6436- 0.0117 (Histamine threshold) 
1. 7356- 0.0321 (Histamine threshold) 
0.1136 + 0.1618 (Allergen-specific IgE) 
0.3422 + 0.4094 (Allergen-specific IgE) 
-0.1886 + 0.2127 (Skin titer) 
-0.7705 + 0.6640 (Skin titer) 
0.3390- 0.0088 (Histamine threshold) + 0.1383 (Allergen-specific IgE) 
0.9804- 0.0249 (Histamine threshold) + 0.3429 (Allergen-specific IgE) 
0.1065 - 0.0101 (Histamine threshold) + 0.1849 (Skin titer) 
0.0245 - 0.0282 (Histamine threshold) + 0.5891 (Skin titer) 
0.2198- 0.0089 (Histamine threshold) + 0.1178 (Allergen-specific IgE) 
+ 0.0566 (Skin titer) 
0.2306-0.0253 (Histamine threshold)+ 0.2142 (Allergen-specific lgE) 
+ 0.3558 (Skin titer) 
Table VII. The initial values of VC and FEY 1 according to the inhalation reaction and histamine 
threshold. 
Inhalation reaction Positive Mean 
n = 12 SD 
Negative Mean 
n= 18 SD 
Histamine threshold ,;;8mg/ml Mean 
n= 18 SD 
)16 mg/ml Mean 
n= 12 SD 
None of the differences is statistically significant (Student's t test). 
*Expressed as percent of the expected value according to height. 
Initial values* 
vc FEV1 
107.8 94.2 
13.5 18.7 
102.8 97.7 
14.0 18.6 
104.5 93.7 
13.6 20.1 
104.8 99.9 
15.2 11.9 
A number of studies supported our assumption that histamine release from 
peripheral leukocytes may be considered a suitable model for mast cell histamine 
release after allergen challenge.22• 23 We found that the amount of histamine re-
leased after incubation of the leukocytes with allergen correlates well with the serum 
concentration of specific IgE. This concentration can be considered indicative of the 
number of cell-bound specific IgE molecules. 24 It can therefore be understood that 
the addition of the histamine release did not improve the correlation coefficient 
between the inhalation reaction and the histamine threshold plus specific lgE con-
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centration or skin titer. The histantine release thus seems unnecessary for the pre-
diction of the reaction after inhalation of allergen in the individual patient. 
We thank Dr. R. Voorhorst for making available the allergen, Dr. R. Aalberse 
for measurement of the allergen-specific IgE concentration, and Dr. J. P. M. de 
Kroon for statistical advice. 
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Paragraph 8.3 
Significance of the bronchial responsiveness to histamine in allergen-induced bron-
chial obstruction on different occasions 
H. J. Neijens, K. F: Kerrebijn 
Department of Paediatrics, Subdepartment of respiratory diseases, Erasmus Uni-
versity, Medical School, Sophia Children's Hospital, Rotterdam, The Netherlands 
Summary 
An increase in the bronchial responsiveness (BR) to histamine was associated 
with a positive in stead of a negative allergen inhalation reaction, while a decrease 
in BR diminished the inhalation reaction to allergen. The reaction was unchanged 
in the patients with a stable BR. This relationship was relevant, because the sensiti-
zation to the allergen and the baseline FEY 1 were without significance variance. 
Introduction 
Bronchial responsiveness (BR) to histamine and metacholine is important in 
the bronchial reaction to allergen inhalation 1• 2• >. Besides the sensitization to a 
particular allergen, BR is a determinant in the occurrence of bronchial obstruction 
after allergen challenge. In the same person BR can change. A temporary increase 
is observed after respiratory infections4 · 5, influenza vaccination6 reactions to in-
halation of allergens'· 8 and ozone'. In asthmatics BR can decrease10 during symp-
tomfree periods. The hypothesis that bronchial obstruction after allergen challenge 
may vary with changes in BR has been studied in asthmatic children. 
Methods 
4 patients in whom during a previous study' (frrst occasion) a combination 
was found of a histamine provocation dose (PD) in the normal or nearly normal 
range ~ I6 g. I-1) and a negative reaction to cat dander allergen inhalation, were 
rechallenged (second occasion) when the PD was found to be decreased(~ 8 g. I-1) 
1. This study is supported by the Netherlands Asthma Foundation. (grant nr. 238) 
2. Presented it the Congress "Relationship between respiratory diseases in children 
and adults". Rotterdam, The Netherlands. November 22th. 1980. 
3. Submitted for publicaton. 
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Table I. Comparison of the sensitivity to cat dander allergen, by skin titer and specific lgE concen-
tration, and the baseline values of the FEV 1 in relation with allergen inhalation reactions 
on two occasions. 
Patient groups A. B and C as in figure 1. 
First occasion Second occasion 
Pat. Skintiter Spec. IgE Baseline Skin titer Spec. IgE Baseline 
FEV1% FEV1% 
mg.l- 1 I03uJ-1 predicted mg. J-1 J03u.J-1 predicted 
2.5xlO-~ 70 !08 2.5xiO-' 80 72.5 
~ 2 2.5 2.3 2.5xi0-1 ~ !00 3.3 90 ~ 
0 
" Cl 3 2.5xi0- 1 33 
< 
Ill 2.5xi0- 1 38 90 
4 2.5x!O-' 190 80 2.5xiQ-~ 204 74 
5 2.5x ro-~ 82 90 2.5xio-~ 90 89 
~ 6 2.5x!O-' 178 2.5xi0-2 0 104 196 !06 ~ 
0 
.s 7 2.5xi0- 1 39 
'" 
77 2.5 51 76 
8 2.5xi0- 2 124 96 2.5xi0- 1 !04 76 
~ 
0 
"" 9 2.5xiO-' 46 2.5x IQ-' 78 c 95 54 ~ 
~ 
0 
c 
:> IO 2.5xlO-~ 6 86 2.5xi0- 1 !3 82 
rj 
(group A). A further 4 patients in whom on the first occasion a decreased PD and a 
positive allergen inhalation reaction was evoked, were studied again when the PD 
had become normal (group B). The same was done in two patients in whom the PD 
was unchanged (group C). The age range of the patients was from 9.1 to 10.10 years. 
The period between the first and second occasion varied from I. I to 4.1 
years. Informed consent was obtained from the parents after full information about 
the investigations had been given. During both studies the children were in a stable 
condition and no medication was given between at least two days before the study 
and its conclusion. 
Determination of the bronchial response to histamine and to allergen in-
halation were carried out on four consecutive days between 9 and 12 a.m. in order 
to avoid the influence of circadian rhythmu. BR was determined by means of the 
PD i.e. the lowest histamine concentration out of a series which was followed by a 
!50 
Allergen inhalation 
reaction score 
8 A B c 
6 
4 
"' 
2 
0 
2 4 8 16 32 64 1 2 4 8 16 32 64 1 2 4 8 16 32 64 
Histamine provocation dose (g.l-1 , 2 log scole) 
Figure 1. Allergen inhalation reactions on two occasions ( o first: • second) in the same patients 
in relation to their bronchial responsiveness to histamine. 
Three patients groups are distinguished according to the change in histamine provocation dose: 
A =Decrease: B =Increase: C =Unchanged. 
inhalation time (min.) 
allergen 2.5 X 101 
concentration 2.5 x 102 
(mg. I- 1) 
Allergen inhalation reaction score 
type of the reaction 
immediate delayed 
only 
3 10 
8 7 6 5 
4 3 2 
no reaction = 0 
decrease in forced expiratory volume in the first second (FEY 1) of 15% or more of 
the baseline value (PD 15). This was measured by means of the inhalation of hista-
mine biphosphate in increasing concentrations (doses of 1, 2, 4, 8, 16, 32 and 64 
g. L-'). Histamine was nebulized with the Doppelinhaler (flow of 6 L/min). At the 
beginning of the inhalation patients performed a submaximal vital capacity ma-
noeuvre, after which they breathed at tidal volume for 30 sec. The PD was mea-
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sured on the day prior to the allergen inhalation test. The effect was measured im-
mediately after stopping the administration of histamine. The time between inha· 
lations was about 5 min. With this technique the PD 15 to histamine in healthy 
children is 32 g. L- 1• A decrease in PD 15 means an increase in BR. 
Allergen inhalations were performed with concentrations of 2.5 x 101 and 
2.5 x 102 mg. J-1 of a cat dander allergen solution. These concentrations were 
established from the results of a preliminary test which are not shown here. The 
nebulizer used is the Doppelinhaler (Bliimel, Wiesbaden) with an airflow of 6 L/min. 
The allergen was inhaled for a maximum of 10 min. (first for I min., for a further 
4 min. if there was no reaction within 15 min .. and for another 5 min. if 15 min. 
thereafter still no reaction occurred). The FEV 1 was measured prior to, immediately 
after, and at I. 8 and 24 hr. after the inhalation. The inhalation test was considered 
positive when the FEV 1 diminished to less than 85% of the initial value. The best of 
five successive measurements was taken. A distinction was made between an 
immediate reaction taking place within I hr. after inhalation ad a delayed reaction 
between 4 and 24 hr. afterwards. During the inhalations the subjects breathed 
slowly and somewhat more deeply than normal. After an immediate reaction, an 
isoprenaline aerosol was inhaled to prevent the development of an asthma attack. 
Patients with an isolated delayed reaction on the lower dose were retested with the 
higher dose. which in all of them resulted in an immediate reaction. The results are 
expressed in a score, taking into account the dose of allergen needed and the type of 
reaction (see legend figure 1). In the score the type of the reaction is regarded in 
terms of quantification of the dose and not in a pathophysiological sense. Because 
an isolated delayed reaction changes into an immediate type when the dose of the 
allergen inhaled is increased3 12 , an immediate reaction was rated higher than a 
delayed reaction after the same dose of allergen. 
The degree of sensitization was estimated by the skin titer and the serum con-
centration of the allergen specific IgE. An intracutaneous skin test was done with 
four different concentration (2.5 x lQ-2, 2.5 x 10-1, 2.5, and 2.5 x 101 j.tg/ml). 
In each skin test a control was performed using the solvent. The volar aspect of 
the forearm was used and injections were at least 3 em apart to avoid induction. 
The reaction was considered positive if the diameter of the wheal was 5 mm after 
20 min. The lowest concentration of allergen to which a positive reaction occurs is 
called the skin titer. 
The concentration of allergen-specific lgE was measured by the RAST using 
CNBr-activated Sepharose 4B as solid phase. To I ml packed activated Sepharose, 
5 mg allergen was added. Fifty microliters serum or serum dilution was incubated 
with 0.5 ml of a 1% suspension. After overnight incubation, the Sepharose beads 
were washed, and 1231-labeled anti-lgE antibodies, isolated as described, were 
added. After another overnight incubation, Sepharose-bound radioactivity was 
determined. The counts found were converted to international units (!U) !gE by 
comparison with a dose-response curve obtained by incubation of dilutions of an 
lgE standard serum with Sepharose-coupled anti-lgE antiserum. 
Cat dander allergen was obtained from Dr. R. Voorhorst in Leiden and from 
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Diephuis Inc. in Groningen. Both products were mixed by us, lyophilized, and kept 
at -25°C. Freshly prepared mixture in physiologic saline was used. The batch of 
cat dander allergen was the same on both occasions. 
Results 
As can be seen in Figure I, in all patients in group A a decrease in PD 15 and 
thus an increase in BR was associated with the conversion of a negative into a 
positive allergen inhalation reaction. The reverse was also true. In group B an in-
crease in PD 15 was associated with a decrease in the allergen inhalation score, 
although this became zero in only one patient. The allergen inhalation score and 
the PD were unchanged in both patients in group C. 
Table I shows that sensitization to cat dander allergen was not significantly diffe-
rent on the two occasions (student T test). The baseline FEY 1 differed slightly in 
9 out of the I 0 patients. 
Discussion 
BR is increasingly recognized as an important characteristic of asthma 13• This 
study demonstrates that variations in BR can influence the bronchial response after 
allergen challenge. The findings were not due to differences in allergen sensitization. 
It seems improbable that they were the result of the differences in baseline FEY 1• 
With the exclusion of patient I these differences are within the range which is gene-
rally accepted as non-significant. 
The findings can explain why in many asthmatics the bronchial obstruction 
after contact with an allergen varies in severity or is even absent and also why it 
can be more severe after colds or exposure to air pollution. Also the predominance 
of symptoms at night may be partially explained by the drop in BR due to the cir-
cadian rhythm 11 • 14• 
We thank lneke Strik, Edith Bonze!, Marjan van Smalen and Joke Mazee for 
their technical assistance, Dr. R. Aalberse for measurement of the allergen-specific 
IgE concentrations, Annelies de Reus for secretarial help and Dr. R. Pearse for cor-
recting the English language. 
This work was supported by a grant from the Dutch Asthma Foundation 
(project number 238). 
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CHAPTER 9. GENERAL DISCUSSION 
Based on data from the literature and our studies. the following conclusions 
may be drawn. 
The interaction of factors which are involved in the occurrence of bronchial 
obstruction varies according to the dose and kind of stimulus applied, as well as 
between individuals. 
In allergen-induced bronchial obstruction the mast cells, situated inside the bron-
chial lumen and in the bronchial wall play a primary role, whereas the parasympa-
thetic system is secondarily involved as the pathway along which the reaction 
spreads and modulates throughout the lung. 
In exercise-induced bronchial obstruction both systems are primarily involved 
whereas the contribution of each seems to differ from one individual to another. 
In histantine-induced bronchial obstruction the role of mast cells is less well 
established than in reactions due to allergens or exercise. Inhaled histamine acts 
directly on the histamine receptors of the bronchial smooth muscle. but may also 
generate a parasympathetic reflex as is shown in the recent literature. The relative 
contribution of both pathways is dependent on the dose of histamine, the site of 
deposition and the integrity of the bronchial mucosa. 
The mechanisms which cause bronchial obstruction are slightly variable while 
produced by stimuli which differ widely in character. Differences exist between 
various groups of asthmatic and bronchitic patients in their reactions to various 
kinds of stimuli (G6kemeijer, 1976). Bronchial responsiveness can be regarded as 
a dysregulation, relatively little dependent on the applied stimulus. Originally, to 
test bronchial responsiveness~ histamine and acetylcholine were used as non-allergic 
stimuli and were called aspecific stimuli. A growing number of other triggers have 
become known which cause bronchial obstruction in subjects with hyperresponsive-
ness. They include serotonin, bradykinin, prostaglandin F20 , propanolol, phenyl-
ephrine: physical agents, such as carbon dust and fog: chemical agents, such as 
sulphur dioxide; forced respiratory manoeuvres, exercise, viral infections and 
emotional stress (Horton et a!. 1978). 
The bronchial responsiveness to inhaled histamine and to exercise are positively 
correlated. Thus the bronchial reaction induced by both stimuli seems to be com-
parable, although differences exist. For instance a refractory period is observed after 
exercise, but not after the inhalation of histamine. The exercise test has attractive 
aspects, such as the absence of the administration of a pharmacological agent. 
However. the degree of the bronchial challenge is not simple to control in exercise 
tests. Insufficient information is available about the reproducibility of both tests in 
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the same persons. Therefore it is at present difficult to draw conclusions about the 
value of both tests in the determination of bronchial responsiveness. 
Bronchial responsiveness can be regarded as a reflection of the integrated 
action of a number of factors inside and outside the bronchi, in which dysregulation 
may occur. 
The following factors may be responsible for a hyper- instead of a normal 
responsiveness of the bronchi: 
I. Differences in tone and contractibility of bronchial smooth muscle between 
persons with and without bronchial hyperresponsiveness. This cannot however 
account for the variability in the degree of bronchial responsiveness completely 
(see paragraphs 3.2.d and 4.4.2). 
2. An increase in the sensitivity and accessibility of the sensory receptors as a 
result of a disturbed integrity of the bronchial mucosa. This can contribute 
beyond reasonable doubt to augmented reactions, at least in the case of bronchial 
inflammation~ due to infection and toxic factors. However, infections outside 
the bronchial mucosa may also increase the bronchial responsiveness (see para-
graphs 3.3. 4.3.3 and 4.4.3). 
3. Mediator releasing cells, i.e. mast cells and basophils may also contribute to 
exaggerated responses. This factor seems to be relevant in bronchial responsive-
ness as can be concluded from paragraphs 3.9. 3.10. 4.3.9/10 and 4.4.9/10. Our 
results (shown in paragraph 7.1), also suggest a role of mediator release from 
mast cells in bronchial responsiveness due to exercise. Based upon our observa-
tions that the releasability in patients with an increased bronchial responsiveness 
is greater than the that in patients without an increased bronchial responsive-
ness (paragraphs 7.3 & 7.4), it may be concluded that the releasability influences 
the degree of bronchial responsiveness. The variation in releasability cannot be 
explained by the degree of sensibilization to allergens. 
4. The ~-sympathetic system (see paragraphs 3.5, 4.3.5 and 4.4.5). This is important 
in the counteraction of the smooth muscle contraction. It can be assumed that a 
hypofunction contributes to an increase in bronchial responsiveness. The 
~-sympathetic receptor function is essential in this respect. Recent studies in-
dicate that dirrtinished ~-function can be the result of a decrease in the number 
of functional ~-receptors. possibly due to a conversion of ~ into a-types. Sym-
pathetic fibres are scarce in the bronchi. Therefore the adrenal output must be 
important in the activation of sympathetic receptors in the bron'chi in order to 
counteract obstruction. It is as yet not definitely established whether a diminished 
activity of the adrenal medulla is partly responsible for the occurrence of 
bronchial obstruction in patients with bronchial hyperresponsiveness. A recent 
study (Barnett et a!. 1981) indicates that the catecholamines output of the 
adrenals is relatively low in subjects with, compared to those without, exercise-
induced bronchial obstruction. 
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Figure 1. Schematic representation of the regulation of the bronchial diameter and the cooperation 
of various systems. 
According to the evidence, presented in paragraphs 3.3, 3.4, 4.3 and 4.4, it 
is tempting to speculate that an increase in the parasympathetic reflex activity is 
more important than a deterioration of the ~-sympathetic function during 
exacerbations due to exogenous factors. The change in the dose-response curve 
of the bronchial smooth muscle due to increase in parasympathetic activity is of 
a pre-synaptic type. The curve shifts towards lower doses of the agonist in a 
paralllel way. This implies smooth muscle contraction after doses of stimuli 
which are without effect under normal circumstances (see figure 1, page 24 ). 
5. Low initial values. These reflect a greatly diminished baseline bronchial dia-
meter and may be correlated with a relatively strong bronchial responsiveness. 
However, several studies indicate that this relationship is rather weak and can-
not explain in itself the phenomenon of increased bronchial responsiveness. 
All these 5 factors may play a role in bronchial responsiveness in children. 
Probably their interrelationship varies with the circumstances. Little information is 
available about the variation in the degree of bronchial responsiveness and the rela-
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tive importance of the above mentioned factors with age. Insight into differences 
between bronchial responsiveness in children and adults has to wait until this in-
formation becomes available. 
Although the occurrence of bronchial symptoms induced by allergens and 
other stimuli may influence the state and the reactions of the bronchi temporarily, 
bronchial hyperresponsiveness is predominantly a basic factor in asthma. 
Practical implications 
The degree of bronchial responsiveness in asthmatic patients can indicate the 
likelihood of the occurrence of symptoms. In some patients the bronchial responsive-
ness is permanently increased, while in others it may be variable or (sub)normal. 
Determination of the degree of bronchial responsiveness is particularly useful in the 
following groups: 
a. Subjects with respiratory symptoms. The presence of bronchial hyperresponsive-
ness affords additional evidence for the diagnosis of asthma, besides other 
diagnostic information, such as the medical history and the presence of rever-
sible bronchial obstruction. 
b. Asthmatic patients (symptomatic). The frequency and severity of symptoms, 
which increases with the degree of bronchial responsiveness, can be assessed. 
c. Asthmatic patients (asymptomatic). The residual risk of symptoms may be 
estimated. 
Apart from diagnostic information, the degree of bronchial responsiveness 
may also have significance for the policy of the treatment. In asthmatic patients 
with a marked increased bronchial responsiveness special attention should be paid 
to the prevention of challenges and a sufficient protection by drug therapy. 
Additional studies and recommendations 
We recommend measurement of bronchial responsiveness in asthmatic patients 
at regular intervals. Further studies are needed to obtain more insight into the prac-
tical implications of and the influence of treatment on, bronchial responsiveness. 
Apart from studies in man, continuation of research in animals is also needed with 
respect to the pathophysiology of bronchial responsiveness, and the methods which 
influence it. 
We believe that more studies may allow us to further elucidate determining 
factors between hyper- and normal bronchial responsiveness. The ultimate goal is to 
design methods which will convert hyper into normal responsiveness in a safe and 
effective manner. 
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Algemene discussie 
Op grand van de gegevens in dit proefschrift kunnen de volgende veronder-
stellingen en adviezen worden opgesteld. (zie ook figuur I in de General Discus-
sion) 
Behalve de directe aktivatie van het bronchiale gladde spierweefsel, kunnen de 
sensorische receptoren in combinatie met het parasympathische zenuwstelsel, als-
mede het vrijkomen van mediatoren uit mestcellen en basofiele leucocyten bijdra-
gen aan het ontstaan van bronchus obstructie. Hun onderlinge samenhang lijkt 
enigszins te verschillen; dit hangt af van de stimulus. 
Bij bronchusobstructie door inademing van allergenen spelen de mestcellen, die 
zich zowel in het bronchuslumen als in de bronchuswand bevinden, een primaire roL 
Hierna is het parasympatische systeem belangrijk bij de verspreiding en mogelijk 
ook bij de modulatie van de reactie over alle delen van de long. 
Bij de bronchusobstructie na inspanning lijken zowel de mestcellen alswel het 
parasympatische zenuwstelsel te zijn betrokken. De bijdrage van elk verschilt van 
patient tot patient. 
Bij de bronchusobstructie na inhalatie van histamine is de rol van de mestcel-
len minder duidelijk dan bij de reactie na allergenen of inspanning. Gelnhaleerd 
histamine werkt direct op de specifieke receptoren van de bronchiale gladde spieren, 
maar kan ook een parasympatische reflex induceren via sensorische receptoren in 
het slijmvlies. De bijdrage van elk van beide mechanismen hang! af van de hista-
mine dosis, de plaats van depositie en de toestand van het bronchiale slijmvlies. 
Hoewel grote verschillen bestaan in de aard van de stimuli, lijken de mecha-
nismen waardoor zij bronchusobstructie veroorzaken in grote lijnen vergelijkbaar. 
Enige verschillen bestaan in de bronchiale reacties door enkele soorten stimuli bij 
patienten met astma en bronchitis (G6kemeijer, 1976). Bronchiale prikkelbaarheid 
kan als een algemene bronchiale dysregulatie worden beschouwd, die relatief weinig 
afhangt van de soort van de stimulus. Bronchiale prikkelbaarheid is een uiting van 
de interaktie van een aantal faktoren in en buiten de Iangen die elk ontregeld kunnen 
zijn. 
Oorspronkelijk zijn histamine en acetylcholine als niet-allergische ofzogenaam-
de aspecifieke stimuli toegepast om de bronchiale prikkelbaarheid te meten. Een 
groeiend aantal andere stimuli is bekend geworden dat bronchiale obstructie kan 
veroorzaken bij de aanwezigheid van een toegenomen bronchiale prikkelbaarheid. 
Deze stimuli betreffen onder meer serotonine, bradykinine, prostaglandine F2a, 
propanolol, phenylefrine; fysische factoren zeals koolstof en mist, chemische agentia 
zoals zwaveloxide: geforceerde adembewegingen, inspanning, virale infecties en 
emoties (Horton e. a. 1978)., 
De bronchiale prikkelbaarheid voor het inademen voor histamine en voor in-
spanning zijn gecorreleerd. Dit suggereert dat een verwantschap bestaat tussen de 
bronchiale reactie na beide stimuli, hoewel ook verschillen aanwezig zijn (na bron-
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chusobstructie doorinspanning bestaat een refractaire periode die niet gezien wordt 
na bronchusobstructie door histamine-inhalatie). De inspanningstest heeft aantrekke-
lijke aspecten, zoals de afwezigheid van exogene pharmacologische stoffen. Het 
kwantificeren van de stimulus die uitgeoefend word! op de luchtwegen is echter bij 
de inspanningstest moeilijk. Onvoldoende gegevens zijn beschikbaar om trent de 
reproduceerbaarheid van beide testen bij dezelfde personen, zodat nog geen defini-
tieve uitspraak kan worden gedaan over de waarden van deze testen. 
De volgende factoren kunnen een aandeel leveren bij het ontstaan van ver-
sterkte reacties bij een toegenomen prikkelbaarheid: 
1. Verschillen in tonus en contractiliteit van bronchiale glad spierweefsel tussen 
personen met en zonder toegenomen bronchiale prikkelbaarheid. Deze kunnen 
de variabiliteit in bronchiale prikkelbaarheid niet voldoende verklaren (zie de 
paragrafen 3.2.d en 4.4.2). 
2. Toename in de gevoeligheid en de bereikbaarheid van de sensorische receptoren 
door verstoring van de integriteit van het bronchiale slijmvlies. Dit kan naar aile 
waarschijnlijkheid een verhoogde bronchiale prikkelbaarheid veroorzaken. Dit 
geld! vooral bij aangedaan slijmvlies door infecties en toxische factoren. Echter 
ook infecties buiten het bronchus slijmvlies kunnen de gevoeligheid van de 
sensorische receptoren en daarmee de bronchiale prikkelbaarheid verhogen (zie 
de paragrafen 3.3, 4.3.3 en 4.4.3). 
3. De mate van vrijkomen van mediatoren uit mestcellen en basojiele Ieucocyten. 
Deze factor lijkt op grand van de gegevens in de paragrafen 3.9, 3.10, 4.3.9/10 
en 4.4.9/10 van belang te zijn voor de mate van bronchiale prikkelbaarheid. 
Ook de resultaten van ons onderzoek, weergegeven in paragraaf 7.1. wijzen op 
een rol van mestcellen bij bronchiale reacties na inspanning. Op grand van onze 
waarnemingen dat het vrijkomen van mediatoren bij patienten met een toegeno-
men bronchiale prikkelbaarheid grater is dan bij diegenen met een normale 
bronchiale prikkelbaarheid (paragrafen 7.3 en 7 .4), blijkt dat vrijkomen van 
mediatoren van belang kan zijn voor de sterkte van de broncbiale obstructie ten 
gevolge van diverse stimuli. De variatie in bet vrijkomen van mediatoren kan 
niet worden verklaard uit de mate van sensibilisatie voor allergenen (zie appen-
dices bij 7.1 en 7.3 & 7.4), zodat de aanwezigheid van allergie niet de bepalende 
factor hierbij is. 
4. Het sympatische zenuwsteisel (zie paragrafen 3.5, 4.3.5 en 4.4.5). Dit is belang-
rijk bij de tegenregulatie van de contractie van het gladde spierweefsel en een ver-
laagde functie zal, naar mag worden aangenomen, bijdragen tot bet v66rkomen 
van toegenomen bronchiale prikkelbaarheid. De ~-sympatische receptor functie 
is bierbij van essentiele betekenis. Recente studies wijzen op een vaak voor-
komende vermindering van de ~-sympatische functie bij Cara door een geringer 
aantal functionele receptoren. Dit zou kunnen ontstaan door omzetting van 
~- in a-receptoren, waardoor het effect na aktivatie tegengesteld wordt. Sym-
patische vezels zijn schaars in de bronchi. Het lijkt daarom waarschijnlijk dat de 
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sympatische tegenregulatie van de bronchi voor een belangrijk dee! via de 
circulerende catecholamines uit het bijnierrnerg plaatsvindt. Het is nog onzeker 
of een vermindering hiervan mede verantwoordelijk kan zijn voor een toege-
nomen bronchiale prikkelbaarheid, hoewel recent onderzoek hiervoor wel aan-
wijzingen geeft (Barnett e.a. 1981). 
Tijdens perioden met verergering van het ziektebeeld door exogene factoren 
lijkt toename van de parasympatische reflex activiteit van meer belang dan af-
narne van de 0-sympatische functie, althans volgens de huidige inzichten (zie de 
paragrafen 3.3, 3.4, 4.3 en 4.4). Onder deze omstandigheden ontstaat een 
verandering van de dosis-respons kurve van het bronchiale gladde spierweefsel 
van het pre-synaptische type. De kurve schuift op een parallelle wijze naar een 
lagere dosis van de agonist. Contractie van de bronchus musculatuur na histami-
ne of andere stimuli treedt op na een dosis die geen of een vee! lager effect heeft 
onder normale omstandigheden. (Zie figuur I, bladzij 24). 
5. Lage uitgangswaarden van de longfunctie, hetgeen een uitdrukking is van een 
sterk verminderde bronchiale diameter in rust, kan samengaan met relatief ster-
ke bronchiale prikkelbaarheid. Verschillende studies tonen echter aan dat hun 
samenhang zwak is en geen verklaring vormt voor het fenomeen van verhoogde 
bronchiale prikkelbaarheid. 
In het geval van toegenomen bronchiale prikkelbaarheid bij kinderen kunnen 
al deze 5 factoren een rol spelen. Hun onderlinge samenhang kan varieren. De 
veranderingen in de mate van bronchiale prikkdbaarheid met de leeftijd en de 
betrokkenheid van bovengenoemde factoren bij dit proces zijn nag weinig bestudeerd. 
Pas indien hierover voldoende informatie beschikbaar is. kunnen uitspraken wor-
den gedaan om trent de bronchiale prikkelbaarheid als functie van de leeftijd. 
Hoewel het voorkomen van bronchiale symptomen door allergenen en andere 
stimuli de toestand en de reacties van de bronchi tijdelijk bemvloeden, lijkt een toe-
genomen bronchiale prikkelbaarheid bij Cara voornamelijk een zelfstandige factor 
te zijn. 
Praktische betekenis 
De mate van bronchiale prikkelbaarheid geeft een indruk over de kans op 
symptomen bij patienten met Cara. De bronchiale prikkelbaarheid is bij een dee! 
van de patienten permanent verhoogd terwijl deze bij anderen normaal is of dicht 
bij die van gezonden ligt. Het meten van bronchiale prikkelbaarheid is vooral van 
belang voor de volgende groepen: 
a. Personen met luchtwegsymptomen. De aanwezigheid van toegenomen bron-
chiale prikkelbaarheid steunt de diagnose Cara, naast andere diagnostische aan-
wijzingen zoals de anamnese en de aanwezigheid van reversibele bronchus-
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obstructie. 
b. Patienten met Cara. De mate van bronchiale prikkelbaarheid geeft een indruk 
over de kans op het optreden van symptomen. 
c. Patienten met Cara die sinds geruime tijd geheel of vrijwel geheel symptomen-
vrij zijn. De mate van bronchiale prikkelbaarheid geeft een indruk over de mate 
van verbetering en de potentiele kans op recidief. 
De mate van bronchiale prikkelbaarheid heeft mogelijk ook betekenis voor het 
beleid bij de therapie. Bij patienten met een sterk toegenomen bronchiale prikkel-
baarheid is het wenselijk vee! aandacht te geven aan het zoveel mogelijk voorkomen 
van confrontatie met stimuli en aan voldoende bescherming door medicamenten 
bij exacerbaties en zonodig in perioden met een verhoogde kans hierop. 
Aanvullende studies en aanbevelingen 
Aangeraden word! bepaling van de bronchiale prikkelbaarheid regelmatig te 
verrichten bij patienten met Cara. Verdere studies zijn nodig om meer inzicht te 
krijgen in de praktische betekenis en de be!nvloedbaarheid van bronchiale prikkel-
baarheid. Naast studies bij mensen is ook laboratorium- en dierexperimenteel on-
derzoek nodig met betrekking tot de patho-fysiologie en de methoden ter be!nvloe-
ding van de bronchiale prikkelbaarheid. 
Wij geloven dat voortgezet onderzoek in staat zal zijn de factoren te ontrafe-
len die verantwoordelijk zijn voor een verhoogde in plaats van een normale bron-
chiale prikkelbaarheid. Het uiteindelijke doe! is methoden te vinden die verhoogde 
prikkelbaarheid normaliseren op een veilige en effectieve wijze. 
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CHAPTER 10. SUMMARY 
The aim of this thesis was to review the present knowledge of and to report 
our own studies on bronchial responsiveness. 
In Chapter I the motives and questions of the thesis are discussed. Also some 
remarks about definitions, methods and terminology are mentioned. 
A historical view of the development of the study concerning bronchial re-
sponsiveness is given in chapter 2. In chapter 3 attention is paid to the various fac-
tors which may modify the patency of the airways. These include bronchial smooth 
muscles. sensory receptors, parasympathetic and ~- and a.-sympathetic nervous 
systems. as well as release of mediators. The role of these factors in the bronchial 
responsiveness induced by histamine is analysed in chapter 4. The methodology 
regarding the measurement of histamine-induced bronchial responsiveness is 
discussed. A concept of the mechanisms in bronchial obstruction based on results 
from animal studies is presented. This concept is compared with results of studies in 
humans and adapted in order to have a working hypothesis which enables a better 
understanding of the pathophysiology of bronchial responsiveness in humans. In 
chapter 5 these mechanisms are discussed with regard to bronchial responsiveness 
due to exercise. 
Our studies are reported in chapter 6, 7 and 8. 
In paragraph 6.1 the relationship between the dose of inhaled histamine and the 
degree of bronchial obstruction is measured and analyzed with various methods. 
The dose-response relationship has a curvilinear pattern, i.e. a second degree 
polynomial, if the dose is plotted on a logarithmic scale. 
The histamine threshold or the provocation dose is considered as the first 
criterion to quantify the dose-response relationship. It is defined as the histamine 
dose which causes a given change in FEV1• Histamine thresholds, which are calcul-
ated according to various methods and criteria, correlate well, but differ in value. In 
our opinion a second degree regression equation is in general the optimal method for 
the analysis of the dose-response relationship and for the calculation of the 
provocation dose. A linear regression equation tends to give lower threshold values 
than a second degree regression equation. The step method~ i.e. the method which 
defines the threshold as the lowest administered dose after which a given percentage 
change in FEV 1 is reached~ tends to reveal relatively high values with inevitably less 
accuracy. However, the step method is easy to apply and gives a fair estimate of the 
bronchial responsiveness. 
The second criterion to quantify the dose-response relationship is the slope of 
the curve. The slope does not correlate with the threshold and its biological signi-
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ficance is as yet unclear. We have shown that the administration of doses of hista-
mine per inhalation (aerosol) as a geometrical series with an interval of at least 
three minutes, has no accumulative effect up to the threshold dose. 
The method of administration of the stimulus requires standardization. The 
choice of standardized techniques must be based upon reproducibility and simplicity 
in performance. 
Chapter 7 contains studies of the mechanisms of bronchial responsiveness. 
Both inhaled histamine and exercise are used as stimuli for this purpose. The degree 
of bronchial obstruction after exercise correlates well with the histamine threshold. 
This similarity in responsiveness suggests that the causative mechanisms are com-
parable. 
The study in paragraph 7.1 describes results of protection tests afforded by 
various agents on bronchial responsiveness due to exercise. The results suggest that 
exercise-induced bronchial obstruction is generated by mediator release from mast 
cells in combination with a parasympathetic reflex action. If the contribution of each 
factor is assessed by means of protection tests, it appears that the combination of 
their relative contribution approximates to the total bronchial obstructive effect after 
exercise in most of the patients. However, variability is observed between patients. 
The importance of the counteraction of the sympathetic nervous system is apparent 
from the protective effect of sympathomimetics in most patients. This indicates that 
the bronchial smooth muscle ~-receptors are sufficiently functional in these patients. 
It seems probable that the sympathetic counteraction is neither sufficiently strong 
nor sufficiently rapid in the case of bronchial obstruction due to exercise. 
In paragraph 7.2 the degree as well as the site of maximal flow-limitation with 
respect to time in exercise-induced bronchial obstruction is described. In nearly all 
patients bronchial obstruction shortly after exercise is determined by flow-limitation 
in the more peripheral airways. Then the bronchial obstruction gradually diminishes, 
while the site of maximal flow-limitation rapidly returns towards the central airways. 
The protective action of (3-sympathomimetics was most pronounced in patients with 
a relative strong bronchial obstruction and peripherally located site of flow-limita-
tion. 
In paragraph 7.3 and 7.4 the relationship between the releasability of histamine 
from basophilic leucocytes and the bronchial responsiveness is described. The 
amount of histamine release after one hour incubation of 1 mlleucocytes suspension 
without additional agents (spontaneous histamine release) is compared with both 
parameters of bronchial responsiveness in vivo, the histamine threshold and the 
degree of bronchial obstruction after exercise (paragraph 7.3). Paragraph 7.4 reports 
on a study in which the histamine release due to either increase of calcium influx 
(using the calcium ionophore A 23187), induction of microtubular aggregation 
(using deuterium oxide), or stimulation of the IgE receptor (using anti-IgE) is in-
vestigated. The results indicate that the degree of bronchial responsiveness and the 
releasability of leucocytes after calcium influx or stimulation of the microtubules 
are related. We conclude that the behaviour of the microtubules determines the 
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releasability after calcium influx, as well as after stimulation of the IgE and probably 
other receptors. 
Chapter 8 deals with tbe contribution of the bronchial responsiveness in the 
occurrence of bronchial obstruction after the inhalation of allergens and after exer-
cise. 
Paragraph 8.1 shows tbat the degree of bronchial responsiveness and the seve-
rity of the bronchial obstruction after exercise are associated. 
Paragraph 8.2 shows that tbe severity of tbe bronchial obstruction after the 
inhalation of cat dander allergen is not only dependent on tbe degree of sensitization 
to the allergen, but also to tbe degree of the bronchial responsiveness to inhaled 
histamine. 
In a further study (paragraph 8.3) it is shown that tbe bronchial reaction after 
the inhalation of an allergen switched from negative to positive in association with 
an increase in the bronchial responsiveness to histamine. The reverse, the fact that 
a decrease in the bronchial reaction after inhaling an allergen occurs in association 
with a decrease in the bronchial responsiveness, is also observed. 
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Samenvatting 
Het in dit proefschrift beschreven literatuuroverzicht en onderzoek zijn ver-
richt met als doe! inzicht te krijgen in een aantal aspecten van bronchiale prikkel-
baarheid. 
Hoofdstuk I beschrijft de motieven en de vraagstellingen van het onderzoek, 
terwijl ook enkele opmerkingen over definities, methoden en terminologie zijn ge-
maakt. 
In hoofdstuk 2 is in grote lijnen de ontwikkeling in het verleden van het onder-
zoek naar bronchiale prikkelbaarheid weergegeven. 
In het literatuuroverzicht is aandacht besteed aan diverse factoren die de door-
gankelijkheid van de luchtwegen bepalen, zoals het gladde spierweefsel, de sensori-
sche receptoren, het parasympatische, het ~- en a.-sympatische zenuwstelsel, als-
mede het vrijkomen van mediatoren (hoofdstuk 3). In hoofdstuk 4 is een overzicht 
gegeven van de literatuur met betrekking tot de bronchiale prikkelbaarheid voor his-
tamine en in hoofdstuk 5 met betrekking tot inspanning. Hierbij is uitvoerig aan-
dacht besteed aan de meetmethoden bij onderzoek naar reacties op beide stimuli. 
Geprobeerd is vanuit literatuurgegevens over onderzoek bij dieren en mensen een 
beeld te verkrijgen van de pathofysiologie van de bronchiale prikkelbaarheid. 
Het eigen onderzoek is vermeld in de hoofdstukken 6, 7 en 8. 
In hoofdstuk 6.1 is_ de relatie tussen de dosis ge!nhaleerde histamine en de 
bronchiale respons beschreven alsmede verschillende berekeningsmethoden. waar-
mee deze kan worden gel<.wantificeerd. De dosis-response relatie is op een semi-
logarithmische schaal curvilineair, d.w.z. kan beschreven worden met een tweede 
machts polynoom, indien de dosis op een logarithmische schaal is uitgezet. 
Als eerste karakteristiek is de drempelwaarde of de provocatie dosis bestu-
deerd. Hieronder wordt de histamine concentratie verstaan, na welke een bepaalde 
mate van daling van het expiratoire 1 seconde volume (FEV 1) optreedt, Drempel-
waarden die zijn berekend met verschillende analysemethoden en volgens verschil-
lende criteria, hangen in hoge mate samen, maar verschillen in absolute zin. De 
beste benadering is in het algemeen vanuit een kwadratische analyse van de dosis-
respons relatie. Een lineaire analyse leidt tot systematisch lagere en de vee! ge-
bruikte stapmethode, waarbij de drempel de toegediende histamine concentratie is 
waarna een significante daling van het FEV 1 optreedt, tot systematisch hogere 
waarden. Op grond van de geringe verschillen en de hoge correlatie tussen de 
uitkomsten van de verschillende analysemethoden, lijken de verschillen tussen deze 
methoden geen grote biologische betekenis te hebben. 
Als tweede karakteristiek van de dosis-respons relatie wordt de helling van de 
curve beschouwd. Tussen deze en de histaminedrempel bestaat geen verband. De 
biologische betekenis van de helling is nog onduidelijk. Bij de toegepaste procedure. 
waarbij histamine in oplopende concentraties met intervallen van 3 minuten wordt 
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toegediend tot aan de drempel, treedt geen cumulatie op. Bij hogere concentraties 
moet hiermee in principe wel rekening worden gehouden. 
De kennis omtrent de invloed van variabelen bij toediening van stimuli per 
aerosol is nog lacunair, doch het is duidelijk dat standaardisatie nodig zal zijn ten-
einde vergelijkbare resultaten te verkrijgen. Praktische uitvoerbaarheid en een zo 
goed mogelijke reproduceerbaarheid van elk onderdeel van de methodiek zijn be-
langrijke voorwaarden voor de keuze van de gestandaardiseerde bepalingswijze van 
de bronchiale prikkelbaarheid. 
Bij de onderzoekingen naar de mechanismen die een rol spelen bij de prikkel-
baarheid zijn inspanning en inhalatie van histamine als stimuli toegepast. De sterkte 
van de bronchusobstructie na inspanning is in hoge mate gecorreleerd met de 
histamine provocatiedosis (hoofdstuk 7.1 en 7.3). Dit suggereert dat de er aan ten 
grondslag liggende mechanismen in belangrijke mate overeenkomen. 
In hoofdstuk 7.1 is het onderzoek beschreven waarin deze ten aanzien van in-
spanning zijn bestudeerd. Hierbij is gebruik gemaakt van medicarnenteuze blokke-
ring en stimulatie. Bronchusobstructie door inspanning ontstaat waarschijnlijk via 
een vagus reflex in combinatie met activatie van mestcellen. Hoewel het effect van 
remming van elke factor afzonderlijk van patient tot patient varieert, komt de som 
van beide remmingseffecten vaak ongeveer overeen met een volledige bescherming. 
Algemeen wordt aangenomen dat het sympatische systeem een belangrijke rol 
speelt bij de regulatie van de tonus van het bronchiale gladde spierweefsel, en wel des 
te meer naarmate bronchusobstructie toeneemt. Uit het feit dat toediening van een 
sympathicomimeticum meestal volledig beschermt tegen bronchusobstructie door 
inspanning, hebben wij geconcludeerd dat de gevoeligheid van het eindorgaan voor 
sympatische pn\keling voldoende is. Het lijkt daarom waarschijnlijk dat de sympa-
tische tegenregulatie (circulerende catecholaminen, sympatische innervatie) bij 
patii!nten met bronchusobstructie na inspanning niet adequaat is. 
In hoofdstuk 6.2 is het onderzoek naar het verloop van de sterkte van de bron-
chusobstructie en de plaats van de maximale stroomsnelheid-limitering bij inspan-
ning beschreven. Kort na inspanning schuift deze plaats in de richting van de 
longblaasjes op en wel des te meer naarmate de bronchusobstructie sterker is. 
Daarna vermindert de bronchusobstructie langzaarn terwijl de plaats van de 
maximale stroomsnelheidlimitering snel naar de centrale luchtwegen teruggaat. Het 
beschermend effect door stimulatie van ~-sympatische receptoren is het meest 
uitgesproken bij patii~nten met een sterke bronchusobstructie bij wie de plaats van 
de maximale stroomsnelheid-limitering ver naar de longblaasjes is verschoven. 
In de hoofdstukken 7.3 en 7.4 is de samenhang beschreven tussen prikkel-
baarheid op celniveau in vitro, met name van leucocyten~ en de bronchiale prikkel-
baarheid. Uit een eerste studie hierover (hoofdstuk 7.3) blijkt dat de spontane 
histamine release uit leucocyten gemiddeld hoger is bij Cara patienten met een toe-
genomen bronchiale prikkelbaarheid voor histamine en inspanning dan bij perso-
nen met een !age bronchiale prikkelbaarheid. 
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In hoofdstuk 7.4 zijn de resultaten besproken van voortgezet onderzoek naar 
de prikkelbaarheid van leucocyten. Bestudeerd zijn het vrijkomen van histamine na 
stimulering van de calciuminflux (met de calciumionofoor A 23187), na aktivering 
van de microtubuli (met deuterium oxide) en de lgE-receptor (met anti-IgE). De 
uitkomsten wijzen erop dat de prikkelbaarheid van de basofiele leucocyten, waarbij 
het vrijkomen van histamine de indicator is en de mate van bronchiale prikkelbaar-
heid corre!eren. Wij hebben geconcludeerd dat het gedrag van de microtubuli in 
belangrijke mate de prikkelbaarheid van basofiele leucocyten, zowel na niet-
al!ergene als na al!ergene prikkels, bepaalt. 
In de derde groep studies is de correlatie tussen de mate van bronchiale prik-
kelbaarheid en de bronchiale reactie door enke!e stimuli onderzocht. In hoofdstuk 
8.1 zijn die gegevens uit de hoofdstukken 7.1 en 7.3 gegroepeerd welke de samen-
hang beschrijven tussen de mate van bronchiale prikkelbaarheid en de sterkte van 
de bronchusobstructie door in spanning. N aarmate de bronchia!e prikkelbaarheid 
voor histamine toeneemt, is de sterkte van de bronchusobstructie na inspanning 
grater. 
Bij het ontstaan van bronchusobstructie na inhalatie van kattehuidschilferaller-
geen is een toegenomen bronchiale prikkelbaarheid van essentieel belang naast de 
al!ergeen sensibilisatie (hoofdstuk 8.2). 
In hoofdstuk 8.3 word! aangetoond dat een toename in sterkte van de bron-
chiale prikkelbaarheid en van de bronchiale reactie na allergeeninhalatie samengaan 
en omgekeerd. Hieruit blijkt dat de bronchiale prikkelbaarheid niet aileen van essen-
tieel belang is voor het reactiepatroon na allergeeninhalatie en waarschijnlijk ook 
van diverse andere prikkels, maar tevens kan verklaren waarom bepaalde patienten 
soms wel en soms niet op prikkels reageren. 
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De scbrijver van dit proefscbrift werd in 1943 te Den Burg (Texel) geboren. In 
1962 behaalde bij bet diploma HBS-B aan de "Rijks HBS-Texel". Hiema stu-
deerde bij geneeskunde aan de Universiteit van Amsterdam, waar in 1970 het arts-
diploma werd bebaald. De studie werd een half jaar onderbroken voor een studen-
tenassistentschap op de afdeling Pathologische Anatomie aldaar (hoofd: Prof. Dr. 
C. Wagenvoort). 
Van 1970 tot 1974 specialiseerde hij zicb in de pediatrie in bet Sophia Kinder-
ziekenbuis/ Academiscb Ziekenbuis Rotterdam (hoofd van de afd. Kindergenees-
kunde: Prof. Dr. H. K. A. Visser). Op 1 juni 1974 werd bij als kinderarts in bet 
specialistenregister ingeschreven. In 1974 en 1975 vervulde hij de functie van chef 
de clinique (algemene Kindergeneeskunde). Sindsdien is hij werkzaam als weten-
scbappelijk boofdmedewerker op de afdeling longziekten (hoofd: Prof. Dr. K. F. 
Kerrebijn) in betzelfde instituut. 
N aast kliniscbe werkzaamheden en onderzoek bield hij zich bezig met onder-
wijs. vooral ten behoeve van de specialistenopleiding, o.a. als voorzitter van de arts-
assistenten opleidingscommissie en de algemene onderwijscommissie. Daarnaast 
werden een aantal bestuurlijke en commissiefuncties vervuld, zowel in als buiten het 
kader van bet Academiscb Ziekenhuis Rotterdam. 
Hij is getrouwd met Suzanne Plasschaert en heeft twee kinderen: Karlien en 
Floortje. 
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